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Abstract 
Evidence suggests haematopoietic stem cells (HSCs) can migrate to injured liver and 
influence tissue repair.  However, the molecular adhesive mechanisms governing HSC 
recruitment to injured hepatic microcirculation are poorly understood.  These mechanisms 
were investigated in vivo following murine hepatic ischemia-reperfusion (IR) injury. HSC 
adhesion was significantly enhanced in injured livers and could be reduced by blocking 
CD49d on HSCs or VCAM-1 in vivo. Blockade of HSC CD18, CD31 or CD44 did not alter 
adhesion. HSC adhesion in sham treated CD31-/- animals was raised compared to wild-type 
animals and IR injury did not further raise this adhesion. Studies in vitro demonstrated that 
HSC treatment with inflammatory cytokines or conditioned media/plasma did not 
upregulate adhesion molecule expression but CXCL12 and CXCL1 did significantly enhance 
HSC adhesion to endothelium. However, blockade of CXCR4 (CXCL12 receptor) failed to 
reduce HSC adhesion in vivo following IR injury. Furthermore, we demonstrated exogenous 
HSCs were identified primarily in the pulmonary circulation and intraportal injection raised 
recruitment within the liver irrespective of the presence of injury.  This study provides novel 
evidence for the importance of the VLA-4/VCAM-1 pathway in HSC recruitment to IR 
injured liver, a pathway that may be manipulated in order to enhance hepatic engraftment 
of these cells clinically.   
  
 
 
  
 
“Bernard of Chartres used to say that we are like dwarfs on the shoulders of giants, so that 
we can see more than they, and things at a greater distance, not by virtue of any sharpness 
of sight on our part, or any physical distinction, but because we are carried high and raised 
up by their giant size.” 
John of Salisbury, Metalogicon, 1159 
 
“The doubter is a true man of science; he doubts only himself and his interpretations, but he 
believes in science.”   
Claude Bernard 
 
“If The Flintstones has taught us anything, it's that pelicans can be used to mix cement.” 
“I saw this movie about a bus that had to SPEED around a city, keeping its SPEED over fifty, 
and if its SPEED dropped, it would explode! I think it was called, ‘The Bus That couldn't Slow 
Down’.” 
Homer Simpson 
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1.  General Introduction 
 
1.1.  Hepatic disease and dysfunction 
Liver disease is the UK’s fifth biggest killer and is the only one of the top five on the rise 
(British Liver Trust, 2008). Hepatitis, or inflammation of the liver, is a feature of most acute 
and chronic hepatic diseases and results in the accumulation of inflammatory effector cells 
such as neutrophils and lymphocytes within the liver tissue. The underlying cause of 
hepatitis varies, including hepatotropic viruses (hepatitis virus A-E), herpes viruses (such as 
CMV and EBV) as well as injury induced by alcohol, autoimmune, metabolic and drug 
induced mechanisms. Regardless of the causative mechanism, the outcome of hepatic 
inflammation is broadly similar, although the severity of inflammation varies greatly.  Some 
conditions resolve spontaneously (most cases of hepatitis A and E), while others become 
chronic (hepatitis C and untreated autoimmune diseases) and may progress to cirrhosis and 
chronic liver failure. In others, hepatocellular damage is so severe that the patient develops 
acute or subacute hepatic failure, potentially leading to multiple organ dysfunction 
syndrome and death. In both acute and chronic liver failure treatment options are limited 
to hepatic transplantation. However, the number of available cadaveric livers in recent 
years has fallen rapidly, leading surgeons to turn to marginal livers (Angelico, 2005) or, 
increasingly in many countries to living donor liver transplantation (Abbasoglu, 2008).  
 
1.1.1.  Cellular therapy for hepatic disease  
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Cellular therapies have been used for the treatment of various liver diseases. Indeed, work 
spanning three decades has suggested that hepatocyte transplantation may be useful in the 
treatment of metabolic liver disease where there is an underlying genetic defect that is 
either wholly or predominantly restricted to the hepatocyte. Exogenous hepatocyte 
administration has shown potential benefits in animal models for numerous disorders, such 
as Crigler-Najjar syndrome, hereditary tyrosinaemia and familial hypercholesterolemia (Fox 
and Chowdhury, 2004). Unfortunately, the frequency of liver repopulation from donor 
hepatocytes is low, although inhibition of host hepatocyte regeneration improves the 
seeding efficiency of exogenously introduced hepatocytes (Laconi et al., 1998). 
Furthermore, improvements observed in human trials are dependent largely on the 
hepatocyte origin and route of injection (Ohashi et al., 2001). In a rat model, systemic 
introduction of hepatocytes via the femoral artery resulted in low levels of liver 
sequestration (2% of injected hepatocytes) and high levels of pulmonary recruitment (30%). 
In the same study, injection of hepatocytes via the portal vein resulted in much greater 
hepatic engraftment (52%)  (Picardo et al., 1996).  
 
1.1.2.   Bone marrow derived cells for hepatic regeneration - role of cell 
differentiation  
Relatively recent reports challenged the long-standing dogma that the differentiation 
pathways of cells are strictly defined (Slack and Tosh, 2001).This phenomena, termed 
transdifferentiation or metaplasia, is observed when a cell of one lineage adopts the 
phenotype of another lineage without first dedifferentiating into a more primitive cell or 
precursor. The potential for transdifferentiation has brought about much interest from the 
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field of tissue repair, especially for restoration of tissue damaged by degenerative diseases 
(Gussoni et al., 1999). Bone marrow (BM) cells have received increasing clinical interest as a 
source for cellular therapy and more specifically bone marrow progenitor cells (BMPCs).  
The BM is soft tissue found within the interior of most of the major bones and is 
responsible for maintaining haematopoiesis. It consists of a wide mix of cell types, including 
immature leukocytes (termed blast cells), lymphocytes and progenitor cells, housed within 
a complex supporting environment termed the BM stroma (Krebsbach et al., 1999).  
 
Seminal studies by Petersen and colleagues first identified BM derived cells (BMDCs) as a 
potential source of hepatocytes and hepatic oval cells (Petersen et al., 1999). In this study, 
female rats were lethally irradiated and rescued with male BM. Animals were subsequently 
treated with 2-AAF to block endogenous hepatocyte proliferation and with CCl4 to induce 
hepatic injury. Y-chromosome positive oval cells were detected at day 9 and day 13 post 
transplant, while Y-chromosome positive hepatocytes could be detected only at day 13. 
This suggests initial repopulation of the hepatic oval cells, which then subsequently 
differentiate and repopulate hepatocytes by day 13 post transplant. This finding was 
confirmed by the studies of Theise and colleagues (2000a). Female mice were subject to 
irradiation prior to administration of male BMDCs. Recipients were subsequently tested for 
expression of the male chromosome. All mice tested at 2 months displayed some degree of 
Y-chromosome positivity in the liver, suggesting hepatocyte generation from donor cells. It 
should be noted that in this study, there was no prior injury except for irradiation (which in 
itself is insufficient to cause severe hepatic injury) suggesting that hepatocyte generation 
from BMDCs may play a role in basal tissue renewal. Subsequent work by Alison and co-
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workers also implicated BMDCs in human hepatic regeneration (Alison et al., 2000). Livers 
were examined from both female patients who had received a BM transplant from a male 
donor, and males who had received a liver transplant from a female donor. In both cases, 
donor derived cells expressing hepatic markers could be detected in the liver. 
 
Subsequent work sought to clarify the functional relevance of this recruitment. Lagasse et 
al injected BMDCs into the Fah-/- knockout mouse which represents a model of familial 
tyrosinemia (Lagasse et al., 2000). Lack of the enzyme fumarylacetoacetate hydrolase leads 
to the build up of toxic levels of tyrosine which is responsible for the injury. In this model, 
they found that injection of 1 x 106 unfractionated donor BM cells into Fah-/- mice 
generated large nodules of functional, donor derived hepatocytes accounting for up to 30-
50% of liver mass. More importantly, this large engraftment was accompanied by an 
improvement in biochemical liver function.  
 
In order to identify the cell type responsible for this improved outcome, Lagasse and 
colleagues purified haematopoietic stem cells (HSCs) from BM and used these for 
transplantation into Fah-/- mice. They found that only the HSC population led to wide 
repopulation in mutant mice, with other purified populations having relatively little hepatic 
potential. The specific importance of the HSC fraction in tissue repair was re-enforced by 
work carried out in other organs. It was shown that direct injection of HSCs, defined as Lin- 
c-kit+, into the infarcted left ventricular wall resulted in widespread regeneration and 
improved cardiac function scores.  Similar regeneration was not seen with Lin- c-kit- cells 
(Orlic et al., 2001a). 
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Research from the Grompe laboratory demonstrated in the Fah-/- mouse that hepatic 
engraftment by donor cells occurred even without the presence of injury, further 
suggesting that BMDCs play a role in basal hepatic turnover and repair (Wang et al., 2002). 
However, they found that transplanting enriched HSCs did not enhance hepatocyte 
replacement beyond that seen with whole BM transplantation. A major finding of the study 
was that hepatocyte replenishment did not occur without prior irradiation, suggesting that 
haematopoietic engraftment within the BM was an essential prerequisite for hepatocyte 
replenishment.  
 
Work by the Weissman lab published in Science (Wagers et al., 2002) further examined the 
ability of HSCs to transdifferentiate by injecting a single GFP-marked BM derived HSC into 
lethally irradiated recipients. Analysis of tissues at 4-9 months post-transplant showed GFP+ 
cells present in both the brain and the liver, although the frequency of this 
transdifferentiation was very low. GFP+ cells were shown to form viable Purkinge cells and 
hepatocytes, suggesting that HSCs do indeed possess some potential for 
transdifferentiation. However, the authors stated that HSC transdifferentiation was an 
‘extremely rare event if it occurs at all’.   
 
The plastic potential of HSCs was further addressed in a paper by Jang et al,  where HSCs 
were treated in a porous transwell system with humoral factors released from CCl4 injured 
hepatic tissue (2004). Incubation of HSCs with injured liver tissue resulted in a phenotypic 
shift in the HSCs, which began expressing the hepatic marker cytokeratin-18.  Another 
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recent study by Khurana and Mukhopadhyay also confirmed the ability of HSCs to undergo 
transdifferentiation in vitro after incubation with CCl4 injured liver (2008). Expression of 
albumin, CK-18 and hepatocyte enzymes were seen in transdifferentiated cells. 
Importantly, both studies demonstrated hepatic engraftment of transdifferentiated cells 
when injected into recipients (Jang et al., 2004, Khurana and Mukhopadhyay, 2008).  
 
1.1.3.   Role of Cell Fusion in Hepatic Regeneration 
A number of studies have raised doubts about whether transdifferentiation actually occurs, 
with subsequent studies demonstrating that adult stem cells spontaneously fuse with host 
cells and take on their characteristics.  It was suggested that this event may have been 
misinterpreted as transdifferentiation in previous studies.  Ying and colleagues 
demonstrated that cells isolated from the embryonic stem cells could fuse with cells from 
peripheral tissues and undergo reprogramming (Ying et al., 2002). Further studies 
implicated similar fusion mechanisms in therapeutic liver repair. In serial transplantation 
studies, Wang et al  showed that BM derived hepatocytes were formed by cell fusion 
(2003). Animals received BM from donors which were Fancc-/- (Fanconi anaemia group C 
gene). These animals have no hepatic disorder and were solely used as they provided a 
genetically traceable marker for subsequent analysis. Hepatocytes isolated from tertiary 
recipients had lost the Fancc-/- phenotype, indicating that their formation did not arise from 
transdifferentiation alone. The authors also noted various chromosomal abnormalities 
suggesting male/female cell fusion, including 80-XXXY, 120-XXXXYY and 144-4X4Y. It should 
be noted that transdifferentiation could not be totally ruled out in this study; some 40-XX 
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hepatocytes were detected in male livers who had been the recipients of female BM. Again, 
HSC engraftment was essential before hepatocyte replenishment was seen. 
 
A study by Newsome and colleagues examined the role of human cord-blood derived 
progenitor cells in hepatic regeneration (2003). In this study, human cord blood progenitor 
cells were shown to be rich in haematoprogenitor cells and to stably engraft NOD/SCID 
mice at 8 weeks post transfusion. Human hepatocytes could be detected  in the liver of 
NOD/SCID mice at four, six and sixteen weeks post transfusion. Importantly, this study 
could not find any evidence for cell fusion.  Detected human hepatocytes in NOD/SCID mice 
did not express mouse DNA suggesting fusion had not occurred. In terms of therapy, the 
level of engraftment observed in this study was relatively low.  At most, 0.17% of 
hepatocytes in NOD/SCID liver were human in origin. Whether this frequency is relevant 
therapeutically is unclear.  
 
1.1.4.   Role of HSC Progeny in Hepatic Regeneration 
The prior need for haematopoietic engraftment within the BM suggested that HSC progeny 
may be responsible for hepatic regeneration, rather than (or in addition to) HSCs 
themselves. This was further examined by Willenbring and colleagues using the Fah-/- 
animal model (Willenbring et al., 2004). Transplantation studies revealed that macrophage 
progenitors or pure populations of macrophages were sufficient for hepatocyte 
replacement.  Indeed macrophage fusion has been documented for some time, especially in 
the formation of osteoclasts (Vaananen and Laitala-Leinonen, 2008).  Willenbring and 
colleagues further highlighted the specific importance of macrophages as lymphocytes 
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were not critical for hepatic replenishment.  Animals, transplanted with HSCs isolated from 
Rag1-/- animals (which are unable to form lymphocytes) displayed similar levels of 
hepatocyte replacement to those receiving wildtype HSCs (Willenbring et al., 2004).  
 
1.1.5.  Paracrine functions of stem cells 
Building evidence suggests stem cells are able to contribute to tissue repair via paracrine 
anti-inflammatory mechanisms. In the paw odema model of murine inflammation, tail vein 
administration of fetal-liver derived HSCs significantly reduces paw weight, lymphatic organ 
weight and TNFα release following injury (Biziuleviciene et al., 2007). Following transient 
cochlear ischemia in gerbils, intrascalar injection of HSCs significantly ameriolates hearing 
loss by inducing expression of glial cell line-derived neurotrophic factor (Yoshida et al., 
2007). Mounting evidence suggests that MSCs may possess more potent anti-inflammatory 
abilities than HSCs. Indeed, administration of MSCs following renal IR injury ameliorates 
injury through differentiation independent mechanisms (Tögel et al., 2005). In the study by 
Togel et al, reduced pro- and increased anti-inflammatory cytokine expression was noted 
just 24 hours after injury in MSC treated animals when compared to controls.  
 
 
1.1.6.    Mobilisation of HSCs after Hepatic Injury 
Mobilization of HSCs by granulocyte-colony-stimulating factor (G-CSF) has also been 
observed to ameliorate CCl4 induced liver injury. Furthermore, these mobilized HSCs were 
able to promote host hepatocyte repair (Yannaki et al., 2005). Such reparative functions of 
mobilised HSCs are not limited to the liver.  Orlic et al demonstrated that stem cell factor 
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(SCF) and G-CSF led to a 250-fold increase in Lin− c-kit+ cells in the circulation which resulted 
in more circulating HSCs were available to home to infarcted heart and promote repair.  
Indeed, this mobilisation protocol enhanced heart function post infarct and led to a 
significant increase in survival rates post injury (Orlic et al., 2001b). Furthermore, BM cells 
mobilized by G-CSF improve renal function and animal survival following acute renal injury. 
This effect was shown to be wholly reliant on BM mobilization as ablation of the BM by 
irradiation removed the protective effect of G-CSF treatment (Iwasaki et al., 2005). In a 
model of murine renal IR injuy, mobilization of HSCs with SCF/G-CSF reduces damage by 
lowering granulocyte migration to the kidney (Stokman et al., 2005). 
  
1.1.7.   Clinical Trials 
As a result of these initial studies, clinical trials have been initiated that investigate the role 
of stem cells in hepatic injury. To date, there are at least 11 published studies of clinical 
trials using BM cells for hepatic disease, namely cirrhosis (Houlihan and Newsome, 2008). In 
a study by Gaia et al, eight patients with liver cirrhosis were treated 12 hourly for 3 days 
with a 5μg/kg dose of G-CSF to induce progenitor cell mobilization (2006). This dose led to 
robust peripheral mobilization of CD34+ progenitor cells (over thirteen times that seen in 
untreated controls). Clinical improvement was observed in six of the eight patients at 
follow-up (between 5-17 months). Although the authors note peripheralisation of CD34+ 
progenitor cells, this study does not investigate any direct effects of G-CSF on the injured 
liver. This is important, as it has been suggested G-CSF acts directly on vascular and tubular 
cells in the kidney (Nishida and Hamaoka, 2006). Furthermore, G-CSF mobilizes other cell 
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populations, including endothelial progenitor cells and monocytes (Capoccia et al., 2006, 
Takahashi et al., 1999). 
 
This latter point has been addressed by a number of clinical trials which have used sorting 
techniques to administer specific subsets of cells to patients. In a study by Gordon and 
colleagues, five patients with liver insufficiency were treated with a subset of autologous 
CD34+ cells collected by leukapheresis following G-CSF treatment  (2006). Injection of 
between 1 x 106 and 2 x 108 CD34+ cells resulted in a fall in serum bilirubin and an increase 
in serum albumin at follow-up after 60 days. A subsequent study of the same patients was 
published after 12-18 months follow-up.  Four out of the five patients had maintained 
raised serum albumin levels for at least six months (Levicar et al., 2008). It is important to 
consider that these studies used G-CSF to mobilize CD34+ progenitor cells for leukapheresis 
and the authors did not take into consideration any direct effect of G-CSF on hepatic injury.  
 
Mohamadnejad and colleagues infused 2.5 – 8.0 x 106 magnetically separated autologous 
CD34+ cells into four patients with liver cirrhosis (2007). Cells were obtained from 200ml of 
BM isolated from the iliac crest and reintroduced, after CD34 sorting, via the hepatic artery. 
At two weeks post procedure, one patient died as a result of renal and hepatic failure. 
Another patient in the study had an onset of renal failure at 5 months post procedure. 
Although all patients displayed some improvement in serum albumin levels, they also had 
worsened MELD scores (model for end-stage liver disease) which is a quantitative scale of 
liver disease. Results from this study raise serious concerns regarding the safety of stem cell 
administration via the hepatic artery. The development of hepatorenal dysfunction appears 
Chapter 1: General Introduction 
12 
to be specific either to the volume or type of cells administered.  However, a study from a 
Brazilian group infused 1 x 108 unsorted mononuclear cells via the hepatic artery with no 
mortality (Lyra et al., 2007).  
 
1.1.8.  Mechanisms underlying stem cell therapy – an overview 
The mechanisms involved in HSC mediated repair of the liver are not clear. The literature 
currently suggests that it is in fact HSC progeny that perform restorative functions in the 
liver following injury rather than HSCs per se. A number of groups have shown that BM-
derived progeny are responsible for the therapeutic liver repair in the Fah-/- knockout 
mouse implicating a potential role for BM engraftment prior to therapeutic benefit (Wang 
et al., 2003, Vassilopoulos et al., 2003). In the Fah-/- injury model, repopulation of the liver 
by donor BM derived cells can not be identified without preparative whole body irradiation, 
further suggesting that donor cell engraftment of the BM is required for liver regeneration 
(Wang et al., 2002). The role of direct recruitment of HSCs to the liver is unclear.  
 
The primary mechanism by which HSCs and BM cells provide therapeutic benefit in the liver 
is likely to be via cell fusion with the majority of the literature now supporting this process. 
The role of transdifferentiation appears minor, although many studies do confirm the 
existence of the phenomena – even in papers that predominantly propose cell fusion as the 
majoritive mechanism (Wang et al., 2003). While MSCs do hold some potential in terms of 
paracrine activities at sites of injury, this may not represent a major mechanism for HSC 
mediated benefit as the evidence for this behavior in HSCs has not been shown in major 
injury models such as IR injury. 
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1.2.  Bone Marrow Stem Cells 
 
1.2.1.  Haematopoietic stem cell definition and function 
HSCs are the stem cells responsible for maintenance of homeostasis through continual 
replenishment of all of the various cellular components of the blood such as lymphocytes, 
leukocytes and erthyocytes (Figure 1.1). HSCs were identified in the early 1960s by Till & 
McCulloch as “colony forming units (CFUs)”; defined as cells which were able to give rise to 
haematopoietic nodules in the spleen following transplantation of BM into irradiated 
animals (Till and McCulloch, 1961, Till et al., 1964).  
 
The classical definition of a stem cell infers two properties; self-renewal and potency. In 
terms of self-renewal, the cell must be capable of division, where at least one daughter cell 
retains the phenotype of the parent cell. This is critical to maintain the stem cell pool. In 
terms of potency, the cell must be capable of differentiation into more specialized cell 
types, distinct from the mother cell. The majority of stem cell populations are either 
totipotent (able to form all cell types) or pluripotent (form multiple tissues/organs). Some 
stem cells are unipotent, in that they are only able to differentiate into one cell type 
(hepatocytes are unipotent stem cells).  
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HSC 
CMP 
Pre-T cell 
Meg-CFC 
Mast-CFC 
Eo-CFC 
GM-CFC 
BFU-E 
                 
Pre-B cell CLP 
Erythrocytes 
CFU-E 
Neutrophils 
 
Macrophages 
Eosinophils 
Basophils 
Mast Cells 
  Platelets 
Megakaryocyte 
T-cells  
B-cells  
Figure 1.1. The Haematopoietic System. The haematopoietic system is maintained by 
differentiation of HSCs into more committed progenitors. HSCs primarily differentiate 
into Common Lymphoid Progenitors (CLP) and Common Myloid Progenitors (CMP). 
These progenitor cells then undergo rounds of differentiation and specialize to form 
the multitude of cells of the blood. Adapted from a figure from Blood Lines (Metcalf, 
2005). 
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1.2.2.  Haematopoietic stem cell identification and isolation 
HSCs are found in the BM of the major bones of the body, such as the femur and the tibia. 
They are typically isolated based on surface marker expression, with the most common 
defining population being c-kit+ Sca-1+ Lin- (KSL) (Wognum et al., 2003). Recent work has 
also suggested endothelial protein C receptor (CD201) be used as an additional marker of 
HSCs in murine BM (Balazs et al., 2006). In humans, CD34 is commonly used as a 
stem/progenitor cell marker (Civin et al., 1984) although this is unsuitable in mice because 
up to 90% of adult murine HSCs do not express this marker (Osawa et al., 1996). HSCs can 
also be isolated based on their cellular phenotypes. A small population of cells, termed the 
Side Population (SP), exists in BM and is found to be highly enriched for HSCs. Goodell et al  
demonstrated that a small subset of BM cells, which could be characterized by their ability 
to efflux Hoescht 33342, are highly enriched for repopulating HSCs (1996). 
 
1.2.3.  Other bone marrow stem cell populations 
The BM is made up of a number of other stem cell populations in addition to HSCs. 
Mesenchymal stem cells (MSCs) give rise to the connective tissues of the body, such as 
osteoblasts, myocytes and adipocytes. Adipose derived adult stem cells (ASCs) possess 
many of the characterstics of MSCs and are commonly regarded as a population of MSCs 
located within a different anatomical compartment to ‘traditional’ MSCs. The term 
mesenchymal stem cell is under some debate, as they do not appear to maintain 
characteristics of the mesenchyme (they cannot differentiate into HSCs). Other terms given 
to this population include marrow stromal cells, multipotent stromal cells and 
mesenchymal stromal cells. 
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Endothelial progenitor cells (EPCs) are circulating, BM-derived cells believed to be 
important in vascular maintenance and vasculogenesis. These cells are thought to derive 
from hemangioblasts, which themselves are derived from HSCs (Grant et al., 2002). Tissue 
committed stem cells (TCSCs) have also been found in the BM and give rise to cells that are 
responsible for repairing individual tissues. Cells expressing early liver markers (such as α-
fetoprotein and CK19) have been shown to be located in the BM and possess the ability to 
mobilize into the blood upon trauma (Kucia et al., 2004). It is thought these cells may act as 
a ‘reserve pool’ for tissue repair. Such cells are also resident within the tissues they 
replenish (Majka et al., 2005). The BM also contains multipotent adult progenitor cells 
(MAPCs) which are able to differentiate into mesenchymal cell types, as well as 
endothelium, neural cells and hepatocytes (Schwartz et al., 2002). Interestingly, when 
MAPCs are injected into early blastocysts, they contribute to almost all somatic cells (Jiang 
et al., 2002).  
 
1.3.  Mechanisms of stem cell recruitment 
The surface adhesion molecule profile of HSCs is similar to that of mature leukocytes, likely 
consistent with the fact that leukocytes are derived from HSCs (Becker et al., 1999, Chan 
and Watt, 2001). Studies of HSC recruitment in the BM suggest similar adhesive events 
govern recruitment of HSCs and mature leukocytes and will be discussed later. Although 
our understanding of HSC recruitment to the BM is increasing, little is known about HSC 
recruitment to extra-medullary non-BM sites. An increased understanding of the molecular 
adhesive mechanisms which HSCs use to find their way into damaged or inflamed tissues 
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may give us a starting point from which to manipulate recruitment to enhance regeneration 
and repair.  
  
1.3.1.  Inflammation and the leukocyte adhesion cascade 
The major elements of the leukocyte adhesion cascade that take place during inflammation 
will be discussed further as HSC recruitment appears to follow a similar pattern as identified 
from studies conducted within the BM.  Inflammation is the localised protective reaction to 
irritation, injury or infection mediated by the immune system. The immune system is 
comprised of five classes of leukocytes (neutrophils, eosinophils, basophils, lymphocytes 
and monocytes), which together form the innate and the adaptive arms of the immune 
response. The innate response is the immediate or first line of immune defence against new 
pathogens.  It requires no prior exposure to the pathogen and is activated in response to 
recognition by pattern-recognition receptors (PRRs) of broad ranges of pathogen-specific 
molecular structures (Akira et al., 2006). Upon infection or tissue damage, resident tissue 
cells are activated to secrete cytokines and subsequently leukocytes (neutrophils and 
macrophages) from the innate immune system are recruited into the target area from the 
circulation. Once within the tissue, neutrophils and macrophages clear invading micro-
organisms and damaged cells by engulfment / phagocytosis.  
 
To complement this innate activity, the body has an adaptive immune response, of which 
the effector cells include T- and B-cells. Although the adaptive immune response occurs 
later (7-10 days), it has the benefit of antigenic specificity and immune memory, in that 
subsequent exposure to the same pathogen results in a rapid specific immune response 
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from memory T and B-cells. Recruitment of the cellular components of the immune system 
is increased in response to underlying tissue damage or infection. Recruitment of effector 
leukocytes into inflamed tissue from blood is mediated primarily at the level of the local 
vascular endothelium, which up-regulates cell adhesion molecules (CAMs) on the cell 
surface in response to factors released from the underlying tissue.  The ability of 
endothelium to selectively up-regulate combinations of adhesion molecules and 
chemokines allows it to promote the recruitment of specific types of leukocyte to areas of 
inflammation. 
 
The concept of leukocyte capture from flow has been known since the observations of 
Cohnheim some 130 years ago (Cohnheim, 1877). Since then, our understanding of 
leukocyte recruitment has increased exponentially. The leukocyte recruitment paradigm, in 
its current form, was initially proposed by Butcher and has tethering, rolling, firm adhesion 
and endothelial transmigration as its main dynamic components (1991).   The adhesion 
cascade and the major CAMs involved are summarized in Figure 1.2.    
 
1.3.1.1. Leukocyte Capture and Rolling 
Blood flow velocity in human skin capillaries is approximately 0.5 mm/sec as detected by 
laser Doppler (Stucker et al., 1996). Unsuprisingly, leukocytes must be slowed and captured 
from the prevailing flow if they are to have stable interactions with the local vascular 
endothelium. This capture step usually involves a phase of rolling in which the leukocyte 
rolls along the vessel wall as an essential prerequisite to stable adhesion in vessels with 
high flow. The majority of rolling interactions are mediated by a group of adhesion 
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molecules called the selectins, so named for their similarity to C-type lectins (Rosen and 
Bertozzi, 1996). Selectins are Ca2+-dependent transmembrane adhesion proteins found 
both in vascular endothelium and on circulating leukocytes. A total of three selectins have 
been identified. E-selectin is found on endothelium, P-selectin on endothelium and 
platelets and L-selectin on leukocytes. 
 
1.3.1.1.1. E-selectin 
Expression of E-selectin, a Type I transmembrane glycoprotein, on inactivated endothelium 
in most tissues is negligible but is rapidly induced following treatment with cytokines 
(Brewer and Dam, 2000). Hypoxia is unable to directly mediate up-regulation of E-selectin 
on isolated endothelial monolayers (Zund et al., 1996), although up-regulation is seen in 
vivo following ischaemia-reperfusion injury (Burke et al., 1998), suggesting an indirect role 
of hypoxia in regulating this endothelial selectin. The ligands for E-selectin are expressed by 
a wide variety of cell types, including neutrophils, monocytes, eosinophils, and lymphocytes 
(Brewer and Dam, 2000). E-selectin recognizes sialylated and fucosylated carbohydrate 
structures resembling the tetrasaccharide sialyl Lewis x (sLex) or sialyl Lewis a (sLea) (Zollner 
and Vestweber, 1996). P-selectin glycoprotein ligand-1 (PSGL-1) on leukocytes acts a ligand 
for E-selectin in addition to its role as a ligand for P-selectin (Katayama et al., 2003). An 
additional molecule, E-selectin ligand-1 (ESL-1), has been identified as a major adhesive 
ligand for E-selectin (Steegmaier et al., 1995).  
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1.3.1.1.2. P-selectin 
P-selectin, similar in structure to E-selectin, is expressed within the Weibel-Palade bodies of 
endothelial cells and in the α-granules of platelets (Ivetic and Ridley, 2004). Endothelial 
expression of P-selectin is typically short-lived and achieved by translocation of synthesized 
P-selectin to the cell membrane in response to inflammatory mediators such as histamine 
and some cytokines (Chen and Geng, 2006). Increased transcription of P-selectin occurs in 
response to tumour necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and lipopolysaccaride 
(LPS) (Brewer and Dam, 2000). Leukocytes express just one high affinity ligand for P-
selectin, namely PSGL1, although this can be differentially glycosylated to regulate ligand 
binding. Located principally in leukocyte microvilli, PSGL-1 binds P-selectin on endothelium 
and may be important in mediating the initial step of leukocyte rolling. Interestingly, there 
is evidence to suggest that E- and P-selectin share a degree of redundancy. E-selectin null 
mice display no obvious defect in leukocyte trafficking with a defect only uncovered when 
the activity of P-selectin is also blocked using a function blocking antibody (Labow et al., 
1994).  
 
1.3.1.1.3. L-selectin 
L-selectin is expressed on a wide range of circulating cells including monocytes, neutrophils, 
lymphocytes and haematopoietic progenitors (Brewer and Dam, 2000). L-selectin is 
structurally similar to the other selectins, but contains only two consensus repeats. There is 
evidence for at least three different mechanisms by which L-selectin mediates adhesive 
functions in the microvasculature. Firstly, it is thought that L-selectin expressed on the 
surface of a circulating neutrophil may display glycan ligands for E-selectin, permitting 
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direct selectin-selectin rolling interactions on activated endothelium (Picker et al., 1991). 
Secondly, some evidence from biochemical assays suggests that endothelial cells express 
molecules which directly mediate L-selectin rolling including heparin sulfate proteoglycans  
although the precise nature of the interaction is not well understood (Brewer and Dam, 
2000). The third mechanism suggests L-selectin can mediate rolling of leukocytes on other 
stationary leukocytes. Studies carried out in a flow-based adhesion assay provide evidence 
that stationary leukocytes constitute an L-selectin rich surface on which other leukocytes 
can roll. It is thought that much of the L-selectin rolling is mediated by PSGL-1 on the 
surface of stationary leukocytes.  This type of L-selectin mediated rolling is completely 
absent in PSGL-1 knockout mice (Sperandio et al., 2003).  
 
1.3.1.1.4. CD44, ICAM-1 and VCAM-1 
Non-selectin molecules can also mediate rolling although their contribution to rolling in vivo 
is not clear. CD44, a cell surface glycoprotein, binds the glycosaminoglycan (GAG) 
hyaluronan (hyaluronic acid; HA) and has been shown to partly mediate rolling of 
lymphocytes on tonsillar stromal cells (Clark et al., 1996). Other GAGs such as chondroitin 
sulfate also serve as rolling ligands for CD44. Interestingly, a specific glycoform of CD44 
(HCELL) can act as a ligand for L-selectin (Dimitroff et al., 2000).  
 
There is some evidence to suggest that members of the immunoglobulin superfamily 
intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) 
can mediate rolling of leukocytes on endothelium contrary to their ‘traditional’ role in 
stable adhesion. Arteriolar leukocyte rolling is significantly decreased in ICAM-1 knockout 
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animals (Sumagin and Sarelius, 2007), while the integrin VLA-4 (CD49d/CD29, α4β1) is able 
to mediate tethering and rolling on VCAM-1 (Alon et al., 1995). These findings are 
particularly interesting, as they suggest the existence of a large degree of redundancy 
across the adhesion cascade as a whole. 
 
1.3.1.2. Leukocyte Activation 
After leukocytes have been slowed from flow, factors released from the local endothelium 
mediate activation of the leukocyte which subsequently allows the leukocyte to progress to 
firm adhesion. It has been shown previously that for successful leukocyte recruitment, the 
most important factor is the duration for which the cell remains in contact with the local 
endothelium (Jung et al., 1998). Therefore, for firm adhesion to occur, the leukocyte must 
be sufficiently activated by factors released from the local endothelium.  
 
Cytokines are small (8-30kDa) secreted proteins, which play a central role in the 
maintenance and development of an immune response. In the context of inflammation, 
cytokines are normally secreted from activated endothelial cells where they interact with 
specific cytokine receptors on target cells. Typically, the target cells are inflammatory cells 
such as neutrophils and monocytes. Cytokines are classified according to their 
structure/function. Chemokines are cytokines that are able to establish a chemotactic 
gradient for surrounding cells (chemotactic cytokines). There are four main families of 
chemokines whose names are based on their structure - CC, CXC, C, and CX3C (representing 
cysteine crosslinks and amino acid sequence between them). CXCL12 (CXC-Ligand 12; 
CXCL12) is a well established member of this family. Interleukins (IL) are cytokines that were 
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first identified to be released by leukocytes and which act on other leukocytes but can also 
be released from cells including the endothelium (Delneste et al., 1994). Hence, IL-1 is a 
typical pro-inflammatory member of this family. 
 
The mechanisms by which cytokines act are relatively varied.  They commonly operate in a 
paracrine fashion, acting on cells within the local environment. Cytokines can also operate 
in an endocrine fashion, acting on cells distant to the local environment. This is a common 
cause of tissue-initiated systemic inflammation (Van der Meide and Schellekens, 1996). 
Cytokines are also able to act in an autocrine fashion, acting on the very cells they have 
been produced by.  
 
1.3.1.2.1. Endothelial proteoglycans 
Although most chemokines are secreted in soluble form from the local endothelium, a 
significant proportion are found bound to the luminal surface of the endothelial cell via 
proteoglycans such as heparin sulfate (Middleton et al., 2002). This creates a localized 
inflammatory environment, allowing chemokines to interact with leukocytes without being 
removed from the local area by blood flow. Furthermore, it is suggested that chemokine 
binding to proteoglycans actually enhances their biological activity (Middleton et al., 2002).  
Indeed, the binding of IL-8 to endothelial proteoglycans prolongs its biological activity by 
preventing degradation (Goger et al., 2002).   
 
1.3.1.2.2. Integrin priming 
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One of the major mechanisms by which chemokines activate leukocytes is by the priming of 
integrins, facilitating firm adhesion. Chemokines and cytokines can up-regulate adhesion 
molecule expression on the leukocyte cell surface. This process is also relatively quick as  
treating neutrophils or monocytes with IL-8 or GRO-α for 15 minutes induces a robust 
upregulation in CD11b (αM integrin) (Conklyn et al., 1996). In addition to upregulation, 
treatment of lymphocytes with the CC-chemokine ligand CCL25 or CCL28 activates the α4β7 
integrin, facilitating adhesion via mucosal addressin cell adhesion molecule-1 (MAdCAM-1) 
under conditions of shear stress (Miles et al., 2008). Furthermore, treatment of immature 
human CD34+ cells with the chemokine CXCL12 (SDF-1) activates the integrins LFA-1 (αLβ2 
integrin; CD11a/CD18), VLA-4 and VLA-5 (α5β1; CD49e/CD29), promoting ICAM-1 and VCAM-
1 dependent adhesion and transmigration (Peled et al., 2000). The activation of adhesion 
molecules is relatively rapid, with some cells needing less than five minutes treatment with 
chemokine to elicit activation, and some displaying adhesive characteristics after just one 
minute of treatment (Peled et al., 1999a). 
 
Integrin-mediated adhesion can be upregulated independent of changes in either surface 
expression or avidity. Treatment of lymphocytes with CXCL12 promotes rapid (sub-second) 
clustering of VLA-4 via G-protein coupled signaling; this permits stronger adhesive bonds 
between VLA-4 clusters and VCAM-1 (Grabovsky et al., 2000). Interestingly, there is 
evidence to suggest that affinity and clustering can be stimulated independently (Abram 
and Lowell, 2009). An additional level of complexity exists; integrin clustering can take place 
in either microclusters (0.1nm – 1.0nm) or macroclusters (200+ nm) (Kim et al., 2004).  
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Cytokines released from leukocytes can also act upon local vascular endothelium, raising 
the adhesive status of the bed and increasing the chance of firm leukocyte adhesion. 
Treatment of endothelial monolayers with IL-4 or IL-13, produced by a variety of immune 
cells, induces a robust increase in VCAM-1 expression and morphological changes, including 
the appearance of endothelial fenestrations (Kotowicz et al., 1996). 
 
 
1.3.1.3. Leukocyte Firm Adhesion 
Following activation, leukocytes firmly adhere to endothelium. In the majority of tissue 
beds, firm adhesion does not occur without prior rolling.  However, in low-flow tissue beds 
such as the liver, it has been shown that tethering and rolling on endothelium is not a 
prerequisite for adhesion. This may be a result of the diameter of leukocytes being similar 
to the diameter of the sinusoidal capillary (Kubes et al., 2002).  
 
1.3.1.3.1. Integrins and their receptors 
Traditionally, the major adhesion molecule family involved in firm adhesion are the 
integrins and their ligands (Eniola et al., 2003). The integrins are a family of adhesion 
molecules that regulate cell-cell and cell-matrix adhesion. Integrins exist in their functional 
form as a heterodimer, with larger α-subunits (120-180kDa) and smaller β-subunits (90-
110kDa) (Seftor, 1998). The specific combination of α- and β-subunits defines the specificity 
of the integrin for its ligand (Table 1.1). There are a total of 24 heterodimers known in 
existence, made up from 18 α-subunits and 8 β-subunits (Takada et al., 2007). There is very 
little homology between subunits.  The sequence homology between α-subunits is 30%, 
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while amongst β-subunits sequence homology is 45% (Takada et al., 2007). The importance 
of integrins becomes apparent from the human disorder of leukocyte adhesion deficiency 
(LAD). Three classes of LAD have been identified, with LAD I resulting from a deficiency or 
complete lack of β2 integrin expression. LAD I patients tend to succumb to frequent 
aggressive bacterial infections and rarely survive past the first two years of life (Anderson 
and Springer, 1987). Failure of bacterial clearance results from severe failures in the 
leukocyte adhesion cascade and a marked inability of blood leukocytes to emigrate into 
peripheral tissues (Etzioni et al., 1999).  
 
Efficient adhesion of integrins to their ligands requires conformational changes in the 
molecule which facilitate binding to endothelial counter-receptors. Integrins bind to 
members of the Immunoglobulin superfamily (IgSF) expressed on the endothelial surface 
namely ICAM-1, ICAM-2, VCAM-1 and MAdCAM-1. All members of the IgSF have an 
immunoglobulin domain, named after the immunoglobulin molecules in which the 
structural domain was first identified (Barclay, 2003). Endothelial beds show tissue-specific 
differences in levels of the various IgSF adhesion receptors; for example, MAdCAM-1 is 
preferentially expressed in the intestine where it promotes gut specific recruitment of 
lymphocytes (Ogawa et al., 2005). Even though some molecules are tissue specific in 
normal conditions, they can exhibit ectopic expression in some disease states. Indeed, 
during some inflammatory hepatic states, expression of MAdCAM-1 can be identified on 
sinusoidal endothelium (Adams and Eksteen, 2006).   
 
Chapter 1: General Introduction 
28 
 
Integrin Synonyms Ligands Found on 
αLβ2 LFA-1, CD11a/CD18 ICAM-1, ICAM-2, ICAM-3, ICAM-5 
Lymphocytes, monocytes, 
macrophages, neutrophils, HSCs 
αMβ2 
Mac-1, CR3, 
CD11b/CD18 
iC3b, fibrinogen, heparin, 
plasminogen, ICAM-1, RAGE, JAM-C 
Monocytes, macrophages, 
neutrophils, NK cells  
αXβ2 
p150,95, CR4, 
CD11c/CD18 
ICAM-1, ICAM-2, ICAM-4, VCAM-1, 
iC3b, fibrinogen,  heparin, 
plasminogen,  
Monocytes, macrophages, NK 
cells, dendritic cells, HSCs 
αDβ2 - ICAM-3, VCAM-1 
Monocytes, macrophages, 
neutrophils, eosinophils 
α4β1 
VLA-4, CD49d, 
CD49d/CD29 
VCAM-1, fibronectin 
Lymphocytes, monocytes, 
eosinophils, HSCs 
α4β7 LPAM-1 MAdCAM-1, fibronectin 
Lymphocytes, monocytes, NK 
cells 
αEβ7 HML-1 E-cadherin T-lymphocytes 
α1β1 VLA-1, CD49a/CD29 Collagen T-/B-lymphocytes, monocytes 
α2β1 
VLA-2, GPIa, 
CD49b/CD29 
Collagen 
T-/B-lymphocytes, monocytes, 
progenitor cells(?) 
α5β1 
VLA-5CD49e, 
CD49e/CD29 
Fibronectin 
T-lymphocytes, monocytes, 
progenitor cells(?) 
α6β1 
VLA-6, GPIc, 
CD49f/CD29 
Laminin T-lymphocytes, monocytes 
Table 1.1. Integrin expression on leukocytes. Numerous integrins are expressed on 
circulating leukocytes, with a large degree of promiscuity between integrin ligands. There is 
a small degree of evidence for the presence of α2β1 and α5β1 on CD34
+ progenitor cells, 
although this has not been confirmed on more ‘pure’ HSC isolates. Adapted from various 
sources. 
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 1.3.1.3.2. CD44 
The step of firm adhesion may also involve other non-integrin molecular mechanisms. CD44 
can support firm adhesion through binding either to HA (Zhuo et al., 2006) or via 
interactions with VLA-4 (Nandi et al., 2004). Additionally, CD44-mediated activation of 
surface integrins has been shown to promote recruitment of cancer cell lines to 
endothelium (Fujisaki et al., 1999).   
 
1.3.1.4. Transmigration 
Following firm adhesion, leukocytes must transmigrate through the endothelial monolayer 
and into the underlying tissue parenchyma/stroma. Paracellular transmigration describes 
the passage of a leukocyte through the endothelium, traveling between the junctions of 
endothelial cells. This is the more well-established method of transmigration, although 
evidence now also exists for transcellular transmigration in which the leukocyte migrates 
through a single endothelial cell (Feng et al., 1998). However, this occurrence is much rarer.  
Various adhesion molecules have been implicated in the transmigration process, including 
the integrins, the integrin IgSF counter-receptors, platelet-endothelial cell adhesion 
molecule-1 (PECAM-1; CD31), CD99 and junctional adhesion molecules (JAMs) (Ley et al., 
2007).  
 
In the paracellular route, leukocytes migrate along the endothelium until they reach sites 
between endothelial cells which are supportive of leukocyte transmigration. The process of 
transmigration itself is complex (Petri et al., 2008). Engagement of endothelial adhesion 
molecules with their ligands reduces inter-endothelial contacts, thus promoting 
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transmigration across the endothelial layer (Ley et al., 2007).  Endothelial cells dynamically 
reorganize the localization of adhesion molecules to further promote leukocyte 
transmigration.  Therefore, molecules which may hinder transmigration are translocated 
away from the inter-endothelial junction, while those which enhance transmigration are 
concurrently concentrated at the junctional areas (Ley et al., 2007, Shaw et al., 2001). 
Engagement of junctional adhesion molecules may cause downstream signaling that results 
in the loosening of adhesive contacts between endothelial cells, particularily VE-cadherin 
(Dejana, 2004). The adhesion molecules JAM-A and PECAM-1 are connected to the cadherin 
system, via intracellular binding partners (Ley et al., 2007). There appears to be some 
stimulus specific modulation of the transmigration process; PECAM-1, ICAM-2 and JAM-A 
dependent venular transmigration of leukocytes is seen after treatment with IL-1β, but not 
after treatment with TNF-α (Nourshargh et al., 2006). This may act to selectively permit 
transmigration of specific leukocyte subsets. 
 
 
1.3.1.5. Sub-endothelial migration 
Once leukocytes have traversed the endothelial layer, they then must navigate through the 
layers of basement membrane and into the surrounding tissue. The basement membrane of 
most tissues is relatively complex and is made up of laminins, collagen IV and connecting 
proteins.  Therefore, it constitutes a formidable barrier for a leukocyte to cross. This 
process appears to be mediated, at least in part, by PECAM-1 and α6 integrin family 
members (Wang et al., 2005). Migration of leukocytes is further influenced by the presence 
of a pericyte layer subsequent to the basement membrane in most vessels. Currently, the 
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importance of interactions between leukocytes and pericytes is unclear, although pericytes 
do express adhesion molecules that are able to interact with passing leukocytes (Verbeek et 
al., 1995).   The liver sinusoidal bed differs from most vascular beds in that the sinusoidal 
endothelium lacks a classical basement membrane as it is separated from the underlying 
hepatocytes by the Space of Disse.  How cells cross the Space of Disse is unknown but 
recent evidence suggests that hepatic stellate cells, which act as pericytes for sinusoidal 
endothelial cells, can modulate migration beyond the endothelium (Holt et al., 2009). 
 
1.3.2 HSC recruitment to Bone Marrow Microcirculation 
The BM microcirculation also consists of sinusoidal endothelium, similar to that seen in the 
liver.  Futhermore, primary bone marrow endothelial cells also express CD31, CD44, ICAM-
1, and VCAM-1 (Candal et al., 1996).  Recent in vivo intravital microscopy (IVM) studies have 
partially elucidated adhesion pathways governing transplanted HSC and progenitor cell 
(HPC) homing to BM microcirculation.  All the different classes of adhesion molecules 
appear to play a role in anchoring immature hematopoietic cells to BM microcirculation.  
Work by Frenette et al suggests that the BM homing of HSCs in normal animals is regulated 
primarily by the P- and E-selectins, with the role of VCAM-1 only uncovered after the 
selectin-mediated recruitment has been compromised (1998). Hence, there appears to be a 
potential redundancy for VCAM-1 in BM homing. Indeed, treatment of wildtype mice with 
an anti-VCAM-1 antibody did not reduce HSC homing in lethally irradiated mice (Frenette et 
al., 1998). HSC homing to BM was significantly impaired in P- and E-selectin knockout mice, 
an impairment which could be further exaggerated by treatment of the mice with a VCAM-
1 blocking antibody (Frenette et al., 1998). The ligand expressed on HSCs for these selectins 
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is unclear. Although enzymatic modification of PSGL-1 on the HSC surface increases initial 
interactions with the BM stroma, it does not significantly improve their homing (Hidalgo 
and Frenette, 2005).  
 
 
CD44 and HA have also been implicated in HSC homing to the BM. Enriched human CD34+ 
cells treated with anti-CD44 mAbs display a marked defect in BM homing following 
intravenous injection into NOD/SCID mice (Avigdor et al., 2004). This defect is at least 
partially mediated by HA in the BM.  Treatment of animals with the enzyme hyaluronidase, 
which degrades HA, elicits a similar, although not as marked, decrease in BM homing 
(Avigdor et al., 2004). It is thought that HA-mediated homing is dependent on CXCL12 
activation of CXCR4, which then acts on pathways that modify the localization and activity 
of CD44 (Avigdor et al., 2004). Interestingly, a specific glycoform of CD44 (termed HCELL) 
also acts as a ligand for E- and L-Selectin (Sackstein, 2004). In fact, the affinity of HCELL for 
L-selectin is around five times the affinity of PGSL-1 for L-selectin (Dimitroff et al., 2001). 
Furthermore, HCELL is the most potent ligand for E-selectin expressed by any cell 
(Sackstein, 2004). 
 
1.3.2.1. CXCL12/CXCR4 in BM homing 
The G-protein coupled chemokine receptor CXCR4 and its accompanying ligand CXCL12 
(SDF-1), are implicated heavily in the recruitment of HSCs into the BM microcirculation. 
Interestingly, it should be noted that CXCR4 appears to act as a universal BM homing 
molecule as it is also utilised by CXCR4 expressing neutrophils to home to BM prior to 
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apoptosis (Martin et al., 2003).  Furthermore, tumour micrometastases in the BM also 
express high levels of CXCR4 (Kaifi et al., 2005). Injection of HSCs into the venous circulation 
results in rapid clearance, within minutes (Lapidot et al., 2005). These cells home to various 
tissues, including the spleen, liver and lungs.  From these tissues, HSCs may subsequently 
migrate toward and home into the BM (Lapidot et al., 2005), where they are observed 
within CXCL12 expressing microdomains (Sipkins et al., 2005).  This observation further 
highlights the importance of the CXCL12/CXCR4 axis in HSC recruitment.   Expression of 
CXCL12 is regulated in part by oxygen tension via the activities of the transcription factor 
hypoxia inducible factor-1α (HIF-1α) (Ceradini et al., 2004). As the BM is itself partially 
hypoxic (Ceradini et al., 2004, Lapidot et al., 2005), CXCL12 is expressed by many of the 
stromal cells that line the microenvironments in which HSCs home (Kortesidis et al., 2005). 
The CXCL12 concentration gradient is critical in retaining HSCs within the BM.  Reduction of 
BM CXCL12 levels results in HSC mobilization into the circulation (Petit et al., 2002), while 
increased levels of circulating CXCL12, such as that seen following an extramedullary 
hypoxic injury, promote emigration of HSCs from the BM following an CXCL12 
concentration gradient (Hattori et al., 2001). In addition to the chemotactic properties of 
CXCL12, it also has a well defined signaling effect on HSCs. Activation of CXCR4 by CXCL12 
results in the subsequent rapid and robust activation of integrins on the HSC surface, 
namely LFA-1, VLA-4 and VLA-5 (Peled et al., 2000). This may help facilitate the firm 
adhesion of these cells by anchoring them to their respective ligands. 
 
Although the CXCL12/CXCR4 axis works to promote HSC adhesion and retention in the BM, 
ultimately retention is reliant on specific adhesion molecule interactions within the BM 
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stroma. BM endothelial cells constitutively express the IgSF molecule VCAM-1 (Jacobsen et 
al., 1996) and interactions between this molecule and VLA-4 are important in the homing of 
these cells to the BM following systemic administration. Early work illustrated this 
importance by demostrating that pretreatment of murine haematopoietic progenitors with 
an α4β1 integrin or VCAM-1 blocking antibody significantly impaired BM homing in lethally 
irradiated mice by around 50% (Papayannopoulou et al., 1995). 
 
 
1.3.3 HSC recruitment to Non-BM tissue Microcirculation 
Although there is conflicting evidence whether HSCs are actually beneficial during hepatic 
injury and if so, the mechanism of benefit (fusion vs differentiation), it remains irrefutable 
that if stem cells are to be beneficial in treating human disease, a proper understanding of 
their recruitment to damaged tissues is crucial.  Our knowledge on the molecular adhesive 
mechanisms that govern recruitment of HSCs to BM is increasing, but it is still unclear 
whether similar adhesive events govern HSC recruitment to injured non-BM tissue 
endothelium.   Indeed, while much published work has examined the capacity of stem cells 
as a therapy, very little work has tried to underpin the recruitment mechanisms these cells 
use to engraft within non-BM sites.  
 
A recent study by Zhang et al  has identified the molecular mechanisms that underpin 
progenitor cell recruitment in experimental models of mice undergoing myocardial 
infarction (Zhang et al., 2007). The authors report that recruitment and subsequent fusion 
of progenitor cells is dependant on VLA-4 interactions with VCAM-1. This currently appears 
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to be the only published study that identifies a specific adhesion molecule pair that 
regulates HSC engraftment to an inflamed non-medullary site.  Recruitment mechanisms 
are still unclear for other injured sites, including the liver. A better understanding of such 
mechanisms would facilitate future manipulation of the engraftment process. 
 
 
1.4.  Hepatic ischemia-reperfusion injury 
In order to investigate the adhesive molecular mechanisms governing HSC recruitment to 
the injured hepatic microcirculation, the studies within this thesis have utilised an acute 
model of murine hepatic injury induced by ischaemia and subsequent reperfusion.  Hepatic 
ischemia-reperfusion (IR) injury is a clinically important problem. Poor success and 
morbidity associated with orthotopic cadaveric liver transplantation and major hepatic 
resections is commonly a result of IR injury (Carden and Granger, 2000).  IR injury refers to 
tissue damage caused paradoxically when blood flow is returned to the tissue after a period 
of restricted blood flow (greek. isch- restriction, haema- blood).  Lack of oxygen and 
nutrients creates a condition in which the restoration of blood flow results in inflammation 
and oxidative damage through generation of reactive oxygen species (ROS).  Reperfusion 
therefore exacerbates the ischemic injury.  Indeed, in the liver, the level of hepatic damage 
seen after 3 hours of ischaemia and 1 hour of reperfusion is much greater than after 4 
hours of ischaemia alone (Eltzschig and Collard, 2004).  
 
Initially, ischaemia causes metabolic disturbances within cells resulting in dysregulation of 
energy pathways and ROS release (Figure 1.3). At the outset, cells experience a loss of ATP, 
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rise of intracellular sodium and cell oedema (Fondevila et al., 2003). Ischaemic metabolic 
failure of the mitochondrial respiratory chain leads to the generation of hydroxyl radicals 
during reperfusion through an increased rate of hydrogen peroxide (H2O2) production 
(Gonzalez-Flecha et al., 1993). Evidence suggests that hepatocytes and Kupffer cells are also 
important origins of oxidative stress, although the latter appear to play a minor role as 
depleting Kupffer cells fails to attenuate IR injury (Jaeschke, 2003, Reinders et al., 1997, 
Kumamoto et al., 1999).  
 
Hepatic sinusoidal perfusion failure is also common during the post-reperfusion phase, 
resulting in microcirculatory failure (Jaeschke, 2003). The vascular tone of the hepatic 
sinusoids is a result of a delicate balance between vasodilatory molecules (such as nitric 
oxide and prostacylin) and vasoconstrictory molecules (such as endothelin-1, ET-1). Any 
imbalance between these factors during IR results in dysregulation of vascular tone and 
sinusoidal blood flow, promoting mechanical leukostasis (Vinores et al., 2007). Indeed, 
pharmacological restoration of vascular tone following IR improves blood flow and 
attenuates injury (Shiraishi et al., 1997). Injury is also exacerbated by the substantial 
endothelial recruitment of platelets.  Upto one third of circulating platelets are found in the 
IR injured liver during reperfusion (Sindram et al., 2000). These platelets form micro-
aggregates and are activated when examined by electron microscopy (Cywes et al., 1993). 
Platelets can induce apoptosis in sinusoidal endothelial cells during tissue reperfusion which 
can be prevented by blocking their adhesion (Sindram et al., 2000).  
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Figure 1.3. Mechanisms of Ischemia-Reperfusion injury. Initial injury during the 
ischemic phase takes place intracellularly, with dysregulation of energy metabolism. 
This leads on to further oxidative damage, which subsequently promotes direct 
damage and leukocyte recruitment during the early and late phases of reperfusion. 
Adapted from various sources.   
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As a result of both the oxidatively stressed environment and the vascular mechanical 
disturbances during IR, hepatic microvessels display marked neutrophil accumulation, at 
least in part as a consequence of increased capture by endothelial cell adhesion molecules. 
During the reperfusion phase, neutrophil activation occurs which also results in the 
generation of further damaging ROS (Marti et al., 2004).  Leukocyte recruitment is 
additionally amplified by the release of cytokines from the injured tissue, such as tumour 
necrosis factor-α (TNF-α) and interleukin (IL)-1. During IRI, plasma levels of TNF-α and IL-1 
are raised within 5 minutes of the reperfusion phase (Suzuki and Toledo-Pereyra, 1994). 
Both TNF-α and IL-1 mediate activation of the pro-inflammatory transcription factor NF-κB 
which leads to the generation of further cytokines and chemokines, as well as synthesis of 
adhesion molecules (Ghosh et al., 1998). Hypoxia itself activates a number of additional 
transcription factors, such as hypoxia-inducible-factor-1α (HIF-1α) (Lopez-Lazaro, 2006). 
Hypoxic induction of HIF-1α drives a robust release of CXCL12, establishing a chemokine 
gradient for inflammatory cell recruitment (Ceradini et al., 2004). 
 
Although neutrophil accumulation has been shown in the sinusoids in vivo (Vollmar et al., 
1994), the adhesion molecules responsible have not been fully identified (Jaeschke, 2003). 
It is also thought that the accumulation of neutrophils in sinusoids is a result of numerous 
mechanical factors, such as vasoconstriction, swelling of the vascular lining and reduced 
flexibility of activated neutrophils (Jaeschke, 2003). Whether these mechanical recruitment 
mechanisms also apply to other cell types is unclear. 
 
1.4.1.  Role of sinusoidal adhesion molecules in hepatic IR 
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During IR, the hepatic sinusoidal endothelium plays an active role in both establishment of 
injury and maintenance of an inflammatory state (Montalvo-Jave et al., 2008). In the 
hyperacute stage of the injury, sinusoidal constriction resulting from vasomodulatory 
imbalance promotes leukostasis (Jaeschke et al., 1990). Accumulation of neutrophils within 
the sinusoids perturbs flow, but is not thought to cause complete occlusion (Vollmar et al., 
1996).  
 
The recruitment of leukocytes and platelets is mediated by adhesion molecules expressed 
on the sinusoidal endothelium. Under basal conditions, sinusoidal endothelium expresses 
low levels of ICAM-1 and VCAM-1, with no expression of any of the selectin family members 
(Lalor and Adams, 1999).  Following insult, levels of ICAM-1 and VCAM-1 are raised, and 
although some vessels express E- and P- selectin, selectins are largely absent from the 
sinusoids (Wang et al., 1999, Adams et al., 1996, Grant et al., 2001). Other endothelial 
adhesion molecules such as MAdCAM-1 can be detected under certain specific 
inflammatory conditions and could play a role in IR injury (Ando et al., 2007).  Additionally, 
vascular adhesion protein-1 (VAP-1) is constitutively expressed in the liver and is one of the 
few endothelial beds to exhibit constitutive expression (Lalor and Adams, 1999). VAP-1 has 
been shown to play an important role in lymphocyte recruitment to rejecting rat and 
murine liver allografts (Martelius et al., 2004) and during inflammation in cerebral IR injury 
(Xu et al., 2006), but it is unclear whether it has any role in hepatic IR.  
 
The adhesion pathways mediating neutrophil recruitment during IR injury also include an 
important role identified for ICAM-1 (Montalvo-Jave et al., 2008). ICAM-1 is upregulated on 
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sinusoidal endothelium during hepatic IR injury, due at least in part to the activity of TNF-α 
released from activated Kupffer Cells (Mosher et al., 2001, Colletti et al., 1998). 
Pretreatment of animals with an ICAM-1 blocking antibody, immediately following 
reperfusion, reduces the level of hepatic injury seen at 72 hours post-reflow (Kuzume et al., 
1997). Indeed, ICAM-1-/- animals show a higher rate of survival following total hepatic IR 
injury when compared with wild-type controls (Yadav et al., 1998). It is thought that 
neutrophil adhesion via ICAM-1 is mediated through interactions with integrins LFA-1 
and/or Mac-1 (Monson et al., 2007).  
 
Despite the lack of strong E and P-selectin expression on inflamed sinusoidal endothelium, 
functional studies suggest that selectins play a role in the pathogenesis of hepatic IR injury. 
Administration of β-SQDC9, an L- and P- selectin inhibitor, into IR treated animals 
immediately prior to reperfusion significantly reduces plasma transaminase levels, as well 
as reducing neutrophil infiltration (Shima et al., 2005). Following hepatic IR, P-selectin-/- 
mice display a marked attenuation of neutrophil infiltration and subsequently less hepatic 
injury (Singh et al., 1998). Recruitment may be mediated via direct interactions between P-
selectin and neutrophil PSGL-1, although it should be noted there is evidence to suggest 
that P-selectin, in tandem with ICAM-1, may attenuate injury by modulation of 
inflammatory chemokine release rather than direct adhesive actions (Monson et al., 2007). 
A similar role has been suggested for L-selectin in hepatic IR injury. L-selectin-/- animals 
display a marked decrease in neutrophil infiltration compared to wild-type animals (Yadav 
et al., 1998). Hepatic IR injury increases E-selectin expression on sinusoidal endothelial cells 
in vitro, although whether this translates to an in vivo role is less clear (Burke et al., 1998). 
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E-selectin has been shown to play a role in neutrophil recruitment during cerebral IR injury 
(Zhang et al., 1996), but whether this finding correlates with the events during hepatic IR 
injury is currently unclear. 
 
The role of VCAM-1 in hepatic IR injury is unclear. Blockade of VCAM-1 alone in other 
models of IR shows no benefit (Justicia et al., 2006, Bowden et al., 2002) but this finding has 
not been investigated fully in hepatic IR. It has been suggested that the α4 integrins may act 
as an alternative mechanism for neutrophil recruitment into inflamed tissues (Johnston and 
Kubes, 1999) and this may be uncovered in the absence of β2 integrin mediated recruitment 
(Monson et al., 2007, Bowden et al., 2002). Neutrophils isolated from arthritic mice display 
increased adhesion to VCAM-1 in a flow-based adhesion assay when compared to 
neutrophils isolated from controls (Johnston and Kubes, 1999) suggesting that neutrophils 
activated in vivo can bind to VCAM-1. Interestingly, this increased adhesion is seen without 
an upregulation of α4 expression levels, suggesting a change in integrin activity or affinity 
(Johnston and Kubes, 1999). 
 
1.5. Summary 
BM-derived HSCs may potentially aid tissue repair and contribute to restoration of 
damaged hepatocytes.  The precise beneficial mechanisms are poorly understood and 
probably include hepatocyte restoration via fusion-dependent mechanisms, a small effect 
due to transdifferentiation into functional hepatocytes and/or paracrine effects that 
promote liver regeneration and suppress local inflammation.  Regardless of the beneficial 
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mechanisms, understanding the molecular basis of hepatic HSC recruitment and 
engraftment is critical for design of future therapeutic trials. 
 
Evidence supporting a beneficial role for HSCs in liver injury includes the fact that they can 
differentiate into hepatocyte-like cells when co-cultured with injured hepatocytes and 
elevated numbers of circulating HSCs have been observed after extensive liver resection 
and alcoholic hepatitis.   Expression of the potent HSC chemokine, CXCL12, is increased 
within injured liver which facilitates HSC recruitment from BM via the circulation (Hatch et 
al., 2002).  The liver acts as a HSC niche during foetal development and low numbers of c-
kit+ Sca-1+ Lin- (KSL) HSCs can be detected within adult mouse liver.  Collectively, these 
studies provide evidence that BM-derived HSCs infiltrate inflamed liver and may have 
potential therapeutic use as tools to promote liver regeneration.   
 
However, HSCs are rare cells constituting <0.05% of the BM (Chen et al., 1997) and this 
scarcity has hindered their clinical use (Dahlke et al., 2006).  If HSC therapy is to be realized, 
a better understanding of the molecular adhesive factors regulating engraftment at injured 
sites is essential in order to develop strategies to enhance recruitment.   It is possible that 
HSCs utilise the same classes of adhesion molecules used by mature leukocytes for 
recruitment to inflamed sites.  However, there is an extreme lack of published literature 
that has addressed this and the molecular adhesive events that govern HSC recruitment 
within injured non-BM sites is currently unknown.  If HSCs do hold promise in the context of 
regenerative diseases or the repair of tissue injury, what is clear is that we need to have a 
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better understanding of how HSCs home to tissues and what local factors influence their 
retention and integration. 
 
 
1.6. Aims and Hypotheses 
The major hypothesis of this thesis is that HSCs are recruited to the hepatic microcirculation 
following hepatic IR injury and that the mechanism is selective and can be experimentally 
manipulated. More specifically, the aims of this thesis are as follows : 
 
1. Hepatic IR injury significantly promotes adhesion of HSCs to the sinusoidal 
 microcirculation 
2. Blockade of specific adhesion molecules on the HSCs would significantly reduce HSC 
 adhesion post-injury in vitro and in vivo 
3. Blockade of specific adhesion molecules on the endothelium would significantly 
 reduce HSC adhesion post-injury in vivo 
4. HSC adhesion can be modulated positively by pre-treatment with specific cytokines 
5. HSCs recruited to the injured liver may have immunomodulatory effects thereby 
 reducing subsequent mature leukocyte recruitment 
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2.  Materials and Methods 
 
2.1.   Materials  
 
2.1.1.  Antibodies 
All antibodies used in this thesis were used at the concentrations detailed in Table 2.1, 
unless specifically listed elsewhere.  
 
2.1.2  Common Materials 
A number of materials were used repeatedly in this thesis and are presented in  
Table 2.2 for clarity. Materials referred to in the text were obtained from the indicated 
suppliers unless otherwise stated. 
 
2.2.   Cell Culture, Cell Isolation and Cell Preparation 
 
2.2.1.  Cell Counting 
For all cell counting, a standard Neubauer haemocytometer was used.  Trypan blue (9:1) 
was added to cell suspensions prior to counting to ensure exclusion of dead cells from the 
final count. Cells were centrifuged and subsequently resuspended in 1ml and well mixed. 
90µL of Trypan Blue was added to 10ul of cell suspension, and approximately 20μl of the 
resulting suspension was viewed using a hemocytometer under a x10 objective. The 
number of cells that had not taken up the blue stain (viable cells) were counted in the four  
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Antibody Conj Clone Origin  Target  Isotype Company Concn 
IgG2 Control N/A RTK4530 Rat N/A IgG2b Cambridge Bioscience 80μg/ml 
IgG1 Control N/A RTK2071 Rat N/A IgG1,κ Cambridge Bioscience 80μg/ml 
LE-AF anti-CD31 N/A MEC13.3 Rat Mouse IgG2a Cambridge Bioscience 80μg/ml 
LE-AF anti-CD49d N/A R1-2 Rat Mouse IgG2b Cambridge Bioscience 80μg/ml 
LEAF anti-CD44 N/A IM7 Rat Mouse IgG2b Cambridge Bioscience 80μg/ml 
NA-LE anti-CD18 N/A GAME-46 Rat Mouse IgG1 BD Pharmingen 80μg/ml 
LE-AF anti-CD62L N/A MEL-14 Rat Mouse IgG2a Cambridge Bioscience 80μg/ml 
Purified anti-CXCR4 N/A 247506 Rat Mouse IgG2b R&D Systems 80μg/ml 
anti-CD31 FITC MEC13.3 Rat Mouse IgG2a Cambridge Bioscience 1:50 
anti-CD49d FITC R1-2 Rat Mouse IgG2b Cambridge Bioscience 1:50 
anti-CD44 PE IM7 Rat Mouse IgG2b eBioscience 1:50 
anti-CD18 FITC GAME-46 Rat Mouse IgG1 Santa Cruz Biotech. 1:50 
anti-CD62L FITC MEL-14 Rat Mouse IgG2a eBioscience 1:50 
anti-Sca-1 PE D7 Rat Mouse IgG2a eBioscience 1:50 
anti-c-kit (CD117) Cy5 2B8 Rat Mouse IgG2b eBioscience 1:50 
anti-CD34 FITC RAM34 Rat Mouse IgG2a eBioscience 1:50 
anti-CD11b FITC M1/70 Rat Mouse IgG2b eBioscience 1:50 
anti-CD45R FITC RA3-6B2 Rat Mouse IgG2a eBioscience 1:50 
anti-Ter-119 FITC Ter-119 Rat Mouse IgG2b eBioscience 1:50 
anti-CD8 FITC 53-6.7 Rat Mouse IgG2a eBioscience 1:50 
anti-CD5 FITC CD5 Rat Mouse IgG2a eBioscience 1:50 
anti-Gr-1 FITC RB6-8C5 Rat Mouse IgG2b eBioscience 1:50 
anti-VCAM-1 N/A MK/3 Rat Mouse IgG1 Abcam 1:100 
CD16/32 N/A 93 Rat Mouse IgG2a eBioscience 1:20 
Polyclonal anti-rat IgG TR Polyclonal Goat Rat IgG Frc. Abcam 1:250 
Rat IgG control FITC eB149/10H5 Rat Mouse IgG2b eBioscience 1:50 
Rat IgG control PE eB149/10H5 Rat Mouse IgG2b eBioscience 1:50 
 
Table 2.1. Antibodies used in this thesis. Antibodies were purchased from: Cambridge 
Bioscience, Cambridge, UK; BD Pharmingen, Oxford, UK; Santa Cruz Biotechnology, Santa 
Cruz, US; eBioscience, San Diego, US; abcam, Cambridge, UK. 
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Material Abbreviation  Manufacturer Location 
Acetone - Fisher Scientific Leicestershire, UK 
3-aminopropyltriethoxysaline APES Sigma Poole, UK 
Ammonium Hydrochloride NH4Cl Sigma Poole, UK 
Bovine Serum Albumin BSA Sigma Poole, UK 
5’6-carboxyfluorescein diacetate 
succinimidyl ester 
CFSE 
Molecular Probes 
(Invitrogen) 
Paisley, UK 
Dextran - Pharmacosmos Holbaek, Denmark 
Dimethyl Sulphoxide DMSO Sigma Poole, UK 
Heat inactivated Fetal Bovine Serum FBS Invitrogen Paisley, UK 
Gelatin (Type I from porcine skin) - Sigma Poole, UK 
Ketamine Hydrochloride - Pharmacia Animal Health Northamptonshire, UK 
L-Glucose - Sigma Poole, UK 
L-Glutamine (GlutamaxTM) - Invitrogen/PAA Labs Paisley/Peteboro’, UK 
Murine Epidermal Growth Factor mEGF Peprotech London, UK 
Murine Interleukin-6 mIL-6 Peprotech London, UK 
Non-essential amino acids - Invitrogen Paisley, UK 
Penicillin - Invitrogen/PAA Labs Paisley/Peteboro’, UK 
Phosphate Buffered Saline PBS Invitrogen Paisley, UK 
Potassium Bicarbinate KHCO3 Sigma Poole, UK 
Propridium Iodide PI Sigma Poole, UK 
Sodium ethylene tetraacetic acid Na.EDTA Sigma Poole, UK 
Sodium Chloride NaCl Sigma Poole, UK 
Streptomycin - Invitrogen Paisley, UK 
TrypLE – Trypsin Like Enzyme TrypLE Invitrogen Paisley, UK 
Trypan Blue - Sigma Poole, UK 
Trypsin-EDTA - Invitrogen Paisley, UK 
Xylazine Hydrochloride - Millpledge Vetinary Nottinghamshire, UK 
 
Table 2.2. Chemicals used frequently in this thesis. Products were purchased from 
companies shown. Abbreviations (if applicable) are also shown. 
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grid 1 x 1mm2 fields.  The average count from the four grids was calculated and multiplied 
by 1 x 105 to yield the number of cells per ml.  
 
2.2.2.   HPC-5 and HPC-7 culture 
HSC lines have been used for most of the experiments within this thesis.  Intravital studies 
monitoring HSC trafficking have been limited due to cell rarity and difficulty isolating 
sufficient numbers for detection following systemic infusion (Chen et al., 1997).  Therefore, 
this study utilized an adult and embryonic murine hematopoietic progenitor cell line, HPC-5 
and HPC-7 respectively. HPC-5 and HPC-7 cells were a generous gift from from Professor 
Leif Carlsson (University of Umeå, Sweden). These cell lines display characteristics of 
primary HSCs, such as being highly enriched for surface markers characteristic of the most 
immature HSCs including c-kit+, Sca-1+, CD34− and Lin− (Pinto do Ó et al., 2002, Pinto do Ó et 
al., 1998). Additionally, HPC-5 cells reconstitute haematopoiesis upon
 transplantation into a 
lethally irradiated host (Pinto do Ó et al., 2002). The HPC-7 cell line has been used 
extensively for studies investigating the control of HSC growth and differentiation at a 
molecular and cellular level (Wilson et al., 2009, Pimanda et al., 2008). Furthermore, this 
cell line is considered superior to other HSC lines such as FDCP-1 mix or FDC-P1 mix, which 
have been routinely utilized by leading laboratories to monitor HSC trafficking with the 
murine BM intravitally (Mazo et al., 1998, Katayama et al., 2004). In this thesis (Chapter 4), 
the adhesion molecule profile of HPC-7 and HPC-5 was examined and found to be 
consistent with the profile expected of HSCs (although data for HPC-5 is not shown, results 
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are similar). Furthermore, we also show these cells express CXCR4 – the receptor for 
CXCL12 commonly found on HSCs (Chapter 5).  
 
Cells were cultured in Stem Pro Serum Free Medium (SFM) 34 (Invitrogen) supplemented 
with 50U/ml penicillin, 50U/ml streptomycin and 2mM L-Glutamine, and conditioned 
medium from CHO K3 cells at a concentration of 1 in 10.  Both HPC-5 and HPC-7 growth is 
strictly dependent upon the presence of SCF. CHO-K3 cells generate SCF as a result of a 
stable transfection (see below). In addition to SCF, HPC-5 cells are dependent on IL-6 and 
were cultured in the presence of 10ng/ml murine IL-6. Both cell types were maintained 
daily at a density of between 0.8 – 1.3 x 106 cells/ml.  
 
2.2.3.   CHO K3 cell culture 
CHO K3 cells were also generously obtained from Professor Leif Carlsson (University of 
Umeå, Sweden). CHO K3 cells were grown to confluence in gelatin coated flasks. CHO K3 
were maintained in Dulbecco’s Modified Eagles Medium (DMEM, Invitrogen) containing 
10% FBS, 50U/ml penicillin, 50U/ml streptomycin, and 2mM L-Glutamine. To generate SCF-
containing medium, confluent CHO K3 cells were left for 48 hours without a change of 
media. Thereafter, the media was changed to Stem Pro 34 SFM (Invitrogen) supplemented 
with 0.5% FBS. Cells were cultured for 24 hours and the media replaced with fresh Stem Pro 
34 SFM with 0.5% FBS. Cells were incubated for a further 48 hours and the media from 
these cells was collected and filtered. Conditioned media was then stored at -20oC until 
required for supplementation of HPC media.  
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2.2.4.  Murine Cardiac Endothelial Cell (MuCEC-1) Culture 
Isolation of primary murine endothelial cells is typically very difficult and requires elaborate 
and time consuming purification techniques (Marelli-Berg et al., 2000). Furthermore, 
overgrowth of contaminating cells often prevents long-term culture of these populations 
(Marelli-Berg et al., 2000). As a result of the difficulties encountered with primary isolates, 
an immortalised murine cardiac endothelial cell line was used (MuCEC-1) (Bouis et al., 
2001). MuCEC-1 cells were obtained from Dr. Elaine Lidington (Imperial College School of 
Medicine, UK). Cells were grown to confluence in gelatin coated flasks. MuCEC-1 cells are 
isolated from H-2Kb-tsA58 mice, which express a thermoliable strain (tsA58) of the SV(40) 
large T antigen (tsA58 TAg) which allows the production of conditionally immortalised cell 
lines (Lidington et al., 2002). Endothelial cells generated from these cell lines are 
characterised by their phenotypic cobblestone appearance and their ability to form tubes 
on an artificial extra-cellular matrix, as detailed in the paper by Lidington et al (2002). 
Furthermore, these cells were shown to be positive for ICAM-1 and VCAM-1, with selectin 
expression neglible (Lidington et al., 2002). MuCEC-1 were maintained in DMEM containing 
10% FBS, supplemented with 50U/ml penicillin, 50U/ml streptomycin and 2mM L-
Glutamine and 10ng/ml mEGF. At confluence, cells were enzymatically dissociated using 
Trypsin-EDTA, washed in complete media and split 1 in 3. For static adhesion assays, a 
confluent flask of MuCEC-1 was enzymatically dissociated using Trypsin-EDTA, washed in 
complete media and one third resuspended in 30ml of complete medium. 1ml of the 
resulting cell suspension was then added to each well of a 24 well plate containing a pre-
treated coverslip (please refer to section 2.4.) and allowed to grow to confluence prior to 
use. 
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2.2.5.  KG1a cell culture 
The KG1a cell line is a primitive human haematopoietic myeloid progenitor cell line, 
characterised by a robust expression of the human stem cell marker CD34 (Koeffler et al., 
1980).  KG1a cells were a kind gift from Dr. Heather Crosby (University of Birmingham, UK). 
They were used in intravital experiments to compare human and murine progenitor cell 
trafficking within murine hepatic microcirculation in vivo.  Cells were maintained in RPMI 
1640 (PAA Laboratories), containing 10% FBS (Invitrogen), 100U/ml L-glutamine, 100ug/ml 
penicillin and 292ug/ml streptomycin.  
 
2.2.6.   Whole bone marrow (WBM) cell preparation 
Whole bone marrow (BM) cells were isolated from the femurs and tibias of donor C57BL/6 
mice (Harlan, Oxon, UK). Animals were sacrificed by cervical dislocation and the hind limbs 
(both fibias/tibias) were separated from the hip-bone. Muscle was carefully removed from 
the bones and each bone was placed on ice until bone removal was complete. Small 
sections were moved from the epiphysis of each bone. The bone was subsequently washed 
through with ice-cold DMEM (supplemented with 10% FCS, 2mM L-Glutamine, 50U/ml 
Streptomycin, and 50U/ml Penicillin) using a 26G needle. Cells were pelletted and 
subsequently treated with ACK lysis buffer to lyse erythrocytes (0.15mM NH4Cl, 10mM 
KHCO3, 0.1mM Na.EDTA, pH 7.2-7.4). ACK lysis buffer was incubated with cells for 3 minutes 
and then immediately diluted 1:1 with ice-cold PBS. Cells were pelletted and washed twice 
by cold centrifugation (1200rpm, 4°C, 5 mins) in PBS supplemented with 0.1% BSA.  
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2.2.7.  Leukocyte isolation 
Leukocytes were isolated from donor 8-10 week old C57Bl/6 mice. Mice were 
anaesthetised by isoflurane, followed by CO2 narcosis. Following the cessation of breathing, 
a laporotomy was performed to enable access to the descending aorta. Blood was drawn 
from the descending aorta into heparin coated 1ml syringes. Blood obtained (approximately 
700μl) from one animal was added to 3ml of 1% dextran (in 0.9% saline) and subsequently 
topped up with 1% dextran (in 0.9% saline) to a final volume of 10ml. Erythrocytes were 
allowed to sediment for 30 minutes at room temperature and the leukocyte rich 
supernatant transferred to a new tube. Cells were pelletted and washed twice by cold 
centrifugation (4°C) in cold PBS supplemented with 0.1% BSA. Residual erythrocytes were 
subjected to hypotonic lysis by suspension in 7ml 0.2% NaCl with ten gentle inversions 
followed by hypertonic rescue by one inversion of an additional 7ml of 0.6% NaCl 
supplemented with 0.1% L-Glucose. Remaining leukocytes were washed once in PBS 
supplemented with 0.1% BSA. Leukocytes were resuspended in 1ml PBS with 0.1% BSA and 
counted. Cells were washed a further time in PBS with 0.1% BSA and resuspended to 1 x 106 
cells/100μl.  
 
2.2.8.  MACS cell isolation of primary HSCs 
Some experiments were conducted using a freshly purified population of Lin-ve Sca-1+ve BM 
cells.  These cells were isolated using a magnetic activated cell sorting (MACS) technique. 
Isolations were performed as per the manufacturers protocol (Mitenyi Biotech, Surrey, UK). 
Whole BM cells were obtained from the BM of the tibia and fibia of donor animals. Once 
isolated, cells were washed in MACS buffer by centrifugation (1200rpm, 4ºC, 5 mins). MACS 
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buffer consisted of PBS supplemented with 0.5% BSA and 2mM EDTA at pH 7.2. Cells were 
counted and washed a further time in MACS buffer. Cells were then resuspended in 90μl of 
MACS buffer per 107 total cells. 10μl of primary antibody was added and cells were 
incubated in darkness on ice for 10 minutes.  For lineage depletions, the primary antibodies 
were biotinylated lineage cocktail antibodies (CD5, CD45R (B220), CD11b, Gr-1 (Ly-6G/C), 7-
4, and Ter-119). For Sca-1+ isolations, the primary antibody used was anti-Sca-1-FITC. 
Following incubation with primary antibodies, 1ml of MACS buffer was added per 107 cells 
and cells were washed by centrifugation (1200rpm, 4°C, 5 mins). Supernatant was removed, 
and cells were resuspended in 80μl of MACS buffer per 107 total cells. To this, 20μl of 
secondary antibody coated microbeads were added to the cell suspension. For Sca-1+ 
isolation, the secondary antibodies were anti-FITC-microbeads. For lineage depletions, the 
secondary antibodies were anti-Biotin microbeads. Cells were washed by adding 1ml MACS 
buffer per 107 cells and centrifugation (1200rpm, 4°C, 5 mins). Cells were resuspended in 
500μl MACS buffer and run through an MS (for Sca-1) or LS (for Lineage depletions) 
separation column in the presence of a magnetic field, in order to retain positively labeled 
cells. The column was rinsed, and washed through with 3 washes of 500μl (MS) or 1.5ml 
(LS) MACS buffer. The column was then removed from the magnet and positively retained 
cells were washed from the column by flushing at high force 1ml (MS) or 3ml (LS) of MACS 
buffer through the column.  To isolate Lin-Sca-1+ cells, whole BM was initially depleted for 
lineage positive cells, and then subsequently Sca-1 positively selected from the remaining 
population. Cells were collected and analysed by FACS to check purity.  Isolates were 
typically 95% positive for the target population. 
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2.2.9  Fluorescent cell labelling  
Cell labelling was achieved using the flourescein label, 5’6-Carboxyfluorescein Diacetate 
Succinimidyl Ester (CFDA-SE). CFDA-SE is a non-fluorescent, cell permeable flourescein 
derivative, which is modified by intracellular esterases to render the molecule fluorescent. 
Modification by these intracellular enzymes also renders the modified molecule cell 
impermeant.  Cells (HPC-7 & HPC-5: 3 x 106 cells; whole bone marrow (WBM) ≈ 5 x 107 cells; 
KG1a: 3 x 106 cells; Leukocytes: ≈ 2 x 106) were washed with 1ml pre-warmed (37oC) PBS 
with 0.1% albumin in PBS (0.1% PBSA). Cells were then resuspended in 2ml pre-warmed 
0.1% PBSA, in preparation for staining. Stock CFDA-SE was diluted to 10mM in DMSO and 
aliquoted for future use. 2μl of 10mM CFDA-SE was added to 2ml of PBSA resulting in a 
staining solution at 10μM. 2ml of this solution was added to 2ml of cell suspension, 
resulting in a final staining volume of 4ml at 5μM CFDA-SE. Cells were incubated with the 
CFDA-SE solution for 10 minutes at room temperature in the dark. The staining reaction 
was quenched with 6ml of ice-cold complete Stem Pro SFM 34 medium (Invitrogen) for 
HPC-7 and HPC-5 cells or DMEM (Invitrogen) for WBM cells and leukocytes. Cells were then 
washed three times by centrifugation (1200rpm, 4°C, 5 mins) in relevant media and 
recounted. Cells were suspended to 1 x 106 per 100μl and kept on ice until 30 minutes prior 
to systemic injection for intravital experiments.  
 
2.2.10.  Acridine orange labelling of leukocytes 
For some experiments, leukocytes were labelled in vivo using the cell-permeable nucleic 
dye, Acridine Orange (Sigma-Aldrich, Poole, UK). When bound to DNA, Acridine Orange 
displays a similar fluorescent spectra to FITC, with an excitiation maximum of 502nm and an 
Chapter 2: Materials and Methods 
55 
emission of 525nm (green). To visualise leukocytes, animals were injected intra-arterially 
with 100μl of 200μg/ml Acridine Orange. If required, an additional 50μl of 200μg/ml of 
Acridine Orange was injected every 45 minutes.  
 
2.2.11.  Cell adhesion molecule blocking 
To identify critical surface adhesion molecules involved in recruitment, some cells were 
resuspended in 250μl of PBS supplemented with 0.1% BSA and containing 80μg/ml of the 
appropriate blocking antibody.  These included either the LE-AF isotype control (RTK4530) 
or LE-AF anti-CD31 (MEC13.3), LE-AF anti-CD49d (R1-2), LE-AF anti-CD44 (IM7) or NA-LE 
anti-CD18 (GAME-46). FACS studies were performed in order to ensure 80μg/ml is an 
adequate dose to ensure complete blockade of the respective antigen. Cells were incubated 
with blocking antibody for 15 minutes prior to CFSE staining. For some experiments, 
animals were injected with anti-VCAM-1 blocking antibodies (clone 429). Animals were 
surgically prepared as described previously. Immediately following ischemia, 70µg of anti-
VCAM-1 in 100µl was injected via the carotid artery. Control animals received an isotype 
control immediately following ischemia. A dose of 70µg is consistent with concentrations 
published in the literature using the same antibody (Belcher et al., 2005, John and Crispe, 
2004, Orito et al., 2007). 
 
2.2.12.  FITC-BSA production 
At the end of all intravital experiments, 200µl of FITC-conjugated bovine serum albumin 
(FITC-BSA) was injected intra-arterially.  When introduced systemically, it is retained within 
the vasculature, unless the integrity of the vessel is disturbed, thereby facilitating easy 
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visualisation of the vasculature and confirming blood flow (Kalia et al., 2002b).  10% FITC on 
celite was conjugated to bovine serum albumin (both Sigma, Poole, UK) by mixing the FITC, 
BSA and 10ml of bicarbonate buffer (pH 9.0) overnight at 4ºC . The resulting mixture was 
centrifuged at 10-12,000rpm for 10 minutes, and conjugated/unconjugated BSA separated 
by dialysis (12,000MW cut off; Spectrum Laboratories, CA, USA). Prepared FITC-BSA was 
frozen and stored until use in eppendorfs. 
 
2.3  Monitoring Cell Trafficking in vivo using Intravital Microscopy 
 
2.3.1.   Animals 
Animal experiments were completed with prior approval of the local ethics committee and 
the United Kingdom Home Office, in accordance with the Animals (Scientific Procedures) 
Act of 1986 under Project Licence 40/2749 (held by Dr. Neena Kalia). 9-11 week old male 
C57Bl/6 mice were obtained locally (Biomedical Services Unit, University of Birmingham, 
UK). Some experiments were condcuted on PECAM-/- mice (generous gift from Dr. Tak Mak, 
Amgen Institute, Toronto, Canada). PECAM-/- mice were bred from heterozygotes on a 
C57Bl/6 background and maintained locally (colony held by Professor Chris Buckley). 
PECAM-/- phenotype was confirmed by flow cytometric analysis of peripheral blood 
leukocytes (Duncan et al., 1999). All animals had ad libitum access to food and water.  
 
2.3.2.   Surgical Preparation  
Anaesthesia was induced by intraperitoneal administration of Ketamine (100 mg/kg Vetalar; 
Amersham Biosciences and Upjohn Ltd., UK) and xylazine hydrochloride (10 mg/kg; 
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Millpledge Pharmaceuticals, UK) delivered in 0.9% saline.  Maintenance anaesthesia was 
delivered intra-arterially as required. The trachea and right common carotid artery was 
cannulated with polyethylene portex tubing (Smiths Medical, Hythe, UK) to assist breathing 
and to allow administration of labelled cells and additional anaesthetic. A midline 
laporotomy was perfomed by cutting along the linea alba, an avascular fibrous structure 
found between the left and right rectus abdominis muscles. To facilitate liver 
exteriorisation, the left and right rectus abdominis muscles were removed using a cautery 
pen and the facilform ligament was cut releasing the liver from the diaphragm. 
 
 
2.3.3 Induction of Ischemia-Reperfusion Injury  
In some animals, uni-lobular ischaemia was induced by application of an atraumatic 
vascular clamp to the hepatic artery and hepatic portal vein supplying the left hepatic lobe 
for a period of 90 minutes.  Importantly, this allowed ischaemia to be induced in the left 
lobe alone as our preliminary studies demonstrated that even relatively short periods of 
total hepatic ischaemia resulted in significant mortality.  The liver lobe was reperfused by 
removal of the clamp and the animal was immediately prepared for intravital monitoring by 
moving it onto a custom designed plastic board with the liver exteriorised onto a glass 
microscope slide. The liver was then covered with Saran wrap to reduce the effects of 
respiratory movements and also to prevent superfusate buffer (see below) from 
accumulating beneath the liver.  Throughout the experiment, the preparation was 
continuously perfused by a bicarbonate-buffered saline solution (36ºC, pH 7.4) aerated with 
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5% CO2, 95% N2. Animals in sham procedures were exposed to the same liver manipulations 
as injured animals except the vascular clamp was not applied. 
 
2.3.4. Alanine Aminotransferase (ALT) levels following IR injury  
To biochemically confirm that hepatic injury had occurred, blood samples were obtained 
from mice subject to sham or IR procedures at different time points.  Increased levels of 
serum ALT are directy proportional to the extent of liver injury. Samples were analysed 
using an Olympus Au400 analyser.  The automated analyzer facilitates ALT activity and 
monitors light absorbance at 340nm which is relative the level of enzyme in the sample. 
Sampling was performed by the Department of Clinical Chemistry at the Birmingham 
Women’s Healthcare NHS Trust (Birmingham, UK). 
 
2.3.5.  Quantification of Cell Trafficking in vivo  
Using the x10 objective, one hepatic field of view (413μm x 308μm) was pre-selected 
containing 1-2 post-sinusoidal venules and sinusoidal capillaries.  After capturing a 10 sec 
digital video, fluorescent cells were administered intra-arterially as a 100μl bolus at 30 
minutes post-reperfusion.  1 minute recordings were taken from the same pre-selected 
field of view every five minutes for a period of 60 minutes (ie. until 90 min post-
reperfusion).  At the end of this monitoring period, an additional six fields of view were 
taken in order to ensure the events taking place in the pre-selected field of view 
represented those taking place in other regions of the liver. These 6 regions were not 
randomly selected but followed a strict pre-determined pattern. The six regions were 
selected relative to the position of the initial field (Figure 2.1). Events in the pre-selected 
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region were considered representative if the final level of cell adhesion was within two 
standard deviations of the mean of the six fields examined following the experiments. Two 
standard deviations are typically expected statistically to contain around 95% of the 
population. At the end of some intravital experiments, 100μl of FITC-conjugated BSA was 
injected to visualise the vasculature and confirm the presence of blood flow. All recordings 
were stored digitally using Slidebook software (versions 4.1 – 4.1.16, Intelligent Imaging 
Innovations, Denver, US) and analysed offline.  
 
Quantification of the cell trafficking intravitally has been well documented in the field of 
microcirculation research (Vowinkel et al., 2004, Anthoni et al., 2006, Wallace et al., 1999). 
Free-flowing cells were identified as cells which were visible in the field of view but were 
either non-static, or static for less than 30 seconds. Observation of rolling interactions 
within sinusoidal capillaries were extremely rare – as a result, experiments were not 
analysed for numbers of rolling cells.  Adherent cells were identified as cells which were 
visible in the field and static for more than 30 seconds.  Cells which entered the field of 
view after the mid-point of the 1 minute recording were classified as free-flowing, as it was 
impossible to ascertain if they remained adherent beyond 30 seconds.  Adhesion of 
fluorescently labelled cells was extremely rare within the post-sinusoidal venules and 
occurred predominantly within sinusoids.  Therefore, adhesion was presented as total 
adhesion per field of view.  When quantifying levels of adhesion, only those cells observed 
within the focal plane were counted.  Therefore, out of focus cells, identified by their 
inability to present as punctate ovoid elements in the field of view, were not counted. 
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Figure 2.1. Selection Criteria for Field of View to Monitor for Adhesive Events Intravitally. 
Six fields of view were selected at the end of experiments to ensure data obtained from the 
initial pre-selected field of view were representative of events taking place across the whole 
liver. Events in the pre-selected region were considered representative if the final level of 
cell adhesion was within two standard deviations of the mean of the six fields examined 
following the experiments. Two standard deviations are typically expected to contain 
around 95% of the population. 
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Results are expressed as mean adherent or free flowing cells per field per minute at each 
time point ± SEM. 
 
2.3.6.  Anti-inflammatory effects of HPC-7 cells following IR injury  
To examine the potential anti-inflammatory effects of HSCs following IR injury, experiments 
were performed to investigate whether pre-administration of a HPC-7 bolus could 
subsequently reduce leukocyte recruitment following IR injury when compared to a saline 
bolus.  Animals were surgically prepared as described above.  Ischemia was similarly 
induced (at a time denoted T0) and reperfusion was commenced after 90 minutes ischemia 
(T90).  One minute was allowed for restoration of hepatic flow subsequent to which 5x106 
or 1x106 unlabelled HPC-7 cells in 100μl PBS were injected via the carotid artery or hepatic 
portal vein respectively. To directly inject cells via the hepatic portal vein, a 30G (BD 
Microlance, Drogheda, Ireland) needle was used.  Bleeding was prevented by applying 
gentle pressure on the vessel using a small haemostatic swab. Animals suffering excessive 
bleeding were sacrificed at the point of blood loss and excluded from analysis. Control 
animals received a 100μl bolus of saline. It should be noted that injections via the portal 
vein led to frequent bleeding and introducing cells via this route was not persued routinely.   
 
To monitor exogenous leukocytes, cells were isolated from two strain and age matched 
donor mice, labelled with CFSE and 5 x 105 cells injected at 2.5 hours post-reperfusion via 
the same route as the first injection.  After 15 minutes, animals were subsequently culled, 
and tissues examined using an Olympus IX81 inverted microscope (Olympus, UK).  
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2.3.7.  Quantification of HSC Recruitment in Major Organs ex vivo  
For some experiments, specific organs were examined ex vivo for labelled cell recruitment 
using an Olympus IX81 inverted microscope. Animals were culled and the injured and non-
injured liver, kidney, spleen and lungs were removed after intravital experiments were 
completed. All organs were washed twice in 0.9% saline to remove traces of blood.  The 
lungs and liver lobes were placed on a plastic dish and the flat vascular surface was 
visualised. The kidneys and spleen were sectioned coronally and sagitally respectively, 
further washed to remove excess blood, placed on a plastic dish and the inner surface 
visualised. Ten fields of view were selected in a set pattern; an initial field was selected 
blindly in the bottom left hand corner of the tissue, and subsequent fields were selected 
relative to the initial field while ensuring whole organ coverage.  Fluorescent cells were 
counted manually using blinded counting software (see 2.4.3). 
 
2.4.   Quantification of Cell Adhesion in vitro 
 
2.4.1.  Frozen Tissue Static Adhesion Assay 
The Stamper-Woodruff static adhesion assay was used to examine cell adhesion to snap 
frozen sections of liver in vitro (Stamper and Woodruff, 1976). C57BL/6 mice were 
subjected to hepatic IR injury or sham surgery.  The liver lobe was removed, snap frozen in 
liquid nitrogen and stored at -80ºC until ready for sectioning.  The livers were embedded in 
Cryo-M-bed (Bright Instruments, Cambridge, UK) and 10μm sections were obtained using a 
Bright Instruments cryostat and mounted on X-tra™ adhesive microscope slides (Surgipath, 
Peterborough, UK). For some experiments, sections were mounted on standard glass 
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microscope slides pre-coated overnight with 10% Poly-L-lysine at 4ºC (Sigma-Aldrich). 
Sections were stored at -20ºC until use when they were fixed in 100% acetone for 5 
minutes, washed in PBS and encircled using a wax immunology pen (Immedge; Vector 
Laboratories, Peterborough, UK). 100μl of cell suspension (HPC-5/HPC-7/WBM/KG1a) was 
added to each slide and incubated in a humidified tray on a laboratory rocker for 20 
minutes. Slides were then immediately fixed for five minutes in 100% acetone and sections 
subsequently washed in PBS.  Slides were dried, coverslips mounted using Gel Mount 
aqueous mounting medium (Sigma) and analysed using a Zeiss Axiovert Microscope (Carl 
Zeiss, Hertfordshire, UK) and Zeiss Axiovision Software. Ten separate fields were selected 
from each tissue using a set field pattern with fields of view containing large portal areas 
excluded. An initial field was pre-selected in the bottom left hand corner of the tissue and 
subsequent fields selected relative to this to ensure full organ coverage. Fluorescent cells 
were counted manually using blinded counting software (see 2.4.3). Results are expressed 
as mean adhesion per field ± SEM. 
 
2.4.2.  Endothelial Cell Static Adhesion Assay 
The endothelial static adhesion assay was used to monitor cell adhesion to endothelial cells 
in vitro. Small coverslips (13mm) were pre-treated with APES to aid endothelial cell 
adhesion. Coverslips were further prepared for the static adhesion assay by washing with 
5M nitric acid (overnight), running water (4 hours), 25ml acetone (three washes) and 25ml 
4% APES in acetone (2 washes).  Coverslips were then left in a dark place overnight and 
washed further with acetone (2 washes) and finally with distilled water. All coverslips were 
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autoclaved prior to use.  Endothelial cells (MuCEC-1) were cultured to confluence on the 
treated coverslips which were placed in the bottom of 24 well plates.  
 
Media was removed from the endothelial monolayers which were then washed twice with 
1ml warm PBS containing 0.1% BSA (0.1% PBSA). Following washing, 5 x 105 HPC-7 cells (in 
500µl) were added to the endothelial monolayers for 5 minutes.  HPC-7 cells were pre-
treated with 20ng/ml TNF-α, 20ng/ml CXCL12, 20ng/ml IL-1β, or 20ng/ml CXCL1 (all made 
up in complete Stem Pro 34 SFM) for 4 hrs.  Since cytokines were diluted in PBS, an 
appropriate volume of PBS alone was used as a control.  HPC-7 cells were labelled with 5μM 
CFSE to aid visualisation.  For CFSE-activation studies in Chapter 3, HPC-7 cells were 
visualised using phase-contrast microscopy.  
 
Endothelial monolayers were washed with warm 0.1% PBSA and left for 10 minutes to allow 
transendothelial migration. Following this period, HPC-7 cells and endothelium were fixed 
by incubation with 2% glutaraldehyde in PBS for 15 minutes at 37ºC. The fixative was then 
washed away three times with 0.1% PBSA. Plates were stored at 4ºC until ready for 
analysis. Coverslips were removed from wells and mounted on X-tra™ adhesive microscope 
slides (Surgipath, Peterborough, UK) with gel mount aqueous mounting medium (Sigma). 
CFSE labelled HPC-7 cells were imaged using a Zeiss Axiovert Microscope (Carl Zeiss, 
Hertfordshire, UK) and Zeiss Axiovision Software. Non-CFSE labelled HPC-7 cells were 
imaged using a phase contrast microscope. Ten separate fields were selected from each 
endothelial monolayer using a set pattern to ensure randomness. An initial field was 
selected blindly in the bottom left hand area of the endothelial monolayer and subsequent 
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fields were selected relative to the initial field while ensuring complete coverage (pattern: 
select initial field, move two fields up, move two up, move two right, move two down, 
move two down, move two right, move two up, move two up, move two right). Slides were 
analysed and cells counted using the public domain ImageJ analysis software (Wayne 
Rasband, NIH, US).  
 
2.4.3.  Development of Software to Ensure Observer Blind Quantificataion 
In order to ensure observer blind quantifictaion of tissue analysis occurred, software was 
developed (Figure 2.2). Image frames were saved in folders representing experiments and 
the details fed into the application. The program subsequently randomises the order in 
which the images are displayed for counting. Counting takes place manually with the 
operator performing the counting unaware as to which experiment the frame originates 
from.  After all fields from all experiments have been counted, the data is collated into the 
respective experiments. The application can be downloaded gratis from 
http://www.dephilon.com/Counter.exe. 
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Figure 2.2. Analysis of adhesion using custom written blind counting software. Adhesion in 
frames were counted manually using custom software. The experimental set is not visible at 
any point during the counting procedure and thus reduces observer bias.  
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2.5.   FACS-based studies 
 
2.5.1.  Standard FACS protocol for use on cell suspensions  
Progenitor cells were removed from incubation media by cold centrifugation (1200rpm, 
4ºC, 5 minutes). Cells were subsequently washed by centrifugation in cold PBS and 
resuspended in 100μl PBS containing 0.1% BSA and 5% FBS for 15 minutes on ice to block Fc 
receptors. For some experiments, Fc receptor blockade was achieved by incubation with Fc 
Block (CD16/32) on ice for fifteen minutes. Blocking Fc receptors reduces subsequent 
non-specific antibody binding. Following Fc Block, cells were incubated with primary 
antibody at the recommended dilution (see Table 2.1) for 15 minutes in darkness and on 
ice. If appropriate, following incubation with primary antibody, cells were incubated with 
secondary antibodies (again at the appropriate dilution) for a further 20 minutes in 
darkness and on ice. Following antibody incubation, cells were washed three times by 
addition of 100μl PBS with 0.1% albumin and centrifugation. Following washes, cells were 
resuspended in 300μl 0.1%PBSA and supplemented with 0.6μl of 0.5mg/ml propidium 
iodide (PI), a popular red fluorescent nuclear and chromosome counterstain. It is not 
permeant to live cells so enables visualisation of dead cells from a general population.  
 
Following PI addition, suspensions were loaded onto and analysed on a BD FACSCalibur 
flow cytometry system. The system has two available excitation lasers (488nm and 635nm) 
allowing the use of multiple coloured dyes, which can be detected on four different filters 
(FL1-4). FL1 allows detection of dyes with an emission wavelength of around 530nm 
including flourescein isothiocyanate (FITC). FL2 allows detection of dyes with an emission 
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wavelength of around 585nm including phycoerythrin (PE). FL3 allows detection of dyes 
with an emission wavelength of around 670nm including propidium iodide (PI). FL4 allows 
detection of dyes with an emission wavelength of around 661nm including Cy5. Cell 
counting was terminated following the collection of 10,000 live (PI-negative) events. 
 
2.5.2.   Confirmation of adhesion molecule blockade 
The role of various adhesion molecules in permitting adhesion of HPC-7 cells both in vitro 
and in vivo was determined using an array of specific function blocking antibodies.  
However, prior to antibody use for blocking experiments, FACS based studies were used to 
confirm complete blockade of the specific adhesion molecule. HPC-7 cells were suspended 
in aliquots of 1.2 x 107 cells in 100μl PBSA. Each aliquot was treated with increasing 
concentrations of the function blocking antibody (0, 10, 20, 40, 80, 160μg/ml) for 15 
minutes. Cells were subsequently washed twice in 100μl of 0.1% PBSA.  Following washing, 
cells were incubated with 2μl of a fluorescent conjugate of the same clone as the blocking 
antibody (see Figure 2.3) for 15 minutes in darkness. Cells were subsequently washed twice 
in 200μl of 0.1% PBSA and finally resuspended in 300μl of 0.1% PBSA.  Suspensions were 
supplemented with 0.6μl of PI (1:500). Cells were analysed using standard FACS procedures. 
Fluorescent intensity was taken as the mean fluorescent intensity of 10,000 live (PI-
negative) cells.  
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2.5.3.  Conditioned media incubations  
In order to determine whether factors released from injured liver could modulate 
expression of adhesion molecules on HSCs, HPC-7 cells were treated with tissue 
conditioned media (TCM). Experiments were conducted using hepatic and intestinal tissue 
in order to determine whether any changes in adhesion molecule expression were induced 
specifically by the liver or any similarly injured organ. C57BL/6 mice were subjected to 90 
minutes partial hepatic ischaemia or, for comparison purposes, 45 minutes small intestinal 
ischemia (clamping of the superior mesenteric artery) followed by reperfusion for one hour. 
Control animals underwent sham surgery.   
 
Following reperfusion, the entire injured liver lobe or a 2cm section of jejunal gut tissue was 
harvested into 2ml of complete Stem Pro and disrupted using an electronic tissue 
homogeniser (Power Gen 125; Fisher Scientific, Leicestershire, UK). Homogenates were 
incubated for 24 hours and then filtered to remove cells and leave soluble mediators. For 
liver homogenates, 2ml of complete Stem Pro was added to make a total volume of 4ml for 
filtering. Suspensions were initially passed through a 70μm filter (BD Falcon, Oxford, UK) to 
remove larger pieces of tissue and then passed through a 0.45μm filter (Millipore, Watford, 
UK). Intestinal homogenates were filtered directly through a 0.45μm filter. 5 x 106 HPC-7 
cells were incubated with 125μl of conditioned medium in 375μl Stem Pro. Controls were 
incubated in 500μl Stem Pro (conditioned medium was generated into Stem Pro). Following 
24 hours incubation, cells were washed and analysed by FACS (using standard protocols) for 
any shifts in adhesion molecule expression (see section 2.5.1).  
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2.5.4  Cytokine incubations 
To analyse the effect of inflammatory cytokines on HPC-7 adhesion molecule expression, 
cells were incubated with various cytokines. HPC-7 were incubated for 24 hours with 
100ng/ml TNF-α, 100ng/ml CXCL12, 25ng/ml IL-1β, or 100ng/ml IL-6 (all made up in 
complete Stem Pro 34 SFM). As cytokines were diluted in PBS, negative controls consisted 
of Stem Pro 34 SFM with an identical volume of PBS. For some experiments, cells were 
treated for different lengths of time with a cocktail of all the above cytokines at 10ng/ml or 
20ng/ml. Following treatment, cells were washed and analysed as per the standard FACS 
protocol (see section 2.5.1). 
 
 
2.5.5.  Plasma incubations 
In order to analyse the effect of plasma derived from animals undergoing hepatic IR injury 
on CD49d expression, HPC-7 cells were incubated with conditioned plasma in media. 
Animals (C57BL/6; 25g bwt) were subjected to 90 minutes ischaemia followed by 
reperfusion for one hour. Control animals underwent sham surgery. Following reperfusion, 
Mice were anaesthetised by isoflurane, followed by CO2 narcosis. Following the cessation of 
breathing, a laporotomy was performed to enable access to the descending aorta. Blood 
was drawn from the descending aorta into heparin coated 1ml syringes. Blood was then 
transferred to an eppendorf and plasma isolated by centrifugation (3000rpm, 7 mins, RT). 
This plasma was subsequently isolated, and added 1:4 to Stem Pro medium. 1 x 106 HPC-7 
cells were treated with 1ml of the plasma/medium mixture overnight and CD49d 
expression assessed by FACS, as per standard FACS protocols (see section 2.5.1). 
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3.   Recruitment of HSCs by Ischemia-Reperfusion Injury 
 
3.1.  Introduction and hypotheses 
 
3.1.1.  Introduction 
While the mechanisms by which HSCs convey benefit and induce tissue repair remain 
unclear, recruitment to the tissue of interest is a vital prerequisite. The experiments within 
this chapter investigated whether an experimental model of acute hepatic injury could be 
used to monitor stem cell recruitment after systemic administration. Ischemia-reperfusion 
(IR) injury is a serious clinical problem and has been reported to stimulate stem cell 
recruitment. Following renal IR injury, transplanted HSCs (RhloLin-Sca-1+ckit+) integrate into 
the renal tubule and contribute to regeneration (Lin et al., 2003). In mice subjected to 
myocardial infarction, human CD34+ HSC fusion with host cells prompted cell-cycle re-entry 
of fused cardiomyocytes and thus stimulated their proliferation (Zhang et al, 2007). It was 
suggested that cardiomyocyte re-entry into the cell cycle was a result of reprogramming of 
the host cell by the HSC (Zhang et al., 2007). While studies in the liver have shown that 
populations of progenitor cells can home to the liver post-systemic injection (Jiang et al., 
2002), the chronological dynamics of this adhesion have not been elucidated.  
 
This chapter also presents data comparing the recruitment of adult HSCs with embryonic 
HSCs. Much ethical debate surrounds the therapeutic use of embryonic HSCs (Scott and 
Reijo Pera, 2008). During development, haematopoiesis begins in the dorsal aorta within 
the aorta–gonads–mesonephros region, shifting to the foetal liver before finally occurring 
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in the BM, where haematopoiesis continues during adult life (North et al., 2002, Lux et al., 
2008). Therefore, the function of embryonic HSCs is essentially identical to adult HSCs, 
however, the anatomical compartment in which these cells sit may influence their 
behaviour and properties. While much of the work investigating tissue repair has focused 
on adult HSCs, the recruitment potential, and indeed the regenerative potential, of these 
cells has not been compared in detail to embryonic HSCs in models of the injured liver. 
Should embryonically derived HSCs behave in a manner similar to their adult counterparts, 
it may provide support for use of the more ethically acceptable adult HSCs.  Furthermore, 
this chapter also investigated and compared the recruitment of HSCs with whole BM 
(WBM) cells.  It has been suggested that unfractionated WBM cells may also have potential 
for hepatic regeneration (Grompe, 2003). 
 
 
3.1.2.  Hypotheses 
For the work included in this chapter we hypothesized: 
 
1.  The adhesion status of HSCs is unaffected by treatment with low concentrations of the 
 fluoresent labeling dye, CFSE 
2.  Short periods of total hepatic ischemia provide a reproducible, robust and severe 
 injury model for monitoring the trafficking of administered cells 
3.  The adhesion of whole bone marrow (WBM) cells and HSCs to snap frozen hepatic 
 tissue sections is significantly greater for tissue derived from IR injured animals 
 compared to sham liver  
4.  The adhesion of WBM cells and HSCs to the hepatic microcirculation is 
 significantly raised in vivo in animals subjected to IR injury 
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5.  The recruitment of primary isolated HSCs (Lin-Sca-1+) is significantly raised in 
 vivo in animals subjected to IR injury 
6.  The recruitment of a human HSC-like cell line, KG1a, is significantly raised in vivo in 
 animals subjected to IR injury 
 
3.2.  Methods 
The methods used in this chapter are described in detail in Chapter 2. Briefly, HPC-7 cells 
were incubated with varying concentrations (0µM, 5µM, 50µM) of CFSE in order to 
determine if the staining protocol activates cells. To examine this possibility, cells were 
stained and then exposed to endothelium and their adhesion quantitated using static 
adhesion assays.  In order to establish a viable experimental injury model, C57BL/6 mice 
were subjected to varying periods of ischemia and reperfusion.  Animals underwent either 
total (THI) or partial (PHI) hepatic ischemia as an insult. THI, which injured all four lobes of 
the liver, was achieved by clamping the extra-hepatic portal vein and hepatic artery. PHI 
was achieved by clamping only the left portal vein and left hepatic artery branches that 
feed the left lobe of the liver. All subsequent experiments within this thesis were conducted 
on animals undergoing 90min PHI / 30min R, as high mortality rates were observed with THI 
(see results section).   
 
For immunohistochemistry, sections were isolated from IR (90min PHI / 30min R) or sham 
injured animals, snap frozen and hematoxylin and eosin (H&E) stained to examine the 
morphology of the tissues. In blood analysis experiments, samples from IR (90min PHI / 
30min R) or sham animals were analysed for circulating cell fraction percentage and plasma 
ALT using an automated analysis system (ABX, Montpellier, France). Enzyme levels were 
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obtained using an automatic analysis system (Olympus Au400). Stamper-Woodruff 
adhesion assays were used to quantify cell adhesion to tissue sections in vitro. Tissues were 
isolated from animals and immediately snap frozen, maintaining their morphology and 
protein expression. Cells were then incubated with sections to allow them to adhere to 
adhesion molecules on the section.  Stamper-Woodruff assays were performed on sham 
and IR (90m PHI / 30m R) sections, using 1 x 105 HPC-5, HPC-7, WBM or KG1a cells.  
 
Fluorescent intravital microscopy was performed on male 25-30g C57Bl/6 mice. The carotid 
artery and trachea were cannulated and the animal subjected to either sham or IR 
treatment (90min PHI / 30min R). During reperfusion, the animal was moved on to the 
stage of an intravital microscope and a field of view for analysis was pre-selected. At 30 
minutes reperfusion, 1 x 106 5μM CFSE labeled cells were introduced via the carotid artery 
and their recruitment analysed. For the investigation of primary cell adhesion, between 1.2 
x 105 and 3.3 x 105 Lin-Sca-1- cells were introduced via the carotid artery.  
 
3.3.  Results 
 
3.3.1.  CFSE labelling does not affect the adhesion of HPC-7 cells  
Although HPC-7 adhesion decreased slightly following treatment with 5μM and 50μM, this 
was not statistically significant when compared to untreated (0μM) cells (0μM: 31.20 ± 
4.87, 5μM: 24.10 ± 3.05, 50μM: 24.52 ± 2.23) (figure 3.1.A). Transmigration of cells was not 
observed within the duration of the experiment, even with untreated cells (figure 3.1.B-D).  
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Figure 3.1. HPC-7 cells are not activated by CFSE labeling. Cells were treated with increasing 
concentrations of Carboxyfluorescein diacetate, succinimidyl ester (CFDA-SE). No significant 
effect of CFDA-SE staining on the adhesion of HPC-7 cells (white cells) to MuCEC-1 (dark 
cells) is observed at either 5μM or 50μM compared to volume control (panel A). 
Representative images are shown from 0μM (panel B), 5μM (panel C) and 50μM (panel D) 
CFSE treated HPC-7. Bars represent mean adhesion ± SEM of 5 separate experiments; 
(Panel A: one-way ANOVA). 
A 
B C D 
0μM CFSE 5μM CFSE 50μM CFSE 
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3.3.2.  Total hepatic ischemia has a high mortality rate and is therefore unsuitable 
for continuous monitoring 
IR injury can be fatal, especially if it involves the entire liver (THI). Congestion of blood 
within the feeding portal vessels subsequently leads to intestinal microcirculatory 
congestion which contributes significantly to the assosciated mortality. In order to identify 
a protocol for IR injury which did not cause mortality within the intravital observation 
period, we performed experiments with varying different ischemic protocols. 100% 
mortality was observed in animals subjected to 60m THI or 45m THI, with a slight 
improvement survival in the 30m THI and 20m THI groups (33%) (figure 3.2.). All animals in 
all groups survived their respective ischemic phase, with mortality occurring during the 
reperfusion phase (data not shown). Almost all mortality during reperfusion occurred 
between 1-20 minutes reperfusion (data not shown). As THI was incompatible with animal 
survival, another group was subjected to 90m PHI followed by 90 minutes reperfusion. All 
animals survived this procedure, with survival at 100%. Hereafter IR injury refers to partial 
IR injury of the left hepatic lobe (90 minutes ischemia). 
 
3.3.3.  Histological damage is not present on sections from IR injured animals  
Liver sections were taken from animals subjected to hepatic IR and sham procedures and 
stained with H&E (sections were taken at 30 minutes reperfusion). Sections were examined 
for signs of acute morphological damage. Microscopic examination revealed no obvious 
morphological damage on sections from IR treated when compared to sham treated 
animals (figure 3.3.A-B). Anatomically, tissues appeared undamaged and displayed good 
sinusoidal structure.  
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Figure 3.2. Periods of total hepatic ischemia cause significant mortality in treated animals. 
Animals were subjected to varying periods of total hepatic ischemia (THI) followed by 90 
minutes reperfusion. Mortality within the 90 minute reperfusion duration was monitored. 
Even relatively short periods of THI were associated with significant mortality in mice. In 
contrast, all animals tolerated 90 minutes of partial hepatic ischemia (PHI) to the left 
hepatic lobe followed by 90 minutes reperfusion. The data is presented as percentage 
survival of at least 2 animals (60min THI / 90min R n=2; 45min THI / 90min R n=2; 30min THI 
/ 90min R n=3; 20min THI / 90min R n=3; 90min PHI/90min R n=3) 
Chapter 3: Recruitment of haematopoietic stem cells following partial hepatic ischemia-
reperfusion injury 
80 
 
 
 
 
 
Figure 3.3. Acute hepatic injury is not evident histologically on sections from IR Treated 
animals when compared to Sham Treated animals. Livers were isolated from Sham (panel 
A) and IR (90min / 30min R) treated (panel B) animals (at 30 minutes reperfusion) and 
stained with hematoxylin and eosin (H&E) to examine for acute damage to the hepatic 
architecture. No disruption of the hepatic architecture is visible on sections from either 
Sham or IR treated animals. Images are representative of sections seen in 3 separate sham 
or IR treated animals. 
A 
B 
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3.3.4.  ALT levels and circulating neutrophil counts are raised in IR injury 
In order to confirm the presence of injury, blood samples were examined following 90min 
PHI / 30min R. Levels of ALT were slightly, but insignificantly, raised as a result of sham 
treatment compared to an untreated control (sham: 53.67 ± 7.27 U/L vs untreated: 34 ± 3 
U/L; p > 0.05) (figure 3.4.A). Levels of ALT in both untreated and sham treated animals are 
within normal ranges reported in the literature for mice (Car et al., 1994). However, IR 
injury significantly increased circulating plasma ALT over 30-fold when compared to sham 
controls (sham treated: 53.67 ± 7.27 U/L vs IR treated: 1422 ± 637.80 U/L; P < 0.05) (figure 
3.4.A).  
 
A slight decrease in circulating white blood cells was observed following IR injury but this 
decrease was not significant (sham treatment: 1.80 ± 0.20 x 103/mm3 vs IR injury: 1.02 ± 
0.75 x 103/mm3; P > 0.05) (figure not shown). PHI injury significantly reduced the circulating 
lymphocyte percentage (IR injury: 96.28% ± 0.54% vs sham treated: 83.83% ± 5.51%; P < 
0.05) (figure 3.4.B). A concomitant significant increase in circulating neutrophil percentages 
was observed (sham treated: 2.28% ± 0.46% vs IR treated: 12.39% ± 2.87%; P < 0.01) (figure 
3.4.B).  
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Figure 3.4. Plasma Alanine Aminotransferase (ALT) levels and circulating neutrophil levels 
are significantly increased acutely as a result of Partial Hepatic Ischemiai. Blood samples 
were analysed from Sham and IR treated animals (90 minutes partial ischemia, 30 minutes 
reperfusion) for plasma levels of ALT (a commonly used marker of liver injury) and 
circulating white blood cell counts. Sham treatment did not significantly raise plasma ALT 
when compared to untreated animals (panel A). PHI significantly raised plasma ALT levels 
when compared to Sham treated animals (panel A). Normal range for mice is identified by a 
dashed bar, and obtained from Car et al (1994). PHI significantly increased circulating 
neutrophil levels as a proportion of whole blood (panel B; clear bar: sham injury, filled bar: 
IR injury). Bars represent mean ± SEM of at least 3 experiments; * p < 0.05, ** p < 0.01 
(Panel A: One-way ANOVA with Bonferroni Multiple Comparison Test. Panel B: Unpaired t-
test). Normal range from Car et al (1994). 
A 
B 
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3.3.5.   Whole bone marrow cell adhesion is raised in vitro on IR liver sections  
Significantly more WBM cells bound to sections isolated from IR injured animals when 
compared to sections from sham treated controls (sham control: 31.57 ± 10.56 vs IR  
treated: 63.43 ± 6.45; P < 0.05) (figure 3.5.A). Adhesion was predominantly to the sinusoidal 
capillaries and rarely in the larger portal vessels, therefore portal adhesion was not 
assessed separately (figures 3.5.B-C).  
 
3.3.6.  HPC-7 adhesion is raised in vitro on IR liver sections 
HPC-7 cells are an immortalised embryonic stem cell line, generated by transfection with 
the LIM-Homeobox gene, Lhx2 (Pinto do Ó et al., 2001) and HPC-5s are an immortalised 
adult stem cell line, generated from adult BM by genetic modification (Pinto do Ó et al., 
1998). We used these cell lines as model stem cells to provide a reliable and pure source of 
cells for functional studies.   
 
Significantly more HPC-7 bound to frozen sections of IR tissue compared to sections 
isolated from sham controls (sham sections: 5.13 ± 0.27 vs IR sections: 15.00 ± 3.31; P < 
0.05) (figure 3.6.A). Adhesion of HPC-7 cells was also predominantly sinusoidal (figures 
3.6.B-C). However, the overall adhesion of HPC-7 cells to frozen liver sections was 
significantly less when compared to WBM cells (Sham: WBM: 31.57 ± 10.56 vs HPC-7: 4.75 ± 
0.43; p < 0.05; PHI: WBM: 63.43 ± 6.45 vs HPC-7: 15.00 ± 3.31; P < 0.01) (WBM: Figure 
3.5.A; HPC-7: Figure 3.6.A) 
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3.3.7.  HPC-5 cell adhesion is not raised in vitro on IR liver sections 
Adhesion of HPC-5 cells did not increase on IR sections compared to tissue from sham 
controls (sham controls: 2.03 ± 0.34 vs IR treated sections: 2.17 ± 0.83; P > 0.05) (figure 
3.7.A). Again, adhesion was predominantly sinusoidal with very little portal adhesion 
(figures 3.7.B-C). The overall adhesion of HPC-5 cells to frozen liver sections was 
significantly less when compared to HPC-7 cells (Sham: HPC-5: 2.03 ± 0.34 vs HPC-7: 4.75 ± 
0.43, P < 0.01; PHI: HPC-5: 2.17 ± 0.83 vs HPC-7: 15 ± 3.31, P < 0.05) (HPC-7: Figure 3.6.A; 
HPC-5: Figure 3.7.A).  
 
3.3.8.  Whole bone marrow adhesion is significantly raised in vivo by IR injury 
Significantly more WBM cells adhered to the hepatic vascular bed in IR animals compared 
with sham controls (e.g. at 55 minutes, sham control: 6.20 ± 1.68 vs IR injury: 16.63 ± 2.28; 
P < 0.01) (figure 3.8.A). WBM adhesion in IR animals increased steadily throughout the 
duration of the experiment with adhesion at 60 minutes post-reperfusion significantly 
different from 30 minutes (30 minutes post reperfusion: 9.56 ± 1.71 vs 60 minutes post 
reperfusion: 17.88 ± 2.64; P < 0.05) (figure 3.8.A). In comparison, adhesion in sham treated 
animals remained unchanged throughout the time course of the experiment (eg. 30 
minutes: 2.86 ± 0.88 vs 60 minutes: 6.50 ± 2.47; P > 0.05) (figure 3.8.A). Consistent with the 
in vitro experiments, WBM adhered to sinusoids and not portal areas (figures 3.8.C-D). No 
significant difference was observed between the number of free flowing cells in IR animals 
compared to controls at any time point (e.g. at 55 minutes: sham control: 2.60 ± 1.4 vs IR 
injured: 3.00 ± 0.96; P > 0.05) (figure 3.8.A). Unsurprisingly, there was a tendency for more  
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Figure 3.5. WBM cell adhesion is significantly raised on sections isolated from IR treated 
animals when compared to sham controls. WBM cell adhesion was examined on hepatic 
sections using the Stamper-Woodruff assay. Sections were isolated from sham and IR 
treated (90 PHI / 30 R) animals and 1 x 105 CFSE-labelled WBM cells were exposed to 
sections for 20 minutes. Adhesion was counted in 10 fields on each section, and an average 
for each section obtained. Significantly raised adhesion was observed on sections isolated 
from IR treated animals when compared to sham sections. Results are shown in panel A. 
Representative images are shown of Sham (panel B) and IR treated (panel C) sections. 
White bars represent 100μm. Bars represent mean adhesion ± SEM of at least 3 separate 
experiments; * p < 0.05 (unpaired t-test). 
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Figure 3.6. HPC-7 cell adhesion is significantly raised on sections isolated from IR treated 
animals when compared to sham controls. HPC-7 cell adhesion was examined on hepatic 
sections using the Stamper-Woodruff assay. Sections were isolated from sham and IR 
treated (90 PHI / 30 R) animals and 1 x 105 CFSE-labelled HPC-7 cells were exposed to 
sections for 20 minutes. Adhesion was counted in 10 fields on each section, and an average 
for each section obtained. Significantly raised adhesion was observed on sections isolated 
from IR treated animals when compared to sham sections. Results are shown in panel A. 
Representative images are shown of Sham (panel B) and IR treated (panel C) sections. 
White bars represent 100μm. Bars represent mean adhesion ± SEM of 3 separate 
experiments; * p < 0.05 (unpaired t-test). 
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Figure 3.7. HPC-5 cell adhesion is not raised on sections isolated from IR treated animals 
when compared to sham controls. HPC-5 cell adhesion was examined on hepatic sections 
using the Stamper-Woodruff assay. Sections were isolated from sham and IR treated (90 
PHI / 30 R) animals and 1 x 105 CFSE-labelled HPC-5 cells were exposed to sections for 20 
minutes. Adhesion was counted in 10 fields on each section, and an average for each 
section obtained. Adhesion was not raised on sections isolated from IR treated animals 
when compared to sham sections. Results are shown in panel A. Representative images are 
shown of Sham (panel B) and IR treated (panel C) sections. White bars represent 100μm. 
Bars represent mean adhesion ± SEM of 4 separate experiments (unpaired t-test).  
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Figure 3.8. WBM adhesion is significantly increased in animals subjected to IR injury. 
Adhesion of WBM cells to the hepatic microcirculation in vivo was examined using intravital 
microscopy. Animals were subjected to either sham procedure or IR injury (90min PHI / 
30min R) prior to the introduction of labelled WBM cells (1 x 106 cells, 5μM CFSE, i.a.). One 
field of view was selected prior to introduction of cells and continuously monitored every 5 
minutes to analyse WBM adhesion dynamics. WBM cell adhesion was significantly raised in 
animals subjected to IR injury when compared to sham treated animals (panel A; black line: 
sham treated animals; grey line: IR treated animals). No significant difference was seen in 
free flowing cells between treatments (panel B; black line: sham treated animals; grey line: 
IR treated animals). Representative images are shown of WBM cell adhesion at 50 minutes 
post reperfusion in sham (panel C) and IR treated (panel D) microvasculature. White bars 
represent 100μm. Plots in (A) represent mean adhesion ± SEM of at least 5 separate 
experiments; * p < 0.05, * p < 0.01 (two-way ANOVA with Bonferroni Post Test).  
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WBM Sham WBM IR 
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free flowing cells to be observed immediately after introduction (ie. at 30 minutes post 
reperfusion).  
 
3.3.9.  HPC-7 adhesion is significantly raised in vivo by IR injury  
HPC-7 adhesion was significantly raised in IR animals compared to sham controls (e.g. at 45 
minutes, sham control: 5.60 ± 1.08 vs IR injury: 13.82 ± 1.95; P < 0.05) (figure 3.9.A). In 
contrast to WBM cells, adhesion of HPC-7 in IR animals remained relatively constant 
throughout the time-course of the experiments, and there was no significant difference in 
the number of cells adhering at 30 minutes and 60 minutes post reperfusion (30 minutes: 
12.60 ± 1.67 vs 60 minutes: 12.27 ± 1.31; P > 0.05) (figure 3.9.A). HPC-7 adhesion in sham 
controls also increased gradually throughout the time course of the experiment with 
significantly more cells adhering at 60 compared with 30 minutes (30 minutes: 2.75 ± 1.18 
vs 60 minutes: 7.20 ± 1.2; P < 0.05). In line with in vitro observations, HPC-7 adhesion was 
predominantly sinusoidal (figures 3.9.C-D). No significant difference in free-flowing cells is 
seen between sham and IR treatment (figure 3.9.B). Again, maximal levels of observed free-
flowing cells were seen at 30 minutes post reperfusion (figure 3.9.B). 
 
3.3.10.  HPC-5 adhesion is significantly raised in vivo by IR injury 
Although adhesion of HPC-5s was not increased on frozen injured liver PHI sections, HPC-5 
adhesion was significantly raised in IR animals compared to sham controls (e.g. at 45 
minutes: sham control: 5.00 ± 0.70 vs IR injury: 17.17 ± 1.90; P < 0.001) (figure 3.10.A). 
Adhesion remained relatively constant during the time-course of the experiment, with 
adhesion at 30 minutes not significantly different from adhesion at 60 minutes (30 minutes:  
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Figure 3.9. HPC-7 adhesion is significantly increased in animals subjected to IR injury. 
Adhesion of HPC-7 cells to the hepatic microcirculation was examined following IR using 
intravital microscopy. Animals were subjected to either sham procedure or IR injury (90m 
PHI/30 R) prior to the introduction of labelled HPC-7 cells (1 x 106 cells, 5μM CFSE, I.A.). One 
field of view was selected prior to introduction of cells and monitored to analyse HPC-7 
adhesion dynamics. HPC-7 cell adhesion was significantly raised in animals subjected to IR 
injury when compared to sham treated animals (panel A; black line: sham treated animals; 
grey line: IR treated animals). No significant difference was seen in free flowing cells 
between treatments (panel B; black line: sham treated animals; grey line: IR treated 
animals). Representative images are shown of HPC-7 cell adhesion at 50 minutes post 
reperfusion in sham (panel C) and IR (panel D) treated microvasculature. The appearance of 
cells of various sizes is a result of cells occupying differing focal planes. White bars 
represent 100μm. Plots in panel A represent mean adhesion ± SEM of at least 5 separate 
experiments; * p < 0.05, ** p < 0.01 (two-way ANOVA with Bonferroni Post Test). 
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Figure 3.10. HPC-5 adhesion is significantly increased in animals subjected to IR injury. 
Adhesion of HPC-5 cells to the hepatic microcirculation was examined following IR using 
intravital microscopy. Animals were subjected to either sham procedure or IR injury (90m 
PHI/30 R) prior to the introduction of labelled HPC-5 cells (1 x 106 cells, 5μM CFSE, I.A.). One 
field of view was selected prior to introduction of cells and monitored to analyse HPC-5 
adhesion dynamics. HPC-5 cell adhesion was significantly raised in animals subjected to IR 
injury when compared to sham treated animals (panel A; black line: sham treated animals; 
grey line: IR treated animals). No significant difference was seen in free flowing cells 
between treatments (panel B; black line: sham treated animals; grey line: IR treated 
animals). Representative images are shown of HPC-5 cell adhesion at 50 minutes post 
reperfusion in sham (panel C) and IR treated (panel D) microvasculature. White bars 
represent 100μm.  Plots in panel A represent mean adhesion ± SEM of at least 5 separate 
experiments; * p < 0.05, ** p < 0.01, *** p < 0.001 (two-way ANOVA with Bonferroni Post 
Test) 
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15.67 ± 2.11 vs 60 minutes: 13.83 ± 2.21; P > 0.05) (figure 3.10.A). Similarly, HPC-5 adhesion 
in sham controls remains constant, with adhesion at 30 minutes not significantly differing 
from 60 minutes (30 minutes: 8.00 ± 2.42 vs 60 minutes: 5.50 ± 0.96; P > 0.05).    
 
Adhesion of HPC-5 cells was predominantly sinusoidal (figures 3.10.C-D). The observed 
number of free-flowing cells in IR animals did not generally differ from that seen in sham 
controls; an exception being at 50 minutes post reperfusion where a significant increase in 
free flowing cells was seen in IR animals (sham control: 0.00 ± 0.00 vs 2.40 ± 0.92; P < 0.05) 
(figure 3.10.B). 
 
3.3.11.  Introducing HPC-7 or WBM cells at 5 minutes reperfusion does not 
significantly alter adhesion at 60 minutes post-reperfusion 
In the above intravital experiments, exogenous cells were introduced at 30 miniutes post-
reperfusion. However, these exogenously administered cells may compete with 
endogenous cells (eg. inflammatory neutrophils) for sites of adhesion (Rey-Ladino et al., 
1998). In order to examine this possibility, WBM and HPC-7 cells were introduced into IR 
treated animals at 5 minutes post-reperfusion, when endogenous leukocyte recruitment 
was likely to be less than at later time points post-reperfusion (Fox-Robichaud et al., 1998). 
No difference in adhesion was seen with WBM cells introduced at 5 or 30 minutes post-
reperfusion (e.g. WBM adhesion at 60 minutes post reperfusion: cells introduced at 5 
minutes: 19.00 ± 4.34 vs cells introduced at 30 minutes: 17.88 ± 2.64; P > 0.05) (figure 
3.11.A). No significant difference was observed in free-flowing WBM cells whether 
introduced at 5 or 30 minutes reperfusion (e.g. WBM free-flowing at 60 minutes post 
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reperfusion: cells introduced at 5 minutes: 4.50 ± 1.94 vs cells introduced at 30 minutes: 
3.50 ± 0.63; P > 0.05) (figure 3.11.B).  
 
Although fewer HPC-7 cells adhere at the earlier time points when cells were introduced at 
5 minutes post reperfusion rather than 30 minutes, this reduction was not significant at any 
time point (e.g. HPC-7 adhesion at 40 minutes post reperfusion: cells introduced at 5 
minutes: 9.60 ± 0.81 vs cells introduced at 30 minutes: 15.36 ± 2.62; P > 0.05) (figure 
3.11.C). At 60 minutes reperfusion, adhesion was comparable between both populations of 
cells (e.g. HPC-7 adhesion at 60 minutes reperfusion: cells introduced at 5 minutes: 12.40 ± 
1.36 vs cells introduced at 30 minutes: 12.27 ± 1.31; P > 0.05) (figure 3.11.C). Perhaps 
unsurprisingly, significantly more HPC-7 cells were seen free-flowing at the earliest time-
point (30 minutes reperfusion) when introduced at 30 minutes reperfusion (free-flowing 
cells at 30 minutes: introduced at 5 minutes: 0.60 ± 0.24 vs introduced at 30 minutes: 4.50 ± 
0.64; P < 0.05) (figure 3.11.D). No significant differences in free-flowing HPC-7 cells was 
observed at any other time-points (figure 3.11.D).  
 
3.3.12.  Lin
-
Sca-1
+
 cell adhesion is not enhanced by IR injury 
To examine whether primary freshly isolated immature cells share adhesion characteristics 
with the HPC-7 cell line, Lin-Sca-1+ cells were injected into hepatic IR treated animals and 
adhesion assessed using intravital microscopy. Interestingly, no significant differences were 
seen in the levels of recruitment of Lin-Sca-1+ cells in IR injured animals compared to sham 
controls (e.g. adhesion at 55 minutes: sham: 9.35 ± 1.81 vs. IR injury: 9.26 ± 2.32; P > 0.05) 
(figure 3.12.A). Levels of free-flowing Lin-Sca-1+ are not significantly different between sham  
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Figure 3.11. Introducing WBM or HPC-7 cells at 5 minutes post-reperfusion does not 
significantly alter their adhesion compared to cells introduced at 30 minutes reperfusion. 
Animals were subjected to 90 minutes partial hepatic ischemia, with 1x106 cells introduced 
at either 30 minutes post reperfusion (black line) or 5 minutes post reperfusion (grey line). 
The time point at which WBM cells are introduced does not significantly alter adhesion at 
any point during reperfusion (panel A), nor does it significantly effect free flowing WBM 
cells (panel B). Similarly, the time point at which HPC-7 cells are introduced does not 
significantly alter adhesion at any point during reperfusion (panel C), although significantly 
more cells are seen free flowing at 30 minutes when introduced at 30 minutes reperfusion 
rather than 5 minutes (panel D). Figures represent mean adhesion (or free flowing cells) ± 
SEM of at least 5 separate experiments; * p < 0.05 (two-way ANOVA with Bonferroni Post 
Test). 
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Figure 3.12. Recruitment of Lin
-
Sca-1
+
 cells to the liver is not enhanced by IR injury. Adhesion 
of Lin-Sca-1+ cells to the hepatic microcirculation was examined following IR using intravital 
microscopy. Animals were subjected to either sham procedure (black line) or IR injury (90m 
PHI/30 R; grey line) prior to the introduction of labelled Lin-Sca-1+ cells (between 1.2 x 105 
and 3.3 x 105, 5μM CFSE, I.A.; data is adjusted to 1 x 106 cells – see methods). One field of 
view was selected prior to introduction of cells and monitored to analyse adhesion 
dynamics. No difference in adhesion is noted between sham and IR treated animals (panel 
A). No difference in free-flowing cells is seen between control and IR animals (panel B). 
Figures represent adjusted adhesive/flowing cells ± SEM from six  separate experiments 
(multiple comparison test shows no points of significance). 
A 
B 
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and IR treated animals (e.g. free-flowing cells at 55 minutes: sham: 1.52 ± 1.52 vs. IR: 0.28 ± 
0.27; P > 0.05) (figure 3.12.B). The adhesion of Lin-Sca-1+ cells was again predominantly 
sinusoidal.   
 
3.3.13.  Adhesion of the human progenitor cell line, KG1a, is not raised by IR injury 
The human myelomonocytic cell line, KG1a, has been frequently used as a surrogate for 
human haematopoietic progenitor cells (Wagner et al., 2008, Dimitroff et al., 2005). KG1a 
recruitment was assessed in both the in vitro Stamper-Woodruff and the in vivo intravital IR 
injury model. In vitro, KG1a adhesion was not significantly raised on sections isolated from 
IR animals compared to sections from sham controls (sham sections: 2.27 ± 0.87 vs IR 
sections: 2.80 ± 1.25; P > 0.05) (figure 3.13.C). Levels of KG1a adhesion observed on hepatic 
sections were comparable to those seen with HPC-5 (figure 3.7.A) and HPC-7 (figure 3.6.A) 
but not as high as WBM adhesion (figure 3.5.A). In the intravital model, KG1a cells were 
introduced into C57Bl/6 mice at 30 minutes reperfusion. Immune rejection was deemed 
unlikely to occur within such a short time-scale removing the need to use immunodeficient 
mice. No significant difference in KG1a adhesion was observed between sham and IR 
treated animals (e.g. at 50 minutes reperfusion: sham control: 43.67 ± 13.35 vs IR treated: 
34.40 ± 10.48; P > 0.05) (figure 3.13.A). Much higher numbers of KG1a cells were recruited 
in vivo to the hepatic microvasculature when compared with WBM (figure 3.8.A), HPC-7 
(figure 3.9.A) and HPC-5 cells (figure 3.10.A). Numbers of free flowing cells were not 
affected by IR injury when compared to sham control (e.g. free flowing cells at 45 minutes 
reperfusion: sham control: 2.67 ± 1.45 vs IR treated: 2.20 ± 0.66) (figure 3.13.B).  
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Figure 3.13. IR injury does not promote hepatic recruitment of the human progenitor cell 
line, KG1a. Intravital microscopy was used to monitor the recruitment of the human 
myeloid progenitor cell line, KG1a, following hepatic IR injury. Animals were subjected to IR 
injury (90min PHI / 30min R) prior to the introduction of labelled KG1a cells (1 x 106 cells; 
5μM CFSE). Levels of KG1a adhesion and free flowing cells are similar in both sham and IR 
treated animals (panels A and B; black line: sham treated, grey line: IR treated). 
Additionally, KG1a adhesion is not raised on sections isolated from IR treated animals 
(panel C). Panels A and B represent mean adhesion/free-flowing cells ± SEM of at least 3 
separate experiments. Panel C represents mean adhesion ± SEM of 3 separate experiments 
(panels A and B: two-way ANOVA; panel C: unpaired t-test). 
A 
B C 
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3.4.  Discussion 
This study provides novel in vitro and in vivo evidence that hepatic HSC recruitment is 
increased in response to murine IR injury. This response was observed for three different 
cell populations; WBM cells and both adult and embryonic HSCs. Interestingly, hepatic IR 
injury does not significantly alter adhesion of primary isolates of progenitor cells (Lin-Sca-1+ 
cells) or human progenitor cells (KG1a). However, this study does demonstrate for the first 
time that primary HSCs can be indentified in the liver (injured or not) immediately after 
exogenous administration and without previous BM engraftment. Although previous 
studies of injury mediated HSC recruitment to the liver used chronic injury models (Alison et 
al., 2000, Theise et al., 2000b, Petersen et al., 1999) the current data provides the first 
evidence that HSCs are also recruited rapidly to the hepatic microvasculature following an 
acute hepatic injury.   
 
The increased adhesion of WBM, HPC-5 and HPC-7 cells to hepatic sinusoids after IR injury 
is consistent with studies reporting recruitment of HSCs to hypoxic organs along cytokine 
concentration gradients (Ceradini et al., 2004). The role of these cells following recruitment 
is unclear and it is not possible to determine whether transmigration and thus tissue 
engraftment into the surrounding interstitium occured as the the resolution of images 
obtained from these intravital experiments is too low.  Interestingly, similar levels of 
adhesion were observed with HPC-5, HPC-7 and WBM cells which suggests the presence of 
a potential upper limit for progenitor cell adhesion.  Alternatively, the comparable levels of 
adhesion may represent consistent levels of rapid cell clearance.  In a similar study, labeled 
MSCs are cleared from the rat circulation within 15 minutes (Yocum et al., 2005). Work 
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from our lab has suggested that HSCs are rapidly cleared from the circulation.  It was 
demonstrated that high levels of adhesion were only seen within the murine cremaster 
muscle microcirculation after four bolus injections of HPC-7 cells were administered 
systemically every 30 minutes (Y Zhao, unpublished observations, 2007).  
 
A potential concern with introducing exogenous cells and monitoring their adhesion in vivo 
is the fact that they may have to compete with endogenous circulating cells. Exogenously 
introduced stem cells injected into early embryos display competition with endogenous 
cells for engraftment space (Harder et al., 2002). To account for this, we also introduced 
cells at 5 minutes reperfusion as well as at 30 minutes as endogenous cell adhesion early on 
in reperfusion is likely to be lower than at later time points (Fox-Robichaud et al., 1998). 
Introducing WBM cells at 5 minutes rather than 30 minutes had no significant effect on 
adhesion suggesting that recruitment is dependent upon the stage of injury rather than the 
length of time the cells are in the circulation. Similar results were seen with HPC-7 cells, 
although if introduced at 5 minutes reperfusion, recruitment is initially lower than those 
injected at 30 minutes reperfusion (albeit not significantly). This may represent a low initial 
recruitment during first pass due to a lower severity of injury at that time or poor 
availability of cells as a result of rapid their clearance.  Such rapid clearance of progenitor 
cells has been shown previously; very few cells with CFU capability can be retrieved from 
the circulation just 6 minutes following an intravenous injection of donor Lin- cells into 
recipient mice (Wright et al., 2001). 
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Adhesion of HSCs in the hepatic microcirculation occurs primarily within the hepatic 
sinusoidal capillaries.  The hepatic sinusoids represent a unique low flow vascular bed, with 
three different points of entry for leukocytes. Blood enters the liver either via the portal 
tract or the hepatic artery and then enters the sinusoids either by small communicating 
vessels in or close to the portal tracts or more distally by vessels that drain into the distal 
sinusoids or terminal hepatic veins. The majority of blood flow, however, is distributed 
through the hepatic sinusoids before returning to the systemic circulation via the hepatic 
veins (Lalor et al., 2007). Blood flows through the sinusoids at relatively low levels of shear 
stress, facilitating mature leukocyte adhesion in the sinusoids. The data within this chapter 
also suggests the same applies for recruitment of HSCs.   Interestingly, HSC adhesion 
remains predominantly sinusoidal on static adhesion assays where flow is not an 
influencing factor. As the sinusoids play an important role in IR injury, the delivery of HSCs 
directly to the sinusoids may be an important prerequisite for repair. 
 
Interestingly, IR injury does not enhance the recruitment of Lin-Sca-1+ progenitor cells. HSCs 
constitute a rare compartment within the BM, with at most 0.05% of murine BM cells 
thought to be primitive HSCs (Chen et al., 1997). The most basic accepted definition of HSCs 
is defined by expression of Sca-1 and c-kit and a lack of markers of maturation and 
commitment (Lineage markers), termed KSL cells (Chen et al., 1997). In a typical sort, 
approximately 3000 cells can be retrieved from a single wild-type murine donor (data not 
shown). Such small yields are too small for physiological studies and many donor mice 
would be required to yield enough cells for a single intravital experiment. In a study by 
Massberg and colleagues, 1.5 x 105 KSL cells were introduced intravenously for monitoring 
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of adhesion in the carotid artery (Massberg et al., 2006). To isolate this number of KSL cells, 
approximately fifty donor mice would be required. As a result, our study uses a less 
restrictive isolation profile. Primary cells used for comparison in this study were lineage 
negative and stem cell antigen-1 positive (Lin-Sca-1+). Approximately 0.3% of the adult bone 
murine BM is Lin-Sca-1+ (data not shown). The Lin-Sca-1+ fraction contains cells possessing 
long term haematopoietic reconstituting potential, although it should be noted that other 
cell populations exist within this fraction (Welner et al., 2008). Therefore, the different 
responses in vivo may represent the different make up of these populations. 
 
It is plausible that the HSC lines used within the study are not truly representative of ‘true’ 
primary HSCs which is why their pattern of recruitment is different.  However, the HPC-7 
cell line has been used extensively both locally and in international studies for investigating 
the control of HSC growth and differentiation at a molecular and cellular level (Wilson et al., 
2009, Pimanda et al., 2008). Thus, it is well accepted as being representative of pure HSCs.  
Furthermore, this cell line can reconstitute the hematopoietic compartment in lethally 
irradiated mice, a property of a true stem cell (Pinto do Ó et al., 2002). 
 
This cell line is also considered superior to other HSC lines such as FDCP-1 mix or FDC-P1 
mix, which have been routinely utilised by leading international laboratories to monitor HSC 
trafficking within murine BM intravitally (Katayama et al., 2004, Mazo et al., 1998). It is well 
accepted that in vivo trafficking studies cannot be easily and routinely performed using 
primary cells because of the difficulty in isolating sufficient numbers of primary cells for 
intravital studies. However, trafficking studies conducted using the FDCP mix cell line have 
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increased our understanding of HSC trafficking within BM and our results provide important 
insights into the molecular events governing HSC homing to non-BM sites – this is currently 
unknown.    
 
However, the fact remains that only the cell lines show increased recruitment to the injured 
liver compared with the non-injured liver.  There may be other explanations for this 
difference; the methods used to purify Lin- Sca-1+ cells most likely leads to the isolation of a 
non-heterogeneous non-identical population of BM cells, which may differ substantially in 
their biological properties.  Furthermore, Lin- Sca-1+ cells do not represent a pure HSC 
population and these cells were used because they can be isolated in sufficient numbers for 
in vivo trafficking studies.  The differences between the homogeneous cell line and the less 
well-defined primary cells emphasise the need for further purification to define a more 
uniform population of cells.   
 
This study demonstrates that an acute liver injury is able to attract the HPC-7 cell line to a 
greater degree than non-injured livers.  This in itself is a novel finding since most studies 
investigating stem (HSC or MSC) or progenitor cell recruitment use more severe and chronic 
models of injury.  It is therefore possible that Lin- Sca-1+ cells would be more favourably 
recruited above and beyond controls in more chronic severe models of hepatic injury.  This 
is certainly worthy of future investigations and is something our lab are currently pursuing 
in collaborative studies with Dr Phil Newsome (University of Birmingham) using the carbon 
tetrachloride model of chronic liver injury.  
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In vitro, HPC-7 and WBM cell adhesion was raised significantly on hepatic sections. 
Interestingly, much higher levels of WBM cell adhesion were seen compared to HPC-7 cells. 
This may again be a result of the relative heterogeneity of the WBM cell preparation. 
Studies by Takeuchi and colleagues suggest that approximately 50% of the BM of mice is 
composed of neutrophils (Takeuchi et al., 1987). The higher levels of adhesion observed 
with WBM cells compared to HPC-7 cells may be explained by the relative abilities of 
neutrophils and HSCs to engraft in inflamed tissues. Alternatively, the heterogeneity of 
WBM cells could facilitate adhesion of various leukocyte subsets through various adhesion 
pathways. On the other hand, a homogenous population of HPC-7 cells are likely to utilize a 
narrower range of adhesion pathways.  
 
Somewhat surprisingly, adhesion of HPC-5 cells to frozen hepatic sections is not enhanced 
after partial IR injury. Furthermore, the levels of HPC-5 baseline adhesion seen in vitro are 
much lower than baseline adhesion of any other cell populations. This may reflect 
differential responses to chemokines present immobilised on the surface of the section or 
differences in adhesion molecule expression. For instance, murine embryonic and adult 
HSCs express different levels of Mac-1 (αM integrin) (Ivanova et al., 2002). Interestingly, 
HPC-5 adhesion is raised in vivo following partial hepatic IR injury suggesting distinct 
pathways of adhesion in vitro and in vivo. This may highlight a requirement for flow for 
adhesion of HPC-5 cells. Alternatively, HPC-5 adhesion in vivo may be enhanced by factors 
that are not present on the in vitro Stamper-Woodruff assay. Interestingly, the innate 
homing mechanisms of adult and embryonic HSCs do appear to have some differences with 
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embryonic HSCs homing to the BM less efficiently in irradiated adult hosts compared to 
adult HSCs (Perlingeiro et al., 2001).  
 
KG1a cells were originally isolated in 1980, as a subtype of the human myeloid cell line, KG1 
(Koeffler et al., 1980). KG1a cells are frequently used as a model of human hematopoietic 
progenitor cells (Morimoto et al., 1994, Wagner et al., 2008, Dimitroff et al., 2000). We 
found that KG1a adhesion is not increased in IR treated C57Bl/6 mice when compared to 
sham controls. This may be a result of species differences or more subtle differences in 
phenotype between HPC-5/HPC-7 cells and KG1a cells. For example, KG1a cells do not 
express surface CXCR4 unlike primary HSCs and thus their response to the chemokine 
CXCL12 may be limited (Tavor et al., 2004, Lapidot et al., 2005). Furthermore, KG1a cells 
display different levels of response to CD44 blocking antibody when compared to primary 
HSCs (Wagner et al., 2008). These differences may explain the inability of IR injury to 
promote KG1a adhesion to the hepatic microcirculation.  
 
Total hepatic ischemia (THI) in mice is fatal (Matsumoto et al., 2005) and we demonstrated 
that even short periods of ischemia (20 minutes total hepatic ischemia) result in high 
mortality and thus THI was not a viable option for our experimental model. Alternatively, 90 
minutes partial hepatic ischemia (PHI) was well tolerated by all mice for up to 90 minutes 
post-reperfusion. Although other murine models do exist to replicate THI, they require 
relatively complex surgery and long recovery times (∼ 3 weeks) prior to the initiation of THI 
(Matsumoto et al., 2005).  We found that our model of hepatic IR injury resulted in a 
consistent and significant 50 fold increase in circulating ALT comparable to those seen in 
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other published studies using PHI (Llacuna et al., 2006). Furthermore, previous studies 
confirm that PHI periods below 50 minutes are insufficient to produce robust injury, 
confirming the suitability of the  90 minute partial ischemic period used in the current 
studies (Devey et al., 2008). Although no histological damage was visualised on hepatic 
sections stained with H&E, it has been shown previously that apoptotic liver damage occurs 
within 6 hours post IR injury (Schlossberg et al., 1996). It should be noted that male mice 
were used throughout these studies. It has been shown that there are gender differences in 
the cytokine response to hepatic IR injury; TNF-α release and hepatocellular damage is 
‘moderately’ raised in male mice compared to females (Crockett et al., 2006).  
 
Blood sampling post IR injury revealed a significant shift in the mature leukocyte profile 
within the systemic circulation. IR injury significantly increased the level of circulating 
neutrophils while reducing the level of circulating lymphocytes. It is unclear from these 
results whether this represents a recruitment of lymphocytes in the liver, which 
subsequently reduces their numbers in the circulation, or a BM release of 
mature/immature neutrophils into the circulation of IR injured animals. The shifts in 
leukocyte compartmentalisation are likely to be a collective result of these factors. In other 
models of acute injury, significant mobilisation of neutrophils takes place some hours 
following insult (Sato et al., 1998). It has been shown previously that metamyelocytes 
(immature granulocyte precursors) can be detected in the pulmonary microcirculation 
following intestinal IR injury (Kalia et al., 2002a) and acute recruitment of CD4+ lymphocytes 
can occur within one hour of hepatic reperfusion (Caldwell et al., 2005). This recruitment 
may be important for initiating the neutrophil-dependent phase of IR injury; CD4+ 
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lymphocytes release IL-17 upon activation, a pro-inflammatory cytokine that stimulates 
recruitment of neutrophils (Yu and Gaffen, 2008). Whether this behaviour is important for 
HSC recruitment is unclear, and not deducible from this study. 
 
To summarise, we have demonstrated using both in vitro and in vivo techniques that HSC 
recruitment to the hepatic microcirculation is significantly raised as a result of IR injury. 
Interestingly, IR injury promotes the recruitment of both adult and embryonic derived HSCs 
to similar levels, suggesting potential similarities in their recruitment mechanisms. In vitro, 
HSCs appeared to adhere to the vessel linings of the sinusoids on hepatic sections, and in 
vivo, recruitment of HSCs took place exclusively within the sinusoidal vessels. Interestingly, 
the recruitment of primary Lin-Sca-1+ cells was not raised as a result of IR injury, nor was the 
recruitment of human progenitor cell line, KG1a. The molecular basis for this recruitment 
will be addressed in the following chapter.  
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4. Mechanisms of haematopoietic stem cell recruitment during murine IR injury 
 
4.1.   Introduction and Hypotheses 
 
4.1.1.  Introduction 
The adhesion mechanisms involved in HSC recruitment to medullary sites are relatively well 
defined in comparison to extra-medullary sites (Mazo et al., 1998, Frenette et al., 1998). 
The liver has been at the centre of experimental and clinical studies investigating injury 
mediated HSC recruitment, yet it is still not clearly demonstrated whether exogenously 
administered HSCs home to ischemic liver or sites of inflammation from peripheral blood.  
The efficiency and molecular basis of this process and the vascular adhesion molecules 
involved are not known. 
  
The previous chapter provides evidence for the recruitment of HSCs during acute IR injury 
in both in vitro and in vivo adhesion assays. Furthermore, both adult (HPC-5) and embryonic 
(HPC-7) HSCs are recruited to the liver in this model of injury. Should HSCs prove beneficial 
in models of hepatic injury, one of the major problems in translating the studies to therapy 
is the sub-therapeutic recruitment of transplanted cells.  Methods that allow an 
improvement in the engraftment of HSCs (and indeed other adult stem cells) are a high 
priority for cellular therapies.  A better understanding of the adhesion mechanisms that 
modulate recruitment, and more specifically the adhesion molecules involved, may allow us 
to modulate recruitment and enhance engraftment.   
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The adhesive mechanisms governing HSC recruitment to BM microcirculation are relatively 
well understood with contributions of various selectins and integrins well described 
(Lapidot et al., 2005, Mazo et al., 1998). Very few studies have examined the adhesion 
pathways utilised by HSCs to home to non-BM tissues. Recently, studies by Zheng and 
colleagues suggested that fusion of HSCs and cardiomyocytes in vivo is dependant on the 
α4β1 integrin/VCAM-1 pathway (Zhang et al., 2007). 
 
HSCs do express adhesion molecules also utilised by mature leukocytes for recruitment into 
inflamed liver and Lin-Sca-1+ HSC express αL, α1, α3, α4, α5, α6, β1 integrins, L-selectin, CD44 
and PECAM-1 (Becker et al., 1999). Hepatic sinusoidal endothelial cells express various 
counter-receptors, including VAP1, ICAM-1 and VCAM-1 (Adams and Eksteen, 2006). It is 
therefore plausible that interactions between these molecules may play important roles in 
HSC recruitment.   
 
4.1.2.  Hypotheses 
For the work in this chapter, we hypothesised:  
 
1. Individual blockade of HSC adhesion molecules (CD18, CD31, CD44, CD49d) 
significantly reduces HSC adhesion post IR injury  
2. HSC recruitment seen following IR injury is reduced in CD31-/- animals 
3. Adhesion molecule upregulation is detectable on samples of hepatic IR tissue 
when compared to sham treated controls 
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4.2.  Methods 
The methods used in this chapter are described in detail in Chapter 2. Briefly, HPC-7 cells 
were phenotyped for expression of the adhesion molecules of interest after incubation with 
fluorescently conjugated antibodies against CD49d (FITC), CD49e (PE), CD44 (PE), CD31 
(FITC), CD18 (FITC) and CD11b (FITC). The effective function blocking concentration was also 
determined for these antibodies allowing us to use them in Stamper-Woodruff in vitro 
adhesion assays and intravital microscopy studies.  CD31 deficient mice were used to 
determine the role of endothelial CD31.  Immunohistochemistry was performed on sham 
and IR treated animals (90 PHI / 30 R) treated with primary antibodies against murine CD31, 
CD44 and VCAM-1 conjugated to a secondary Texas Red antibody.   
 
4.3.  Results 
 
4.3.1.  HPC-7 cells express a panel of common adhesion molecules 
In order to investigate adhesion mechanisms of HPC-7, a prior knowledge of adhesion 
molecule expression on these cells is essential. HPC-7 cells were analysed by flow cytometry 
for surface expression of the adhesion molecules CD49d, CD49e, CD44, CD31, CD18 and 
CD11b. HPC-7 cells showed a robust expression of CD49d (figure 4.1.A), CD49e (figure 
4.1.B), CD44 (figure 4.1.C), CD31 (figure 4.1.D), CD18 (figure 4.1.E) and L-Selectin/CD62L 
(figure 4.1.F). However, HPC-7 cells did not express the αM integrin subunit, CD11b (data 
not shown). The adult HSC line, HPC-9 (an equivalent of the line adult HPC-5) expressed a 
similar repertoire of adhesion molecules CD49d, CD49e, CD44 and CD31 (figure not shown). 
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Figure 4.1. HPC-7 cells express a repertoire of common adhesion molecules. HPC-7 cells 
were examined using FACS for expression of common adhesion molecules involved in 
homing. HPC-7 cells express CD49d (panel A), CD49e (panel B), CD44 (panel C), CD31 (panel 
D), CD18 (panel E) and L-Selectin (panel F) (filled panel: negative control, solid line: relevant 
adhesion molecule antibody). FACS histograms are representative of 3 separate 
experiments. 
A B 
C D 
E F 
CD49d CD49e 
CD44 CD31 
L-Selectin CD18 
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4.3.2.  Adhesion molecules can be blocked by pretreatment with function blocking 
antibodies 
To ensure that the function blocking antibodies used in the molecular studies were able to 
block at given concentrations, a FACS based assay was used. For all antibodies tested,  
80μg/ml of blocking antibody was an effective concentration to reduce fluorescence 
intensity down to control levels, suggesting blockade of surface antigen (CD49d: 0µg/ml: 
8.44 ± 0.27 vs 80µg/ml: 2.82 ± 0.19; P < 0.001; CD44: 0µg/ml: 393.2 ± 31.72 vs 80µg/ml: 5.5 
± 0.74; P < 0.001; CD31: 0µg/ml: 8.09 ± 0.15 vs 80µg/ml: 2.280 ± 0.07; P < 0.001; CD18: 
0µg/ml: 19.83 ± 0.39 vs 80µg/ml: 2.59 ± 0.04; P < 0.001) (figures 4.2.A-H). No difference 
was seen between 80μg/ml and 160μg/ml blocking antibody treated cells. Conversely, 
40μg/ml blocking antibody was not sufficient to elicit complete blockade in CD49d and 
CD44 treated cells (figures 4.2.A-D). Interestingly, we were unable to block L-selectin with 
blocking antibodies at any concentration up to 160μg/ml (data not shown). 
 
4.3.3.  HPC-7 adhesion is not significantly reduced in vitro by blockade of CD49d 
The role of CD49d was investigated in vitro by monitoring HPC-7 adhesion to frozen liver 
sections using the Stamper-Woodruff assay, HPC-7 cells were pre-treated with an anti-
CD49d blocking antibody and their adhesion to IR sections quantified. Although treatment 
with an anti-CD49d blocking antibody resulted in a minor reduction in adhesion this was not 
statistically significant (IgG treated cells: 4.63 ± 2.10 vs anti-CD49d treated cells: 2.47 ± 1.14; 
P > 0.05).  Treatment of cells with an anti-CD49d blocking antibody did not affect the 
anatomical localisation of recruitment as cell adhesion still remained exclusively along 
sinusoidal linings (figures 4.3.B-C).  
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Figure 4.2. CD49d, CD44, CD31 and CD18 can all be blocked with treatment of 80μg/ml of 
relevant blocking antibody. HPC-7 cells were treated with specified concentrations of 
blocking antibody, then analysed by FACS for free antigen (see Figure 2.3). In all cases, 
80μg/ml of blocking antibody is enough to reduce fluorescence to control levels. Plots and 
figures are shown for CD49d (panels A and B), CD44 (panels C and D), CD31 (panels E and F) 
and CD18 (panels G and H) (solid fill: negative control, solid line: 80μg/ml treated, dashed 
line: 0μg/ml treated/volume control). FACS plots are representative of an individual 
experiment, while bar graphs represent geometric mean MFI ± SEM of 3 experiments.  
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Figure 4.3. Blocking CD49d on HPC-7 does not significantly reduce adhesion in vitro on 
sections isolated from IR treated animals. The effect of CD49d blockade on HPC-7 adhesion 
was examined using the Stamper-Woodruff static adhesion assay. Treatment of cells with 
80μg/ml anti-CD49d mAb fails to reduce adhesion on IR sections when compared to cells 
treated with IgG control (80μg/ml). Although blockade of CD49d appears to cause a general 
decrease in adhesion, this drop is not statistically significant. Representative images of IR 
sections with IgG treated (panel B) and anti-CD49d mAb treated (panel C) HPC-7 cells are 
shown. White bars represent 100μm. Data represents mean adhesion ± SEM of 6 separate 
experiments (unpaired t-test). 
A 
B C 
HPC-7 IgG HPC-7 anti-CD49d 
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 4.3.4.  HPC-7 adhesion is significantly reduced in vivo by blockade of CD49d 
The role of CD49d was also investigated in vivo.  Anti-CD49d pre-treated cells (1 x 106 ) were 
introduced into the intravital model of partial hepatic IR injury via the carotid artery. HPC-7 
adhesion was significantly reduced by pretreatment with an anti-CD49d antibody (e.g. at 55 
minutes, isotype control: 15.5 ± 1.89 vs anti-CD49d treated: 6.33 ± 1.61; P < 0.01) (figure 
4.4.A). Levels of adhesion remain constant for both groups throughout the monitoring 
period (figure 4.4.A), with levels of adhesion at 60 minutes not being significantly different 
from adhesion at 30 minutes (eg. isotype control, 30 minutes post reperfusion: 10.5 ± 1.52 
vs 60 minutes reperfusion: 14.17 ± 2.02; P > 0.05; anti-CD49d treated, 30 minutes post 
reperfusion: 6.33 ± 1.43 vs 60 minutes post reperfusion: 6.17 ± 1.77; P > 0.05). Treatment of 
cells with an anti-CD49d antibody did not significantly alter the number of free-flowing cells 
observed during monitoring (e.g. free-flowing at 55 minutes: isotype control: 1.50 ± 0.56 vs 
anti-CD49d treated: 0.50 ± 0.37; P > 0.05) (figure 4.4.B). Significantly more HPC-7 cells were 
observed free-flowing at 30 minutes reperfusion in both groups, this being the time point 
closest to injection (figure 4.4.B). Treatment of cells with an anti-CD49d blocking antibody 
did not alter the anatomical localisation of recruitment as cell adhesion still remained 
exclusively sinusoidal (figures 4.4.C-D).   
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Figure 4.4. HPC-7 adhesion is significantly reduced in vivo by treating HPC-7 cells with a 
CD49d blocking antibody. Adhesion of HPC-7 cells to the hepatic microcirculation was 
examined using intravital microscopy following treatment with blocking antibodies. Animals 
were subjected to IR injury (90m PHI/30 R) prior to the introduction of either CD49d 
blocked or IgG treated HPC-7 cells (1 x 106 cells, 5μM CFSE, i.a.). HPC-7 cell adhesion was 
significantly reduced by pre-treatment with a CD49d blocking antibody (panel A; black line: 
IR + IgG treated cells; grey line: IR + CD49d treated cells). No significant difference was seen 
in free flowing cells between treatments (panel B; black line: IR + IgG treated cells; grey 
line: IR + CD49d treated cells). Representative images are shown of HPC-7 cell adhesion at 
50 minutes post reperfusion with IgG (panel C) and CD49d (panel D) treated cells. White 
bars represent 100μm. Plots in panel A and panel B represent mean ± SEM of at least 5 
separate experiments; * p < 0.05, ** p < 0.01 (two-way ANOVA followed by Bonferroni Post 
Test for points of significance). 
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4.3.5.  HPC-7 adhesion is significantly reduced by in vivo blockade of VCAM-1 
To determine whether VCAM-1, one of the counter-receptors for VLA-4, was involved in 
recruitment, VCAM-1, was blocked by intra-arterial administration of a blocking antibody in 
vivo. Animals were subjected to partial hepatic IR injury and treated with VCAM-1 blocking 
antibody at 1 minute post-reperfusion. Control animals received an isotype matched 
control antibody. HPC-7 adhesion is significantly reduced by treating animals with anti-
VCAM-1 (e.g. at 55 minutes post reperfusion, isotype control: 12.8 ± 1.77 vs. anti-VCAM-1 
treated: 5.25 ± 1.03; P < 0.01) (figure 4.5.A). Levels of adhesion remain constant throughout 
the monitoring period figure 4.5.A), with adhesion for both groups at 60 minutes not 
significantly different from adhesion at 30 minutes (e.g. isotype control treated, 30 minutes 
post reperfusion: 12.20 ± 1.53 vs. 60 minutes reperfusion: 11.60 ± 0.68; P > 0.05; anti-
VCAM-1 treated, 30 minutes post reperfusion: 5.75 ± 1.44 vs. 60 minutes post reperfusion: 
6.75 ± 1.44; P > 0.05) (figure 4.5.A). Intraarterial treatment with an anti-VCAM-1 antibody 
did not significantly alter the number of free-flowing cells observed during monitoring (e.g. 
free-flowing at 55 minutes: isotype control: 0.00 ± 0.00 vs. anti-VCAM-1 treated: 0.00 ± 
0.00; P > 0.05) (figure 4.5.B). Intraarterial treatment with an anti-VCAM-1 blocking antibody 
did not alter the anatomical localisation of recruitment as cell adhesion still remained 
exclusively sinusoidal (figures 4.5.C-D). 
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Figure 4.5. HPC-7 adhesion is significantly reduced in vivo by intra-arterial administration of 
a VCAM-1 blocking antibody. Adhesion of HPC-7 cells to the hepatic microcirculation was 
examined using intravital microscopy following intra-arterial treatment with a VCAM-1 
blocking antibody. Animals were subjected to IR injury (90m PHI/30 R), with intra-arterial 
administration of 70μg (in 100μl saline) of VCAM-1 or IgG control at 1 minute reperfusion. 
At 30 minutes reperfusion, HPC-7 cells were introduced (1 x 106 cells, 5μM CFSE, I.A.). HPC-
7 cell adhesion was significantly reduced by pre-treatment with a VCAM-1 blocking 
antibody (panel A; black line: IR + IgG administered; grey line: IR + anti-VCAM-1 
administered). No significant difference was seen in free flowing cells between treatments 
(panel B; black line: IR + IgG administered; grey line: IR + anti-VCAM-1 administered). 
Representative images are shown of HPC-7 cell adhesion at 50 minutes post reperfusion 
with IgG (panel C) and VCAM-1 (panel D) treated animals. White bars represent 100μm. 
Plots in panel A and panel B represent mean ± SEM of at least 5 separate experiments; * p 
< 0.05, ** p < 0.01 (two-way ANOVA followed by Bonferroni Post Test for points of 
significance) 
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4.3.6.  HPC-7 adhesion to IR injured hepatic microvasculature in vivo is 
independent of CD44 
HPC-7 cells were pre-treated with a CD44 blocking antibody prior to injection at 30 minutes 
post-reperfusion. Control cells were treated with an isotype control antibody. Pre-
treatment of HPC-7 cells with a CD44 blocking antibody did not significantly reduce 
adhesion post-IR injury when compared to cells treated with an isotype control (e.g. 
adhesion at 55 minutes: isotype control: 15.50 ± 1.89 vs anti-CD44 treated: 17.00 ± 3.86; P 
> 0.05) (figure 4.6.A). Levels of adhesion remain constant throughout the monitoring period 
(figure 4.6.A), with adhesion in both groups at 60 minutes not significantly different from 
adhesion at 30 minutes (e.g. isotype control treated, 30 minutes post reperfusion: 10.50 ± 
1.52 vs. 60 minutes reperfusion: 14.17 ± 2.02; P > 0.05; anti-CD44 treated, 30 minutes post 
reperfusion: 13.40 ± 2.94 vs. 60 minutes post reperfusion: 17.80 ± 3.60; P > 0.05) (figure 
4.6.A). Significantly fewer free-flowing HPC-7 cells were observed when cells were pre-
treated with a CD44 blocking antibody (e.g. free-flowing cells at 50 minutes: isotype 
control: 2.00 ± 0.28 vs. anti-CD44 treated: 0.20 ± 0.09; P < 0.01) (figure 4.6.B). Again, the 
maximum number of free-flowing cells was seen at 30 minutes post-reperfusion (figure 
4.6.B). Treatment of cells with an anti-CD44 blocking antibody did not alter the anatomical 
localisation of HPC-7 recruitment as cell adhesion still remained exclusively sinusoidal 
(figures 4.6.C-D). 
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Figure 4.6. HPC-7 adhesion is not affected in vivo by pre-treating HPC-7 cells with a CD44 
blocking antibody. Adhesion of HPC-7 cells to the hepatic microcirculation was examined 
using intravital microscopy following treatment with blocking antibodies. Animals were 
subjected to IR injury (90m PHI/30 R) prior to the introduction of either CD44 blocked or 
IgG treated HPC-7 cells (1 x 106 cells, 5μM CFSE, I.A.). HPC-7 cell adhesion was not 
significantly reduced by pre-treatment with a CD44 blocking antibody (panel A; black line: 
IR + IgG treated cells; grey line: IR + CD44 treated cells). Significantly fewer free flowing cells 
were observed when they had been pre-treated with the CD44 blocking antibody (panel B; 
black line: IR + IgG treated cells; grey line: IR + CD44 treated cells). Representative images 
are shown of HPC-7 cell adhesion at 50 minutes post reperfusion with IgG (panel C) and 
CD44 (panel D) treated cells. White bars represent 100μm. Plots in panel A and panel B 
represent mean ± SEM of at least 5 separate experiments; * p < 0.05, ** p < 0.01, *** p < 
0.001 (two-way ANOVA followed by Bonferroni Post Tests) 
A B 
C D 
HPC-7 IgG HPC-7 anti-CD44 
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4.3.7.  HPC-7 adhesion to IR injured hepatic microvasculature in vivo is 
independent of CD18 
HPC-7 cells were pre-treated with a CD18 blocking antibody prior to injection at 30 minutes 
reperfusion. Control cells were treated with an isotype control antibody. Pre-treatment of 
HPC-7 cells with anti CD18 did not significantly reduce adhesion seen post-IR injury when 
compared to cells treated with an isotype control (e.g. adhesion at 55 minutes: isotype 
control: 15.5 ± 1.89 vs. anti-CD18 treated: 13.17 ± 1.66; P > 0.05) (figure 4.7.A). Levels of 
adhesion remained constant throughout the monitoring period (figure 4.7.A), with 
adhesion in both groups at 60 minutes not significantly different from adhesion at 30 
minutes (e.g. isotype control treated, 30 minutes post reperfusion: 10.50 ± 1.52 vs. 60 
minutes reperfusion: 14.17 ± 2.02; P > 0.05; anti-CD18 treated, 30 minutes post 
reperfusion: 11.17 ± 1.89 vs. 60 minutes post reperfusion: 14.00 ± 1.26; P > 0.05) (figure 
4.7.A). Blocking CD18 did not significantly alter free-flowing cells observed when compared 
to IgG control (e.g. free-flowing at 55 minutes: isotype control: 1.50 ± 0.23 vs. anti-CD18 
treated: 1.33 ± 0.88; P > 0.05) (figure 4.7.B). The majority of free-flowing cells were 
observed at 30 minutes reperfusion, the earliest time point after injection (figure 4.7.B). 
Treatment of cells with an anti-CD18 blocking antibody did not alter the localisation of 
HPC-7 recruitment and adhesion remained exclusively sinusoidal (figures 4.7.C-D). 
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Figure 4.7. HPC-7 adhesion is not affected in vivo by pre-treating HPC-7 cells with a CD18 
blocking antibody. Adhesion of HPC-7 cells to the hepatic microcirculation was examined 
using intravital microscopy following treatment with blocking antibodies. Animals were 
subjected to IR injury (90m PHI/30 R) prior to the introduction of either CD18 blocked or 
IgG treated HPC-7 cells (1 x 106 cells, 5μM CFSE, I.A.). HPC-7 cell adhesion was not 
significantly reduced by pre-treatment with a CD18 blocking antibody (panel A; black line: 
IR + IgG treated cells; grey line: IR + CD18 treated cells). No differences were observed in 
flowing cells regardless of treatment (panel B; black line: IR + IgG treated cells; grey line: IR 
+ CD18 treated cells). Representative images are shown of HPC-7 cell adhesion at 50 
minutes post reperfusion with IgG (panel C) and CD18 (panel D) treated cells. White bars 
represent 100μm. Plots in panel A and panel B represent mean ± SEM of at least 5 separate 
experiments (two-way ANOVA). 
A B 
C D 
HPC-7 IgG HPC-7 anti-CD18 
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4.3.8.  HSC adhesion to IR injured hepatic microvasculature in vivo is independent 
of CD31 expressed on the HSC 
HPC-7 cells were treated with a CD31 blocking antibody prior to injection at 30 minutes 
reperfusion. Control cells were treated with an isotype control antibody. Pre-treatment of 
HPC-7 cells with a CD31 blocking antibody did not significantly reduce adhesion seen post-
IR injury when compared to cells treated with an isotype control (e.g. adhesion at 55 
minutes: isotype control: 15.50 ± 1.89 vs. CD31 treated: 13.43 ± 3.23; P > 0.05) (figure 
4.8.A). Levels of adhesion remain constant throughout the monitoring period (figure 4.8.A), 
with adhesion in both groups at 60 minutes not significantly different from adhesion at 30 
minutes (e.g. isotype control treated, 30 minutes post reperfusion: 10.50 ± 1.52 vs. 60 
minutes reperfusion: 14.17 ± 2.02; P > 0.05; anti-CD31 treated, 30 minutes post 
reperfusion: 12.29 ± 3.01 vs. 60 minutes post reperfusion: 15.14 ± 3.94; P > 0.05) (figure 
4.8.A). Blocking CD31 on HPC-7 cells did not significantly alter free-flowing cells observed 
when compared to IgG control treated cells (e.g. free-flowing cells at 55 minutes: isotype 
control: 1.50 ± 0.23 vs. CD31 treated: 1.50 ± 0.67 P > 0.05) (figure 4.8.B). The majority of 
free-flowing cells were observed at 30 minutes reperfusion, the earliest time point after 
injection (figure 4.8.B). Treatment of cells with an anti-CD31 blocking antibody did not alter 
the anatomical localisation of HPC-7 recruitment as cell adhesion still remained exclusively 
sinusoidal (figures 4.8.C-D). 
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Figure 4.8. HPC-7 adhesion is not affected in vivo by pre-treating HPC-7 cells with a CD31 
blocking antibody. Adhesion of HPC-7 cells to the hepatic microcirculation was examined 
using intravital microscopy following treatment with blocking antibodies. Animals were 
subjected to IR injury (90m PHI/30 R) prior to the introduction of either CD31 blocked or 
IgG treated HPC-7 cells (1 x 106 cells, 5μM CFSE, I.A.). HPC-7 cell adhesion was not 
significantly reduced by pre-treatment with a CD31 blocking antibody (panel A; black line: 
IR + IgG treated cells; grey line: IR + CD31 treated cells). No differences were observed in 
flowing cells regardless of treatment (panel B; black line: IR + IgG treated cells; grey line: IR 
+ CD31 treated cells). Representative images are shown of HPC-7 cell adhesion at 50 
minutes post reperfusion with IgG (panel C) and CD31 (panel D) treated cells. White bars 
represent 100μm. Plots in panel A and panel B represent mean ± SEM of at least 5 separate 
experiments (two-way ANOVA) 
A B 
C D 
HPC-7 IgG HPC-7 anti-CD31 
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4.3.9.   CD31
-/-
 animals display raised and maximal adhesion for HPC-7 without a 
prior need for IR injury 
There is evidence to suggest there is a low basal expression of CD31 in the hepatic sinusoids 
(Neubauer et al., 2000, Neubauer et al., 2008).  Therefore, the role of endothelial CD31 in 
HSC recruitment was also investigated using CD31-/- mice. HPC-7 cells (expressing CD31) 
were injected into CD31-/- mice at 30 minutes reperfusion and adhesion monitored. HPC-7 
cells were also injected into sham treated CD31-/- animals. Following sham treatment, 
adhesion of HPC-7 cells was significantly raised in CD31-/- animals when compared to strain 
and age matched wildtype sham controls, although adhesion falls to control levels at 60 
minutes reperfusion (e.g. sham treatment, adhesion at 30 minutes reperfusion: wild-type 
animals: 2.75 ± 1.18 vs. CD31-/- animals: 15.17 ± 2.93; P < 0.001; sham treatment, adhesion 
at 60 minutes reperfusion: wild-type animals: 7.20 ± 1.20 vs. CD31-/- animals: 9.67 ± 1.33; P 
> 0.05) (figure 4.9.A). Significantly fewer free-flowing cells are observed in CD31-/- animals 
at early time points when compared to wild-type animals (e.g. sham treatment, free-
flowing cells at 30 minutes: wild-type animals: 4.50 ± 0.65 vs. CD31-/- animals: 1.67 ± 0.92; P 
< 0.01) (figure 4.9.B). Interestingly, following IR injury in CD31-/- animals, HPC-7 adhesion is 
not significantly different from that seen in sham controls (e.g. adhesion at 30 minutes: 
sham treated CD31-/-: 15.17 ± 2.93 vs IR treated CD31-/-: 15.67 ± 5.02; P > 0.05) (figure 
4.9.C). Significantly fewer free-flowing cells were observed at the earliest time point 
following reperfusion in sham CD31-/- animals compared to IR CD31-/- animals (e.g. free-
flowing cells at 30 minutes: sham treated CD31-/-: 1.67 ± 0.92 vs. IR treated CD31-/-: 5.67 ± 
1.67; P < 0.001) (figure 4.9.D). Very few free-flowing cells are observed in the later periods 
of reperfusion and there is no significant difference between sham and IR treated animals 
Chapter 4: Mechanisms of haematopoietic stem cell recruitment during murine ischemia-
reperfusion injury – role of specific adhesion 
126 
(e.g. free-flowing cells at 60 minutes: sham treated CD31-/-: 0.60 ± 0.40 vs. IR treated CD31-/-
: 0.33 ± 0.21; P > 0.05) (figure 4.9.D).  Lack of CD31 did not alter the localisation of HPC-7 
recruitment as cell adhesion again remained exclusively sinusoidal similar to wild-type 
controls (figures 4.9.E-F).  
 
4.3.10.  Tissue VCAM-1, CD31 and CD44 are not upregulated as a result of an acute 
IR injury when assessed by immunohistochemistry 
No detectable upregulation in VCAM-1 (figures 4.10.A-B), CD31 (figures 4.10.C-D) or CD44 
(figures 4.10.E-F) was detectable by immunohistochemistry on IR injured hepatic sections 
when compared to sham sections.  No VCAM-1 staining of large vessels or sinusoidal 
endothelium was visibly detectable on any hepatic sections (figures 4.10.A-B). CD31 
staining was primarily localised to large vessels (figures 4.10.C-D), while CD44 primarily 
stained sinusoidal vessels (figures 4.10.E-F).  
 
 
4.4.  Discussion 
Although knowledge of mechanisms governing HSC homing to BM is increasing, very little is 
known about the molecular basis of HSC recruitment to extramedullary sites following 
injury.  Our novel data demonstrate that systemically administered HSCs migrate to the 
injured murine liver and adhere in sinusoidal capillaries with recruitment in vivo being 
dependent on CD49d (α4β1 integrin) and endothelial VCAM-1 interactions.  CD49d had a 
dominant role in our studies, evidenced by failure of CD18, CD44 or CD31 blockade to 
reduce adhesion.    
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Figure 4.9. CD31 knockout animals display raised and maximal adhesion for HPC-7 in vivo 
without a prior need for IR injury. Adhesion of HPC-7 cells to the hepatic microcirculation 
was examined using intravital microscopy. CD31-/- animals were subjected to sham or IR 
treatment (90 PHI/30 R) and HPC-7 cells (expressing CD31) administered following 
treatment. HPC-7 adhesion is significantly raised in CD31-/- sham animals when compared to 
WT sham controls (panel A; black line: WT Sham, grey line: CD31-/- Sham). Significantly 
fewer cells are observed free-flowing in CD31-/- sham animals during early reperfusion 
compared to WT sham controls (panel B; black line: WT Sham, grey line: CD31-/- Sham). IR 
injury does not raise adhesion any further in CD31-/- animals (panel C; black line: CD31-/- 
Sham, grey line: CD31-/- IR). Significantly more free flowing cells are visualised in CD31-/- IR 
animals compared to CD31-/- sham (panel D; black line: CD31-/- Sham, grey line: CD31-/- IR). 
Representative images of CD31-/- sham (panel E) and CD31-/- IR are shown (panel F). Panels 
A-D represent mean ± SEM of at least 5 separate experiments; ** p < 0.01, *** p < 0.001 
(two-way ANOVA followed by Bonferroni Post Test for points of significance). 
E F 
A B 
C D 
HPC-7 CD31
-/-
 Sham HPC-7 CD31-/- IR 
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Figure 4.10. No upregulation of VCAM-1, CD31 or CD44 is detectable by 
immunohistochemistry of sham and IR liver sections. Sections were isolated from sham and 
IR animals, and immunohistochemistry (IHC) performed. VCAM-1 was visibly undetectable 
on both sham (panel A) and IR (panel B) sections.  CD31 and CD44 were detectable on the 
larger portal vessels and sinusoidal endothelium respectively.  However, there was no 
discernable difference in expression between sham and IR sections (CD31: Sham, panel C; 
IR, panel D. CD44: Sham, panel E; IR, panel F). 
A B 
C D 
E F 
VCAM-1 Sham VCAM-1 IR 
CD31 Sham CD31 IR 
CD44 Sham CD44 IR 
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VLA-4 also mediates adhesion of mature leukocytes to endothelium via interactions with 
endothelial VCAM-1 or matrix fibronectin (Elices et al., 1990). The latter interaction has 
been implicated in inflammatory cell recruitment following hepatic IR injury although a 
similar role for the VLA-4/VCAM-1 pathway has not been reported in the murine hepatic IR 
inury model (Moore et al., 2007).  Furthermore, the VLA-4/VCAM-1 pathway has been 
implicated heavily in homing of HSCs to the BM following exogenous stem cell 
transplantation in irradiated hosts (Papayannopoulou et al., 1995). Blockade of VLA-4 on 
progenitor cells significantly reduces homing of HSCs to the BM and concomitantly 
increases circulating progenitor cell numbers (Papayannopoulou et al., 1995). Recent work 
by Ceradini and colleagues (Ceradini et al., 2004) has suggested that HSC trafficking to sites 
of hypoxic injury is a result of local increases in CXCL12.  Hepatic injury also induces release 
of CXCL12 (Kollet et al., 2003) which can subsequently rapidly activate HSC integrins 
including VLA-4, promoting recruitment (Peled et al., 2000). 
 
Previous work from our lab has shown that pre-treatment of HPC-7 cells with an anti-CD49d 
blocking antibody inhibits adhesion in vitro to murine cardiac endothelium under flow 
conditions (figure 4.11 at the end of this chapter). Interestingly, while pre-treatment of 
HPC-7 cells with an anti-CD49d blocking antibody attenuates HPC-7 recruitment in vivo and 
in vitro using flow based adhesion assays, it does not modify adhesion in vitro using static 
tissue adhesion assays. This suggests that other adhesion molecules may be important in 
the recruitment of HSCs to the hepatic microvasculature or flow is an important component 
for VLA-4-dependent adhesion.  Interestingly, VLA-4 supports firm adhesion of T-
lymphocytes and α4 integrin transfected cells on VCAM-1 in vitro when treated with 
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integrin activating factors Mn2+, phorbol ester and mAb TS2/16 (Alon et al., 1995). It is 
possible that in our model of injury, activating factors are present in the local and systemic 
circulation in vivo, but would be absent in the Stamper-Woodruff assay explaining the lack 
of a role for VLA-4 in this assay.   
 
In the current study, functional inhibition of VCAM-1 with an intra-arterial injection of 
blocking antibody significantly attenuated adhesion of HPC-7 cells following IR injury.  In a 
rat model of hepatic IR injury, transcriptional upregulation of VCAM-1 can be detected 
within one hour of reperfusion (Bell et al., 1997). Lymphocyte recruitment following IR 
injury is also largely reliant on VCAM-1 (Lalor and Adams, 1999). It is therefore not 
surprising that the VLA-4/VCAM-1 pathway mediates HSC recruitment to the liver. Indeed, 
the VLA-4/VCAM-1 pathway mediates recruitment of other cell types to the liver inlcuding 
melanoma cells  (Anasagasti et al., 1997). Interestingly, whether VCAM-1 plays a similar role 
in the recruitment of neutrophils following hepatic IR injury is currently not known.  
Neutrophil recruitment during liver reperfusion appears to be predominantly dependent 
largely on the αM integrin Mac-1 (CD11b/CD18) interactions with endothelial ICAM-1 
(Jaeschke, 2003). 
 
Homophilic interactions of the IgSF adhesion molecule CD31 (PECAM-1) play a critical role 
in mature leukocyte adhesion and transendothelial migration in various organs (Rijcken et 
al., 2007, Nolte et al., 2004, Murohara et al., 1996). It is also expressed on HSCs and has 
been shown to play a role in BM homing (Ross et al., 2008).  Although evidence suggests a 
role for CD31 generally in IR injuries (Nolte et al., 2004, Nourshargh et al., 2006), very little 
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evidence implicates the molecule specifically in hepatic IR injury. However, basal expression 
of CD31 has been observed immunohistochemically on human hepatic sinusoidal 
endothelial cells (Pusztaszeri et al., 2006).  In the current study, pre-treatment of HPC-7 
cells with an anti-CD31 antibody did not reduce adhesion post-reperfusion suggesting HPC-
7 recruitment is independent of CD31. 
 
As CD31 also has a significant endothelial component, we investigated HSC adhesion in 
CD31-/- animals. Surprisingly, we demonstrated that HPC-7 adhesion following sham 
treatment was raised in CD31-/- animals when compared to sham treated WT controls.   
Interestingly, work from our lab has recently demonstrated increased whole BM cell 
adhesion to murine skull BM microcirculation in CD31-/- mice (Ross et al., 2008).  This may 
be a result of CD31-/- animals exhibiting a basal or constitutive pro-inflammatory state.  
Goel and colleagues (Goel et al., 2007) investigated the role of CD31 in an endotoxin-
induced model of liver inflammation and demonstrated that CD31 deficiency was 
associated with heightened levels of pro-inflammatory cytokines and reactive oxygen 
species (Goel et al., 2007). CD31 engagement has also been shown to inhibit the production 
of pro-inflammatory cytokines in vivo (Carrithers et al., 2005, Maas et al., 2005). However, 
HPC-7 adhesion was not further raised in CD31-/- IR treated animals compared to sham 
treated CD31-/- animals.  It is possible that maximal adhesion of HPC-7s is attained in the 
sham treated CD31-/- animals which cannot be further enhanced even in the presence of 
injury. Alternatively, it is possible that HSC recruitment to the injured liver is actually 
dependent on endothelial CD31 which is why recruitment within CD31-/- IR treated animals 
is similar to the appropriate control sham treated CD31-/- animals.   
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We demonstrated the abundant expresssion of CD44 on the surface of HPC-7 cells but it is 
also expressed on hepatic endothelium during inflammation (McDonald et al., 2008). Even 
at basal levels, hepatic expression of CD44 is around two orders of magnitude higher than 
any other organ (McDonald et al., 2008).   Furthermore, CD44 is implicated in CXCL12 
mediated trafficking of CD34+ progenitor cells to the BM (Avigdor et al., 2004). MSC 
migration on HA is also significantly mediated by CD44 (Zhu et al., 2006). Collectively, these 
studies suggest that CD44 appears to be a good candidate to mediate HSC adhesion to the 
hepatic microvasculature post IR injury. However, pre-treatment of HPC-7 cells with a CD44 
blocking antibody did not significantly reduce HPC-7 adhesion during IR injury in the current 
study. Some controversy exists regarding the role of CD44 in homing to the BM.  Although 
studies using anti-CD44 antibodies reveal impaired homing (Avigdor et al., 2004), CD44 
knock-out mice demonstrate no defects in this process (Oostendorp et al., 2000). In renal IR 
injury, CD44 blockade significantly reduces neutrophil adhesion to the injured tissue 
(Rouschop et al., 2005). On the other hand, intestinal IR injury leads to a significant 
reduction in CD44 expression in jejunal mucosal endothelium (Heel et al., 1998). If the 
hepatic response to IR injury is similar to that in the jejunum, then the result would be 
lower hepatic endothelial expression of CD44. As a result, blockade of CD44 would have no 
effect on adhesion of HPC-7 cells.  
 
We did not demonstrate a significant role for the β2 integrin, CD18, which is surprising given 
the importance of CD18/ICAM-1 interactions for IR mediated neutrophil recruitment in 
several organs including the liver (Jaeschke et al., 1993).  It is suggested that the major role 
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of the β2 integrins in hepatic IR injury becomes apparent later during reperfusion, when the 
endothelial monolayer is disrupted and leukocyte β2 integrins bind directly to receptors on 
hepatocytes (Kobayashi et al., 2001). Hence the previously described benefits of anti-CD18 
therapy in the liver may be due to it preventing neutrophil interactions with hepatocytes 
rather than sinusoids.  This may explain the ineffectiveness of CD18 blockade in the current 
study since at the times studied, the endothelial monolayer is likely to be relatively intact, 
masking hepatocytes and the adhesion molecules to which HSCs would bind using β2 
integrins.  
 
Recent data suggest that the VLA-4/VCAM-1 pathway alone is capable of facilitating capture 
of progenitor cells within BM, but if its function is compromised a synergistic contribution 
of β2 integrins and selectins is uncovered (Papayannopoulou et al., 2001).  Furthermore, it is 
possible that VLA-4 integrin plays a site specific role in liver since studies from our 
laboratory demonstrate HSC recruitment to IR injured cremaster muscle venules is CD18-
dependent (Zhao et al., 2008).  In addition, it has been shown that HSCs can be activated 
such that the adhesion molecules expressed on the cell surface become ‘primed’ (Peled et 
al., 2000). It is conceivable that the signals released from the endothelium during hepatic IR 
injury are insufficient for β2 integrin activation on HSCs.    
 
During the reperfusion phase of hepatic IR injury, activation of the transcription factor 
NF-κB occurs within 30 minutes and peaks at one hour (Yoshidome et al., 1999). As early as 
90 minutes post-reperfusion, mRNA for ICAM-1 and VCAM-1 are significantly upregulated 
on hepatic endothelial cells (Essani et al., 1997, Yoshidome et al., 1999). The current study 
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used immunohistochemistry to investigate the expression of CD44, CD31 and VCAM-1 
during IR injury.  However, no detectable upregulation of CD44, CD31 or VCAM-1 on hepatic 
sections from IR treated animals was observed when compared to sham treated animals. In 
contrast it should be noted we were unable to detect CD31 on the hepatic sinusoids using 
immunohistochemistry. This may be a result of low CD31 expression which is below the 
sensitivity of the assay.  It is well documented that immunohistochemistry is sometimes 
unsuitable for detecting analytes at low levels (Gusev et al., 2001). 
 
Interestingly, L-selectin could not be blocked, even with monoclonal antibody 
concentrations as high as 160μg/ml of antibody. Whether this represents cycling of blocked 
L-selectin with fresh L-selectin is unclear. It is unlikely to be a result of inappropriate 
antibody; a fluorescent antibody of the same clone identifies clearly identifies L-selectin 
expression. As a result of the relative selectin independence of the hepatic sinusoidal 
vascular bed, this adhesion molecule was not investigated in any detail in our studies.  
 
In conclusion, we report for the first time that VLA-4/VCAM-1 interactions play an 
important role in recruitment of exogenous HSCs to inflamed liver. Modulation of this 
homing mechanism may be used as a therapeutic strategy to improve the efficacy of 
potential stem cell therapy.  This is essential considering the rarity of HSCs, which currently 
limit the ultimate magnitude of therapeutic cellular regeneration based on administering 
these cells exogenously. In a study by Kumar and Ponnazhagan, ectopic expression of the 
α4 integrin on the surface of MSCs significantly promotes recruitment to the bone marrow. 
To achieve this, MSCs were transfected with the α4 integrin subunit using an adenovirus 
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vector. Cells transfected with the α4 integrin displayed a 10-fold enhancement in homing 
when compared to GFP (control) transduced cells (Kumar and Ponnazhagan, 2007). 
Furthermore, in a recent study by Sackstein and colleagues, chemical engineering of MSCs 
enhanced recruitment of these cells to the bone marrow. While MSCs natively do not 
express E-selectin ligands, Sackstein et al. enzymatically converted the native MSC CD44 
isoform into HCELL, a potent E-selectin ligand (Sackstein et al., 2008). Understanding the 
adhesion pathways in HSCs will act a starting point for similar studies aimed to enhance 
recruitment of HSCs to target tissues. 
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Figure 4.11. Blocking HPC-7 cells with an anti-CD49d antibody significantly reduces adhesion 
to MuCEC-1 in a flow based adhesion assay. In a flow based adhesion assay, HPC-7 cells 
(pre-treated with an anti-CD49d mAb) were flown across MuCEC-1. Blockade of CD49d 
significantly reduces adhesion (panel A). Example images of the assay are presented 
(panels B and C). Work was performed by Mr Luke E Durant in our lab (unpublished results, 
2006).  
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5.   Mechanisms of haematopoietic stem cell recruitment during murine 
ischemia-reperfusion injury – role of cytokines  
 
5.1.   Introduction and hypotheses 
 
5.1.1.  Introduction 
The cytokine response to IR injury is robust (Luster, 1998), with production of a variety of 
cytokines providing a strong stimulus for neutrophil recruitment to the injured organ 
(Lentsch et al., 1998, Burne et al., 2001). Cytokines released during hepatic injury include 
TNFα, IL-1, IL-8, macrophage inflammatory protein-2 (MIP-2) but also CXCL12 and MMP-9 
(Kollet et al., 2003). Matrix metalloproteinases, such as MMP-9, are able to modify the 
composition of basement membrane, facilitating HSC emigration into tissues (Dalakas et al., 
2005).  
 
Although the role of inflammatory cytokines/chemokines in mature leukocyte recruitment 
is well established, their role in HSC recruitment to injured tissue is not clear. Currently the 
role of CXCL12 in stem cell homing has been most investigated.  It plays a critical role in HSC 
recruitment to the BM (Kopp et al., 2005) and antibody mediated blockade of the CXCL12 
receptor, CXCR4, prevents BM engraftment of human CD34+ cells in NOD/SCID mice (Peled 
et al., 1999b). Furthermore, CXCL12 is also implicated in the recruitment of HSCs to extra-
medullary sites following hypoxic injury as its release from endothelium is mediated by 
activation of the transcription factor, hypoxia-inducible factor-1 (HIF-1) during periods of 
hypoxia (Ceradini et al., 2004). CXCL12 production by cardiac tissue recruits human 
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CD34+/c-kit+ cells and this has been shown to subsequently confer a vasculogenic effect 
(Askari et al., 2003). In rats, direct injection of a protease resistant form of CXCL12 (S-
CXCL12(S4V)) into infarcted myocardium significantly promotes progenitor cell 
(CXCR4+c-kit+) recruitment and improves cardiac ejection fraction (Segers et al., 2007). 
However, the direct role played by CXCL12 and other major inflammatory cytokines in 
recruiting HSCs to injured liver is not well understood. 
 
CXCL12 mediated recruitment is likely to involve integrin activation on the HSC surface as 
well as the induction of cytoskeletal reorganization and a motile phenotype.  CXCL12 
activates integrins VLA-4, VLA-5 and LFA-1 as evidenced by increased adhesiveness to 
ICAM-1 and VCAM-1 in vitro (Peled et al., 2000).  During liver rejection infiltrating 
lymphocytes express raised levels of functional CXCR4, suggesting the CXCL12/CXCR4 
pathway may be physiologically relevant for leukocyte homing during liver injury (Goddard 
et al., 2001). In addition to inducing activation by a conformational change that switches an 
inactive integrin into an active one, cytokines can also upregulate integrin expression on the 
cell surface. Treatment of various subsets of mature leukocytes with MIP1α or MIP2α 
significantly increases surface expression of the CD11b subunit of the integrin Mac-1 
(Conklyn et al., 1996). Treatment of neutrophils with 200U/ml TNFα for 30 minutes 
significantly upregulates both CD11b and CD18 expression and increases migration 
responses to the chemokine, CCL3 (Montecucco et al., 2008). Upregulation of CD18 on 
neutrophils has also been observed following a 15 minute exposure to RANTES, MIP-1 and 
IL-8 (Conklyn et al., 1996). There is limited data on whether inflammatory cytokines can also 
increase adhesion molecule expression on HSCs.  However, Zhang et al did demonstrate 
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that treatment of human CD34+ cells with IL-6 and TNFα upregulates expression of CD49d 
(Zhang et al., 2007).  
 
The previous chapter demonstrated that HSC recruitment during liver injury is primarily 
dependent upon the VLA-4/VCAM-1 pathway.   However, it is not clear whether increased 
expression or conformational activation of VLA-4 on HSCs is responsible for their 
recruitment nor what the activating factors are.  Therefore, this chapter will investigate 
whether soluble factors released from IR injured liver alter the expression of not only 
VLA-4, but also CD18 and CD44 on the HSC surface. Circulating HSCs would be exposed to 
these soluble inflammatory factors not only within the local microcirculation at the site of 
injury, but also possibly within the systemic circulation.  In order to determine whether 
CXCL12 is responsible for any changes in adhesion molecule expression, the effect of 
CXCL12 on HSCs will be tested.   However, within an inflamed environment, cell recruitment 
is likely mediated by a combination of cytokines acting in synergy and we will also study the 
effect of proinflammatory cytokines including TNFα, IL-6, CXCL1 (CXCL1; keratinocyte 
derived chemokine, a functional murine homologue of human IL-8) and TGFβ.   
Furthermore, the direct role of CXCL12 in mediating HSC recruitment to IR injured liver in 
vivo will be investigated.  Understanding these effects could facilitate modulation of HSC 
recruitment ex vivo prior to cell transfer in order to enhance recruitment. 
 
5.1.2.  Hypotheses 
Our primary hypothesis is that IR injury induces the expression of integrin-activating factors 
in tissue which include CXCL12.  More specifically, we hypothesised that :  
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1. Treatment of HPC-7 cells with a) media conditioned by homogenised tissue 
 supernatant from animals subjected to IR injury b) plasma from animals subjected to IR 
 injury would upregulate adhesion molecule expression 
2.  Treatment of HPC-7 cells with CXCL12, TNFα, IL-6, CXCL1 or TGFβ either alone or as a 
 cocktail would upregulate adhesion molecule expression 
3. Treatment of HPC-7 with inflammatory cytokines, including CXCL12, would enhance 
 their adhesion to endothelium in static adhesion assays 
4.  Blockade of the CXCL12 receptor CXCR4 on HPC-7 cells would significantly reduce 
 injured liver recruitment in vivo 
 
5.2.  Methods 
The methods used in this chapter are described in detail in Chapter 2. Briefly, HPC-7 cells 
were initially examined by FACS for expression of the CXCL12 receptor using fluorescently 
conjugated antibody against CXCR4 (FITC).  Expression of the TNFα receptors, TNFR1 (PE) 
and TNFR2 (PE) was also determined.  HPC-7s were then analysed for changes in expression 
of adhesion molecules following treatment with media conditioned by homogenised 
hepatic IR tissue supernatant or plasma derived from IR animals for 24 hrs.  To determine 
whether any effects observed were tissue specific, cells were also treated with media 
conditioned by homogenised IR treated gut tissue supernatant.  
 
In order to determine which specific cytokines could induce adhesion molecule expression 
changes, HPC-7s were also analysed for changes in expression of adhesion molecules 
following treatment with 100ng/ml of CXCL12, CXCL1, IL-6 or TNF-α, 10ng/ml TGFβ or PBSA 
for between 30 minutes and 24 hours.  FACS analysis was conducted using fluorescently 
conjugated antibodies against CD49d (FITC), CD44 (PE) and CD18 (FITC).  The effects of a 
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cocktail of cytokines on CD49d expression were also determined. HPC-7 cells were treated 
with a cocktail of 20ng/ml IL-1β, 20ng/ml CXCL12, 20ng/ml TNF-α and 20ng/ml CXCL1 for 
0.5, 1, 3, 6 and 24 hours. Data are presented as a percent of control expression for samples 
with an untreated control, or mean fluorescent intensity for groups lacking an untreated 
control (such as sham and IR treated samples). 
 
To investigate the ability of cytokines to regulate adhesion of HPC-7 cells to endothelial 
monolayers, static adhesion assays were conducted using MuCEC-1 seeded on coverslips.  
HPC-7 cells were incubated with cytokines for four hours prior to exposure to endothelium 
and adhesion subsequently monitored.  Data represent mean adhesion ± SEM from four 
experiments. Furthermore, intravital microscopy was conducted using CFSE labeled HPC-7 
cells pre-treated with a CXCR4 receptor function blocking mAb.  Data represent the mean 
adhesion or free flowing cells ± SEM of at least 4 animals per group. 
 
5.3.  Results 
 
5.3.1.  HPC-7 cells express the cytokine receptors CXCR4, TNFR1 and TNFR2 
The cytokine receptor profile of HPC-7 cells is currently not known, so flow cytometry was 
used to determine whether these cells express CXCR4, TNFR1 and/or TNFR2.  HPC-7 express 
CXCR4 (figure 5.1.A), and both TNFR1 and TNFR2 with higher levels of the former (figure 
5.1.B) (figures 5.1.B & 5.1C).  
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5.3.2.  CD44 or CD18 expression is not changed by treatment of HPC-7 cells with 
conditioned media from gut or hepatic IR tissues 
No significant upregulation of CD18 (sham liver conditioned: 36.94 ± 5.41 vs. IR liver 
conditioned: 38.02 ± 1.22; P > 0.05; sham gut conditioned: 39.86 ± 4.51 vs. IR gut 
conditioned: 35.49 ± 8.27; P > 0.05) or CD44 (sham hepatic conditioned: 2081.00 ± 120.70 
vs. IR hepatic conditioned: 2110.00 ± 164.50; P > 0.05; sham gut conditioned: 4105.00 ± 
236.70 vs. IR gut conditioned: 3881.00 ± 961.50; P > 0.05) expression was observed 
following treatment with hepatic IR or gut IR tissue conditioned media compared with sham 
control (figures 5.2.A-D).   
 
5.3.3.  CD49d expression is upregulated by treatment of HPC-7 with hepatic IR and 
gut IR conditioned media 
Treatment of HPC-7 cells with hepatic IR conditioned media increased CD49d expression 
compared to media conditioned with a sham liver sample, but this did not attain statistical 
significance (MFI: sham hepatic conditioned: 31.09 ± 1.21 vs. IR hepatic conditioned: 38.57 
± 5.74; P > 0.05) (figure 5.3.A). No change was seen after treatment with gut IR conditioned 
media (MFI: sham gut conditioned: 29.06 ± 1.62 vs. IR gut conditioned: 23.13 ± 7.00; P > 
0.05) (figure 5.3.B).  
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Figure 5.1. HPC-7 cells express the cytokine receptors CXCR4, TNFR1 and TNFR2 as 
determined by FACS. HPC-7 cells express CXCR4 (panel A), TNFR1 (panel B), and TNFR2 
(panel C) (filled area: negative control antibody, black line: receptor antibody). Figures are 
typical FACS plots representative of three separate experiments.  
A B 
C 
CXCR4 TNFR1 
TNFR2 
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Figure 5.2. Treatment of HPC-7 cells with media conditioned from hepatic and intestinal IR 
tissue does not up-regulate CD44 or CD18. Hepatic and gut IR tissue was prepared, 
homogenised and incubated in media for 24 hours (sham tissue was also obtained). 
Treatment of HPC-7 cells with IR liver tissue media does not up-regulate CD18 (panel A) or 
CD44 (panel C) compared to sham gut tissue. Similarly, IR gut tissue media does not up-
regulate CD18 (panel B) or CD44 (panel D). Representative FACS plots of hepato-treated 
HPC-7 CD18 (panel E) and CD44 (panel F) expressions are shown (filled area: sham 
conditioned, black line: IR conditioned). Figures represent mean ± SEM of at least three 
separate experiments. 
A B 
C D 
E F Hepatic Conditioned Hepatic Conditioned 
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Figure 5.3. Hepatic IR conditioned medium, but not gut IR conditioned medium, modestly 
(but insignificantly) up-regulates CD49d on HPC-7 cells. Hepatic and gut IR tissue was 
prepared, homogenised and incubated in media overnight (sham tissue was also obtained). 
HPC-7 cells were incubated in the relevant media for 24 hours. Hepatic IR conditioned 
media modestly, but insignificantly, up-regulates HPC-7 expression of CD49d (panels A and 
C). Gut IR conditioned medium mediates a general down-regulation of CD49d (panels B and 
D). Panels A and B are representative of mean ± SEM of three separate experiments. Panels 
C and D are representative FACS images. 
A B 
C D 
Hepatic IR conditioned Gut IR conditioned 
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5.3.4.  CD49d expression after treatment of HPC-7 with conditioned plasma from 
hepatic IR  
To identify if the factors mediating the minor CD49d shift were circulating factors, HPC-7 
cells were treated for 24 hours with plasma from hepatic IR treated animals or sham 
treated animals. No change in CD49d expression was seen following treatment with plasma 
from IR animals when compared to plasma from sham controls (MFI: hepatic sham – 
plasma: 15.99 ± 3.89 vs. hepatic IR – plasma: 15.20 ± 3.23; P > 0.05) (Figure 5.4.A). 
 
5.3.5.  CD49d, CD44 and CD18 expression is not significantly changed by 
treatment with individual cytokines 
CD49d expression increased slightly after treatment with CXCL12 (% of control expression: 
107.74% ± 5.17%) (figures 5.5.A & 5.5.D) but not after other cytokine treatments. 
Interestingly, decreased expression was seen following treatment with 100ng/ml IL-6 (% of 
control expression: 74.1% ± 14.94%) (figure 5.5.A), 100ng/ml TNF-α (% of control 
expression: 75.96% ± 2.74%) (figure 5.5.A) and 10ng/ml TGFβ (% of control expression: 
59.22% ± 0.51%) (figure 5.5.A). CD44 expression was not upregulated by cytokine 
treatment, although a drop in expression was observed following treatment with 100ng/ml 
TNF-α (% of control expression: 91.17% ± 0.36%) (figure 5.5.B). CD18 expression was also 
not changed by any of the cytokine treatments (figure 5.5.C).  
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5.3.6.   CD49d expression is downregulated by a cocktail of cytokines in a time-
dependent manner 
CD49d upregulation was not observed at any time point. However, a time-dependent 
down-regulation in CD49d expression was observed (figure 5.6.A) in response to a cocktail 
of 20ng/ml IL-1β, 20ng/ml CXCL12, 20ng/ml TNF-α and 20ng/ml CXCL1. Compared to PBSA 
controls, cell surface CD49d decreased at 30 minutes (% control expression: 96.27% ± 
0.73%), 1 hour (% control expression: 96.85% ± 0.21%), 3 hours (% control expression: 
96.29% ± 0.31%), 6 hours (% control expression: 93.26% ± 0.57%) with maximal reduction at 
24 hours (% control expression: 82.46% ± 2.68%) (figure 5.6.A).   
 
5.3.7.  Treatment of HPC-7 cells with CXCL12 and CXCL1 enhance adhesion to 
MuCEC-1 
The role of various cytokines in directly mediating HSC adhesion was determined in vitro by 
pre-treating HPC-7s for 4 hours with 20ng/ml of CXCL12, CXCL1, TNF-α or IL-1β. Control 
HPC-7 cells were treated with PBSA. HPC-7 cells were then CFSE labelled. Adhesion of HPC-7 
to MuCEC-1 was determined in a static endothelial cell adhesion assay.  Treatment of HPC-7 
cells with 20ng/ml TNF-α did not significantly increase adhesion to murine endothelium 
(cells adherent: PBSA: 21.15 ± 5.42 vs. TNF-α: 28.50 ± 2.50; P > 0.05) (figure 5.7.A). 
Although there was a slight increase, IL-1β did not significantly raise adhesion either (cells 
adherent: PBSA: 21.15 ± 5.42 vs. IL-1β: 44.78 ± 10.01; P > 0.05) (figure 5.7.A). However, 
treatment of HPC-7 cells with CXCL12 significantly enhanced adhesion on murine 
endothelium when compared to control (cells adherent: PBSA: 21.15 ± 5.42 vs. CXCL12: 
59.33 ± 10.50; P < 0.05) (figure 5.7.A). Similarly, treatment of HPC-7 cells with CXCL1 also  
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Figure 5.4. CD49d is not upregulated on HPC-7 cells as a result of overnight incubation with 
plasma from IR treated animals. HPC-7 cells were incubated for 24 hours in plasma isolated 
from sham and IR treated animals. Treatment of cells with plasma isolated from IR animals 
does not up-regulate CD49d when compared to plasma from sham animals (panel A). A 
representative FACS plot is shown (panel B). Panel A represents mean ± SEM of three 
separate experiments.  
A 
B 
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Figure 5.5. Treatment of HPC-7 cells with various cytokines does not up-regulate expression 
of selected adhesion molecules. HPC-7 cells were treated for 24 hours with various 
cytokines to investigate any effect on adhesion molecule expression. Expression of CD49d 
appears to be decreased by treatment with 100ng/ml IL-6, 100ng/ml TNF-α and 10ng/ml 
TGF-β.  (panel A). Almost all cytokines were unable to elicit an upregulation of CD49d 
(panel C), CD44 (panel D) or CD18 (panel E). Representative FACS plot displaying minor 
increase in CD49d expression after CXCL12 treatment is shown (panel C). All panels 
represent expression as a percentage of control ± SEM from three experiments. 
 
A 
CXCL12 
TGF-β TNF-α IL-6 
B C 
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Figure 5.6. Treatment of HPC-7 cells with a cocktail of comparatively low-dose cytokines 
results in a time dependent down-regulation of CD49d. HPC-7 cells were treated for various 
time periods with a cytokine cocktail containing 20ng/ml CXCL12, 20ng/ml IL-1β, 20ng/ml 
TNF-α and 20ng/ml CXCL1. A down-regulation of CD49d was visible at all time points, 
increasing incrementally until 24 hours (panel A). Representative FACS plots are shown 
from 30 minutes (panel B), 1 hour (panel C), 3 hours (panel D), 6 hours (panel E) and 24 
hours (panel F). Bars represent CD49d expression as percent of control ± SEM from 3 
individual experiments.  
A 
B C D 
E F 
30 min 1 hr 3 hr 
6 hr  24 hr 
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Figure 5.7. CXCL12 and CXCL1, but not TNF-α or IL-1β, enhance HPC-7 adhesion to MuCEC-1. 
HPC-7 cells were pre-treated with 20ng/ml of the relevant cytokine for four hours, and 
subsequently labeled with CFSE (5μM). Cells were seeded on MuCEC-1 for five minutes then 
unbound cells washed away. Treatment with CXCL12 and CXCL1 significantly enhance HPC-
7 recruitment on MuCEC-1, a phenomenon not observed for TNF-α or IL-1β (panel A). 
Representative images are given (panel B). Bars represent mean ± SEM of four separate 
experiments; * p < 0.05, ** p < 0.01 (one-way ANOVA followed by a Bonferroni Multiple 
Comparison Test) 
A 
B 
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significantly augmented adhesion on murine endothelium (cells adherent: PBSA: 21.15 ± 
5.42 vs. CXCL1: 65.03 ± 10.04; P < 0.01) (figure 5.7.A).   
 
5.3.8.  CXCR4 blockade does not significantly reduce hepatic HSC adhesion post IR 
injury 
As CXCL12 treatment significantly increased HPC-7 adhesion to endothelium in vitro, the 
counter-receptor CXCR4 was blocked on HPC-7 cells in the in vivo intravital model using 
80μg/ml anti-CXCR4. Control cells were treated with an isotype control. However, blockade 
of CXCR4 did not significantly reduce the adhesion of HPC-7 to the hepatic microvasculature 
post IR injury (e.g. adhesion at 45 minutes: IgG treated cells: 13.50 ± 2.11 vs. CXCR4 treated 
cells: 12.00 ± 3.43; P > 0.05) (figure 5.8.A). Blockade of CXCR4 did not significantly alter the 
number of free-flowing cells observed compared to IgG treated cells (e.g. free-flowing cells 
at 45 minutes: IgG treated cells: 1.17 ± 0.61 vs. CXCR4 treated cells: 0.50 ± 0.29; P > 0.05) 
(figure 5.8.B). The vast majority of free-flowing cells were observed at 30 minutes post-
reperfusion, the nearest time point to injection (e.g. CXCR4 treated: free-flowing cells at 30 
minutes: 4.25 ± 0.63 vs. free-flowing cells at 60 minutes: 0.75 ± 0.48; P < 0.01) (figure 5.8.B). 
Recruitment of cells remained exclusively sinusoidal (figure 5.8.C-D). 
 
5.4.  Discussion  
Despite previously demonstrating a crucial role for VLA-4/VCAM-1 interactions in mediating 
hepatic HSC recruitment, no significant increases in CD49d expression were observed 
following co-incubation of HPC-7s with injured liver conditioned media.   
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Figure 5.8. CXCR4 blockade does not significantly reduce hepatic HPC-7 recruitment post IR 
injury. Recruitment of HPC-7 cells to the hepatic microcirculation was examined using 
intravital microscopy following treatment with a specific blocking antibody. Animals were 
subjected to IR injury (90m PHI/30 R) prior to the introduction of either CXCR4 blocked or 
IgG treated HPC-7 cells (1 x 106 cells, 5μM CFSE, I.A.). Blockade of CXCR4 on HPC-7 failed to 
reduce the adhesion seen post IR injury (panel A; black line: IgG treated, grey line: anti-
CXCR4 treated). No significant difference was seen in free flowing cells between treatments 
(panel B; black line: IgG treated, grey line: anti-CXCR4 treated). Representative images are 
shown of IgG (panel C) and CXCR4 (panel D) treated cells. Figures are representative of 
mean ± SEM of five separate experiments.  
A B 
C D 
HPC-7 IgG HPC-7 anti-CXCR4 
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Furthermore, after testing a panel of cytokines known to play a role in hepatic IR injury 
(Serracino-Inglott et al., 2001), we were also unable to identify cytokines that could 
significantly modulate the cell surface expression of CD49d. Both CXCL12 and murine CXCL1 
significantly increased adhesion of HPC-7 cells to endothelial cells in vitro and given their 
lack of effect on integrin expression this is likely to be the results of conformational 
activation.   However, blocking CXCR4 failed to reduce adhesion in vivo.  
 
The modest increase in CD49d expression after 24 hour incubation with homogenised 
tissue supernatant may reflect a mechanism by which HPC-7 cells are retained within the 
injured microcirculation.  However, the changes were not statistically significant although 
this might reflect a type 2 statistical error and with increased power, significance could have 
been reached.  If a statistical significance could be demonstrated this would suggest that 
the local inflammatory environment can release factor(s) that activate CD49d.  
 
Indeed, our in vitro studies demonstrated that both CXCL12 and CXCL1 were able to 
increase adhesion of HPC-7s to murine endothelial cells.  Murine CXCL1 has been implicated 
in inflammatory cell recruitment following hepatic IR injury (Lentsch et al., 1998) while the 
human functional homologue, IL-8, has been implicated partially in HSC mobilisation from 
the BM (van Pel et al., 2006). However, while a critical role for the CXCL12/CXCR4 pathway 
has been demonstrated in HSC recruitment, a similar role for CXCL1 had not previously 
been identified.    
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As CXCL12 is implicated in BM homing and HSC recruitment to extra-medullary tissues, we 
sought to investigate whether blockade of CXCR4 would reduce adhesion post IR injury. 
Pre-treating HPC-7 cells with CXCR4 blocking antibodies failed to reduce HSC adhesion 
following IR injury. Other cytokines may compensate for the activities of CXCL12, including 
IL-8, which may able to promote HSC adhesion to endothelium. Although blocking CXCR4 
robustly inhibits the BM homing of HSCs (Lapidot and Kollet, 2002), this may reflect more 
tightly defined adhesive mechanisms in the regulation of homing to the BM. 
 
Interestingly, some of the cytokines induced downregulation of CD49d.  IL-6 is released 
during acute hepatic IR injury (Tsuyama et al., 2000) and has anti-inflammatory and hepato-
protective functions (Matsumoto et al., 2006). IL-6 caused a reproducible downregulation 
of CD49d expression and to a lesser extent CD44 and CD18. TGFβ and TNFα also decreased 
CD49d expression.  TGFβ has been shown to play important roles in the regulation of the 
adhesive state of the BM compartment; treatment of BM stroma with TGFβ significantly 
reduces progenitor cell recruitment via CD49d (Robledo et al., 1998). CD49d is crucial in the 
retention of HSCs in the BM (Papayannopoulou, 2004) thus it is possible that release of 
cytokines from the injured liver into the systemic circulation could reduce CD49d on HSCs 
and thereby inhibit BM engraftment.  This would increase the availability of peripheral 
circulating HSCs for subsequent recruitment to injured sites.  Indeed, cytokines such as G-
CSF (granulocyte colony-stimulating factor), used clinically to mobilise stem cells from the 
BM, also work in a similar manner by manipulating numerous retention mechanisms. 
Treatment of progenitor cells with G-CSF significantly reduces their expression of CD49d 
and promotes egress into the circulation (Chen and Xie, 2003).  
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Treatment of HPC-7s with a cocktail of cytokines also reduced CD49d to a similar degree 
with maximal reduction after 24 hours co-incubation. It is possible that certain 
inflammatory environments may actively discourage HSC retention and CD49d 
downregulation could represent a mechanism by which HSCs can be removed from, or are 
prevented from being retained within, injured sites.  This is consistent with the findings of 
other groups suggesting that BM-derived stem cells do not actually need to engraft the 
injured tissue to exert benefit, but rather do so by a paracrine, anti-inflammatory 
mechanism.  Indeed, following renal IR injury, exogenously administered MSC are only 
present in the kidney for 2 hours post reperfusion and not observed after 24 hours (Tögel et 
al., 2005).   
 
Although a paracrine role has been predominantly ascribed to MSCs, HSCs can also exert 
benefit via a similar mechanism.  Yoshida and colleagues demonstrated that exogenously 
administered HSCs could prevent the damage associated with cochlear IR injury.  However, 
this benefit was not dependent on subsequent HSC differentiation or fusion, but rather 
paracrine effects (Yoshida et al., 2006).  Furthermore, HSCs have been reported to secrete 
growth factors with trophic properties, such as Ang1 (Takakura et al., 2000). Interestingly, 
HSCs have been shown to ameliorate hearing loss following cochlear ischemia via 
upregulation of the protein Glial cell derived neurotrophic factor (GDNF) independent of 
fusion or transdifferentiation (Yoshida et al., 2007). 
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Unlike treatment with the individual cytokines, no change in CD49d expression was 
observed when cells were treated with plasma derived from IR injured animals.  During 
tissue damage, cytokines released from the injured endothelium establish a local 
inflammatory microenvironment that facilitates leukocyte recruitment.  Cytokines remain 
within the local vasculature by binding to proteoglycans on the luminal surface of the 
endothelial glycoclayx.  For instance, it has been shown that IL-8 and MIP-1β are 
immobilised on the local endothelium, which prevents their washout by flowing blood (Rot, 
1992, Tanaka et al., 1993).  Thus CD49d activating factors may have been present only 
locally at the site of injury but not in the circulation.  Furthermore, cytokines are rapidly 
cleared from the circulation by both the liver and the kidney which might have left low or 
undetectable levels in plasma (Wollenberg et al., 1993).  
 
TNFα is also a key mediator of neutrophil recruitment in inflammation in part by enhancing 
Mac-1 (CD11b/CD18) up-regulation.  Mac-1 is important for leukocyte migration into 
inflamed tissues.  Montecucco and colleagues observed that treatment of neutrophils for 
30 minutes with TNFα induced significant increases in CD11b and CD18 subunits 
(Montecucco et al., 2008).  However, in the current study treatment of HSCs with TNFα 
does not lead to an upregulation in surface expression of any of the adhesion molecules 
investigated and in vitro only CXCL12 or CXCL1 increased adhesion of HPC-7s to murine 
cardiac endothelial cells. Thus, TNFα appears to play a role in the recruitment of mature 
leukocytes rather than stem/progenitor cells.   Indeed, recent studies from our group have 
demonstrated that recruitment of HPC-7 cells in vivo to the murine cremaster muscle can 
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only be mediated by an intrascrotal injection of IL-1β but not TNFα (Zhao et al., 2008).  It is 
also likely that TNFα acts primarily on the endothelium rather than on HSCs. 
 
The lack of a direct role for TNFα in mediating HPC-7 recruitment in vitro and in vivo (Zhao 
et al., 2008) is somewhat surprising given the observation that HPC-7 cells express 
abundant levels of the TNF-α receptors TNFR1 and TNFR2.  Meldrum et al also identified 
TNFR1 on CD34+ murine BM cells (Meldrum et al., 2006).  However, they demonstrated that 
TNFα served as a signal to progenitor cells to release vascular endothelial growth factor 
(VEGF). Furthermore, by using CD34+ cells derived from TNFR1-/- mice, they identified this 
receptor as being responsible for mediating maximum VEGF production.  VEGF is released 
in large quantities by stem cells and decreases inflammation and apoptosis during ischemia.  
It is therefore possible that the role of TNF receptors on HPC-7 cells is not to mediate stem 
cell recruitment, but to allow the cells to mediate beneficial paracrine effects.   
 
Pretreatment of HSCs with cytokines may be an important prerequisitie to their use in 
clinical therapies. Indeed, ex vivo treatment of BM HSCs with SCF, TPO, IGF-2 and FGF-1 
enhances their in vivo repopulating ability when introduced into lethally irradiated 
recipients (Zhang and Lodish, 2005). In the context of extra-medullary recruitment, 
pretreatment of HSCs with cytokines may be beneficial in enhancing recruitment at sites of 
injury via either adhesion molecule upregulation on the HSC surface or activation of pre-
existing adhesion molecules. While we were unable to show evidence for the upregulation 
of adhesion molecules after cytokine treatment, we have shown that particular cytokines 
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do enhance recruitment in vitro. Further work would examine whether pretreating HSCs 
prior to injection would enhance recruitment to injured organs. 
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6.  Mechanisms by which HSCs may exert beneficial effects 
 
6.1.  Introduction and hypotheses 
 
6.1.1.  Introduction  
The adhesion pathways by which HSCs are recruited to the IR injured liver are at least 
partially elucidated in the previous chapters.  HSC recruitment to injured extra-medullary, 
non-BM sites from the peripheral circulation may prove to be benefical in certain disorders, 
including the treatment of tissue damage post myocardial infarction (Zhang et al., 2007). 
However, the actual mechanisms by which HSCs may exert their benefit once recruited to 
damaged tissue are unclear. In the liver, evidence exists that HSCs can replace lost 
hepatocytes by both cell transdifferentiation and cell fusion although this is a rare event 
(Dalakas et al., 2005, Thorgeirsson and Grisham, 2006).  Alternatively, HSCs and other stem 
cell populations, particularly MSCs, may promote tissue repair through paracrine 
mechanisms. Intramyocardial injection of MSCs following infarction improves cardiac 
function and prevents ventricular remodelling via a secreted biological factor (Gnecchi et 
al., 2005). Furthermore, recruitment of MSCs to the renal microcirculation protects against 
ischemic acute renal failure (ARF), via mechanisms which are independent of 
transdifferentiation or fusion. The presence of HSCs during ARF results in reduced 
inflammatory gene expression (IL-1β, TNF-α, IFN-γ and iNOS) and increased anti-
inflammatory gene expression (IL-10, bFGF, TGF-α and Bcl-2) (Tögel et al., 2005). Whether a 
similar mechanism occurs in the liver is unclear. Indeed, it is even unclear whether HSCs 
share similar paracrine functions as their mesenchymal counterparts. 
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Numerous studies have provided evidence that MSCs promote tissue repair through the 
secretion of paracrine cytoprotective factors.  MSC conditioned media improved cardiac 
function in rat model of myocardial infarction, although the secreted beneficial factor(s) 
was not identified  (Gnecchi et al., 2005).  MSCs also protect against acute renal ischemic 
injury by reducing pro-inflammatory gene expression (IL-1β, TNF-α, IFN-γ and iNOS) and 
increasing anti-inflammatory gene expression (IL-10, bFGF, TGF-α and Bcl-2) (Tögel et al., 
2005). Similar effects have been observed in chemically damaged corneas with infiltration 
of inflammatory CD4+ cells reduced 3 weeks post-injury  (Oh et al., 2008).  Whether HSCs 
impact the degree of inflammatory cell recruitment within the liver and share similar 
paracrine functions as their mesenchymal counterparts is not known.  
 
It is likely that any anti-inflammatory effects would be proportional to the degree of HSC 
recruitment.  Therefore, an important consideration when designing clinical trials is the 
route of delivery of these rare cells. Exogenous myoblasts administered following 
myocardial infarct show differential effects dependant upon the route of injection 
(Fukushima et al., 2008). Injection of isolated liver sinusoidal endothelial cells (LSEC) via the 
portal vein increases their homing to the liver when compared to intrasplenic and 
intravenous introduction (Benten et al., 2005). Given the overall rarity of HSCs, it is crucial 
that these cells are introduced into the circulation by routes which optimise their hepatic 
recruitment.  Indeed, in this thesis, despite one million HPC-7 cells being administered 
systemically via the carotid artery, only small proportions were actually identified within 
the liver.  Extra-hepatic homing of injected HSCs is certainly a significant barrier to 
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successful cellular therapy. Therefore, this chapter will also identify these extra-hepatic 
sites of recruitment.     
 
The use of exogenously administered adult stem cells has gained clinical and experimental 
interest.  However, endogenous HSC mobilisation from the BM and subsequent recruitment 
to sites of injury may also confer benefit.  Many studies have shown elevated HSCs in the 
peripheral circulation during various models of human disease (Kollet et al., 2003, Massa et 
al., 2005, Lemoli et al., 2006). Whether this has a role to play in liver regeneration is 
unclear. However, some studies have found that the contribution of mobilized progenitor 
cells to liver regeneration is negligible (Liu et al., 2006). In our IR injury model, it is not 
known whether liver damage mobilises stem cells into the peripheral circulation and this 
will therefore be investigated.   
 
Circulating neutrophils are recruited to sites of inflammation by adhesion to platelet 
thrombi or platelet microparticles via P-selectin (Palabrica et al., 1992, Kirchhofer et al., 
1997, Forlow et al., 2000).   Recent studies have suggested that stem cells are also guided to 
sites of injury by platelets that release cytokines and also provide a surface for adhesion 
(Massberg et al., 2006).  Endothelial progenitor cells (EPCs) adhere to immobilized platelets 
in vitro via PSGL-1 and CD49d dependent mechanisms and subsequently drive 
differentiation of EPCs and CD34+ cells into endothelial cells (Langer et al., 2006, Stellos et 
al., 2008).  Whether the HPC-7s used in this thesis can bind to platelets adherent on 
endothelial cells will also be investigated in vitro. 
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6.1.2.  Hypotheses 
For the work contained in this chapter, we hypothesized:  
 
1. Introducing HPC-7 cells via the hepatic portal vein would increase their recruitment 
2.  Hepatic recruitment of HPC-7s would reduce leukocyte recruitment and this effect 
 would be greater when cells were introduced via the portal vein 
3.  Significant numbers of HPC-7 cells home to sites other than the liver 
4.  HSCs are mobilised into the peripheral circulation as a result of hepatic IR injury 
5.  Platelets can promote HPC-7 adhesion to TNFα activated endothelium in vitro 
 
 
6.2.  Methods 
Methods used in this chapter are described in detail in Chapter 2. Briefly, cell recruitment 
following 1 x 106 CFSE-labelled HPC-7 administration via the carotid artery and hepatic 
portal vein was compared intravitally.  To determine any anti-inflammatory effects, 1 x 106 
or 5 x 106 unlabelled HPC-7 cells were introduced in IR injured animals via the portal vein or 
carotid artery respectively at 1 minute reperfusion. Reperfusion was continued for 2.5 
hours at which point 5 x 105 CFSE-labelled donor leukocytes were administered via the 
same entry route as the HPC-7 cells. After a further 15 minutes, the injured (left) and 
uninjured (right) liver, kidney, spleen and lungs were isolated and examined for labelled 
exogenous leukocyte recruitment microscopically (see Figure 6.1).  Extra-hepatic homing of 
HPC-5 and HPC-7 cells into these organs was also determined by examining 5 surface fields 
of view microscopically. Data represents mean ± SEM of three separate experiments.  To 
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investigate whether ischemia promotes progenitor cell mobilisation, animals were 
subjected to IR injury and peripheral blood analysed by FACS for circulating progenitor cells 
defined as Lin-Sca1+.  
 
A static adhesion assay was used to investigate platelet-HPC-7 interactions.  MuCEC-1s, 
cultured to confluence on APES-coated coverslips, were treated with 10ng/ml recombinant 
murine TNFα for 4 hours. Although TNFα alone does not promote human platelet adhesion 
to HUVEC (Tull et al., 2006), work in our lab (Holyer, I., unpublished observations) and 
others (Lou et al., 1997) shows treatment of MuCEC-1 with murine TNFα does support 
platelet adhesion. Endothelium was incubated with 2 x 108 platelets or PBS vehicle for 45 
minutes. Unbound platelets were washed away and 5 x 105 CFSE-labelled HPC-7 cells were 
incubated with endothelium for 5 minutes. Unbound HPC-7 cells were washed away, 
coverslips fixed with 2% glutaraldehyde and ten fields counted for adhesive cells. Data 
represents mean adherent cells per field ± SEM of 5 separate experiments.   
 
 
6.3.  Results  
6.3.1.  HPC-5 and HPC-7 home primarily to the lungs following systemic injection 
Similar to the intravital results presented in Chapter 3, HPC-7 and HPC-5 recruitment was 
enhanced in the injured liver lobe subjected to IR injury compared to sham (injured liver 
lobe, HPC-7: sham: 1.35 ± 0.13 vs. IR: 7.87 ± 1.57; P < 0.05; HPC-5: sham: 2.40 ± 0.64 vs. IR: 
8.20 ± 1.40; P < 0.05) (figure 6.2.A-B).  
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Figure 6.1. Protocol used for anti-inflammatory studies. HPC-7 cells were introduced 
following hepatic IR and their effect on the adhesion of exogenously administered 
leukocytes examined. T-0 represents 0 minutes post initiation of ischemia, while T-90 
represents 90 minutes post initiation of ischemia. At T-91 either 1 x 106 or 5 x 106 HPC-7 
cells were administered intra-portally or intra-arterially, respectively. CFSE labelled 
leukocytes were administered at T-240 and tissues isolated 15 minutes later for 
quantitation of leukocyte adhesion. 
T-0 
T-90 (clamp removed) 
T-91 (HPC-7 cells or PBS injected) 
Ischemia 
90minutes 
Reperfusion 
165 minutes 
 
T-240 (leukocytes injected) 
(animal sacrificed and 
adherent cells counted) T-255 
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Although there was also an increase in HPC-7 and HPC-5 recruitment in the non-injured 
hepatic lobe, this difference was only significant for HPC-5 cells (non-injured liver lobe, HPC-
7: sham: 2.00 ± 0.20 vs. IR: 6.27 ± 2.89; P > 0.05; HPC-5: sham: 3.66 ± 0.24 vs IR. 7.53 ± 0.71; 
P < 0.01) (figure 6.2.A-B). HPC-5 and HPC-7 recruitment to the renal microvasculature was 
negligible and the low levels observed were not affected by injury (kidney: HPC-7: sham: 
0.20 ± 0.20 vs. IR: 1.73 ± 0.81; P > 0.05; HPC-5: sham: 1.2 ± 0.2 vs. IR: 1.46 ± 0.27; P > 0.05) 
(figure 6.2.A-B). Significant adhesion of HPC-5 and HPC-7 cells were observed in the spleen, 
although recruitment in this organ was not modified by hepatic injury (spleen: HPC-7: sham: 
10.93 ± 1.27 vs. IR: 14.4 ± 7.67; P > 0.05; HPC-5: sham: 21.47 ± 6.29 vs. IR: 25.67 ± 12.88; P > 
0.05) (figure 6.2.A-B). The majority of adherent cells were visible in the pulmonary 
circulation, with a tendency for increased HPC-7 adhesion in IR treated animals (lungs: HPC-
7: sham: 35.87 ± 8.41 vs. IR: 59.47 ± 6.35; P > 0.05; HPC-5: sham: 63.40 ± 12.42 vs. IR: 69.33 
± 18.10; P > 0.05) (figure 6.2.A-B). 
 
6.3.2.  Administration of HPC-7 cells via the carotid artery following ischemia does 
not reduce subsequent leukocyte recruitment 
Intra-arterial administration of 5 x 106 HPC-7 during early reperfusion did not significantly 
reduce exogenous leukocyte recruitment to the injured liver lobe compared to controls 
(saline: 2.50 ± 1.30 vs. HPC-7: 3.00 ± 1.00; P > 0.05) (figure 6.3A & figure 6.3B). HPC-7 cells 
also failed to reduce leukocyte adhesion in the non-injured liver lobe (saline: 3.70 ± 0.00 vs. 
HPC-7: 3.85 ± 0.85; P > 0.05), kidney (saline: 1.35 ± 0.45 vs. HPC-7: 1.85 ± 0.25; P > 0.05) or 
spleen (saline: 12.15 ± 1.45 vs. HPC-7: 12.35 ± 1.95; P > 0.05). In fact, pre-HPC-7 
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administration significantly enhanced recruitment of leukocytes to the lung (saline: 63.65 ± 
6.35 vs. HPC-7: 77.5 ± 2.20; P < 0.05) (figure 6.3A & figure 6.3B) 
 
6.3.3.  Administration of HPC-7 cells via the portal vein enhances recruitment, but 
injury specific recruitment is lost 
Introduction of HPC-7 cells via the hepatic portal vein significantly enhances recruitment 
seen intravitally at 75 minutes reperfusion by over five-fold (adherent cells at 75 minutes 
reperfusion: carotid artery: 10.50 ± 1.09 vs. portal vein: 51.33 ± 15.72; P<0.001) (figure 
6.4.A). However, no difference in recruitment is seen between sham and IR animals if cells 
are introduced through the portal vein at 75 minutes reperfusion and the equivalent sham 
time point (adherent cells, portal vein injection: 165 minutes sham: 54.67 ± 22.18 vs. 75 
minutes reperfusion: 51.33 ± 15.72; P > 0.05) (figure 6.4.B).  
 
6.3.4.  Administration of HPC-7 cells via the portal vein following ischemia does 
not reduce subsequent leukocyte recruitment 
Intra-portal administration of 1 x 106 HPC-7 during early reperfusion did not significantly 
reduce exogenous leukocyte recruitment in the injured liver lobe compared to controls 
(saline: 5.23 ± 0.24 vs. HPC-7: 6.53 ± 2.78; P > 0.05) (figure 6.5.A & figure 6.5.B). HPC-7 cells 
also failed to reduce leukocyte adhesion in the non-injured liver lobe (saline: 6.27 ± 1.59 vs. 
HPC-7: 7.00 ± 3.08; P > 0.05), kidney (saline: 0.63 ± 0.35 vs. HPC-7: 0.67 ± 0.15; P > 0.05), 
spleen (saline: 4.70 ± 1.38 vs. HPC-7: 5.47 ± 2.77; P > 0.05) and lung (saline: 33.00 ± 6.22 vs. 
HPC-7: 24.77 ± 3.23; P > 0.05) (figure 6.5.A & figure 6.5.B).  
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Figure 6.2. HPC-7 and HPC-5 cells home primarily to the lungs and spleen. Animals were 
analysed for the tissue homing characteristics of HPC-5/-7 following sham and IR injury.  
Following administration of cells (1 x 106 HPC-5/-7, 5μM CFSE, I.A.) into sham and IR treated 
animals (90 PHI/30), cells were allowed to circulate for a further 1 hour. Subsequently, 
tissues were harvested and analysed by fluorescence microscopy. HPC-7 (panel A; clear: 
sham, fill: IR) and HPC-5 (panel B; clear: sham, fill: IR) cells home primarily to the lungs and 
spleen. No renal homing of HPC-7 or HPC-5 was observed. Significantly raised HPC-7 
adhesion was seen in the Left Hepatic Lobe following IR injury (panel A). Significantly raised 
HPC-5 adhesion was seen in the Left and Right Hepatic Lobes following IR injury (panel B). 
Representative images of HPC-7 adhesion in the various tissues is shown (panel C). Panels A 
and B are representative of mean adhesion ± SEM of 3 separate experiments. * p < 0.05, ** 
p < 0.01 (unpaired t-test).   
A B 
C 
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Figure 6.3. Administration of HPC-7 cells via the carotid artery following ischemia does not 
reduce exogenous leukocyte recruitment during reperfusion. WT animals were subjected to 
IR injury (90 minutes), and either 5 x 106 HPC-7 (in 100μl saline) or saline alone were 
introduced to the circulation through the carotid artery at 1 minute reperfusion. At 2.5 
hours reperfusion, 5 x 105 labeled leukocytes (5μM CFSE) were introduced through the 
carotid artery. Cells were allowed to circulate for 15 minutes, and tissues were isolated. 
Administration of HPC-7 cells does not reduce leukocyte recruitment in any organs, actually 
resulting in an increase in leukocyte recruitment to the lungs (panel A; clear: saline, filled: 
HPC-7). Example images are shown (panel B). Results are representative of mean ± SEM of 
2 separate experiments; * p < 0.05 (two-way ANOVA followed by Bonferroni posttests).  
B 
A 
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Figure 6.4. Administration of HPC-7 cells through the hepatic portal vein significantly 
increases their recruitment to the liver, but abolishes the specific injury mediated 
recruitment. HPC-7 cells were introduced into the circulation via the portal vein and 
recruitment at 75 minutes was compared to cells introduced through the carotid artery. 
Administration of HPC-7 cells through the portal vein significantly enhances their 
recruitment during IR injury compared to carotid artery introduction (panel A). However, 
no difference in recruitment is seen between sham and IR animals if cells are introduced 
through the portal vein (panel B). Figures are representative of mean ± SEM of at least 3 
separate experiments (n = 3-10); *** p < 0.001 (unpaired t-test) 
A 
B 
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6.3.5.  HSCs are not mobilized acutely as a result of IR injury 
Previous evidence suggests that HSC can be mobilized into the peripheral circulation 
following hepatic IR injury (Liu et al., 2006). To investigate this, peripheral blood was 
anlaysed by FACS following either partial hepatic IR or sham surgery. Cells were identified 
based on the lack or presence of lineage markers (Lin) and the lack or presence of Sca-1. 
Although there is a general decrease in circulating Lin-Sca-1+ cells (HSCs), the differences are 
not significant (Lin-Sca-1+: sham: 2.11% ± 1.35% vs. 0.59% ± 0.22; P > 0.05) (Figure 6.6A). 
Similarily, although there is a general decrease in circulating cells negative for both lineage 
markers and Sca-1, this decrease is not significant (Lin-Sca-1-: sham: 2.39% ± 0.35% vs. IR: 
1.56% ± 0.06%; P > 0.05) (Figure 6.6A). On the other hand, IR significantly raises the levels 
of circulating lineage positive/Sca-1 negative cells, a population which includes neutrophils 
(Lin+Sca-1- cells: sham: 35.78% ± 4.17% vs IR: 67.03% ± 2.44%; P < 0.001) (Figure 6.6A). 
Consistent with FACS results, blood testing of IR animals revealed an increase in circulating 
neutrophils when compared to sham treated animals (data not shown). The increase in 
circulating Lin+Sca-1- cells is accompanied by a concomitant decrease in cells positive for 
both lineage markers and Sca-1, a population which includes lymphocytes (Lin+Sca-1+: 
sham: 59.72% ± 5.57% vs. IR: 30.82% ± 2.43%; P < 0.001) (figure 6.6.A).  
 
6.3.6.  Adherent platelets do not promote HSC adhesion in vitro 
Adherence of platelets to endothelium was confirmed visually (data not shown). The 
presence of platelets on endothelial cells did not significantly alter HPC-7 adhesion 
compared to endothelial cells without platelets (HPC-7 adhesion: without platelets: 131.80 
± 16.44 vs. with platelets: 149.40 ± 10.43; P > 0.05) (figure 6.7.A). 
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6.4.  Discussion 
Recruitment of exogenously administered labelled donor leukocytes were used as a 
surrogate marker to monitor anti-inflammatory effects of HPC-7s.  However, no differences 
in leukocyte recruitment were observed at the time points investigated.  This was despite 
attempts to enhance hepatic HPC-7 recruitment by introducing high numbers of HPC-7 cells 
via the carotid artery or portal vein.   
 
Furthermore, no mobilisation of Lin-Sca-1+ cells was identified within the peripheral blood in 
this acute injury model.  Data from the in vitro adhesion assays also suggests that HPC-7s 
may not be recruited to sites of injury via interactions with platelets.   
 
Recent studies suggest HSCs may exert their beneficial effects through paracrine anti-
inflammatory mechanisms rather than direct cellular replenishment/repair (Humphreys and 
Bonventre, 2008, Duffield et al., 2005, Tögel et al., 2005).  Fetal liver derived HSCs have 
been shown to reduce inflammatory injury observed during a paw edema model 
(Biziuleviciene et al., 2007).   However, in the current study, injection of HPC-7 s did not 
reduce leukocyte recruitment post IR injury. HPC-7s were administered as soon as possible 
after reperfusion.  Thus in our systems HSCs do not inhibit leukocyte recruitment although 
they could mediate other anti-inflammatory processes.  Inflammation of the liver causes 
injury and an elevation in circulating ALT from necrotic and injured hepatocytes.  Even if 
HSCs are anti-inflammatory, it is unlikely that detection of circulating ALT levels would be 
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Figure 6.5. Administration of HPC-7 cells via the portal vein following ischemia does not 
reduce leukocyte recruitment during reperfusion. WT animals were subjected to IR injury 
(90 minutes) and either 1 x 106 HPC-7 (in 100μl saline) or saline alone were introduced to 
the circulation through the portal vein at 1 minute reperfusion. At 2.5 hours reperfusion, 5 
x 105 labeled leukocytes (5μM CFSE) were also introduced through the portal vein. Cells 
were allowed to circulate for 15 minutes, and tissues were isolated. Administration of HPC-
7 cells does not reduce leukocyte recruitment during IR in any organs when compared to 
saline vehicle alone (panel A; clear: saline, filled: HPC-7). Example images are shown (panel 
B). Results are representative of mean ± SEM of 3 separate experiments; (two-way ANOVA).
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Figure 6.6. HSCs, defined as Lin
-
/Sca-1
+
, are not mobilized acutely as a result of partial 
hepatic ischemia reperfusion injury. Animals were subjected to partial hepatic IR injury (90 
PHI/180 R) or sham treatment, and circulating peripheral blood cells analysed. As a result of 
injury, circulating Lin+/Sca-1- are increased, while circulating Lin+/Sca-1+ cells decrease 
(panel A; clear: sham, fill: IR). Representative FACS plot is shown, R6 representing Lin-/Sca-
1+ cells (panel B; FL1: Lin, FL2: Sca-1). Figures represent mean ± SEM of three separate 
experiments; * p < 0.05 (two-way ANOVA, followed by Bonferroni posttests). 
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Figure 6.7. Presence of adherent platelets does not promote HSC adhesion in vitro using a 
static adhesion assay. Endothelial monolayers were treated with TNFα and platelets or PBS 
was subsequently added. HPC-7 were subsequently exposed to treated endothelium and 
adhesion analyzed. No significant difference in HPC-7 adhesion is seen between 
endothelium exposed to platelets and endothelium exposed to PBS (panel A). 
Representative images are shown of HPC-7 adhesion after endothelium has been treated 
with PBS (panel B) or platelets (panel C). Bars represent mean adhesion per field ± SEM of 
five separate experiments.  
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sensitive enough to detect any HSC anti-inflammatory activity. In order to monitor 
subsequent leukocyte infiltration, labelled leukocytes derived from donor mice were 
introduced and their recruitment quantified.  This approach of administering exogenous 
labelled leukocytes was used instead of injecting the fluorescent label (CFSE) systemically as 
this would have indiscriminately labelled both HPC-7’s and endogenous mature leukocytes.  
Therefore, it is possible that recruitment of endogenous inflammatory cells was inhibited 
but our methodological approach did not allow us to quantitate this.  
 
It is also possible that HSCs need a much longer duration to confer an anti-inflammatory 
effect and this warrants further investigation. Interestingly, MSCs can downregulate 
inflammatory gene expression, upregulate pro-inflammatory gene expression and 
subsequently protect against ischemic injury within 2 hours (Togel et al., 2005).  Whether 
HSCs can regulate protective or inflammatory gene expression is not known.  Overall, our 
data appears to be consistent with the general finding that the stem cell compartment 
responsible for paracrine anti-inflammatory actions are most likely the MSCs (Gnecchi et 
al., 2005, Humphreys and Bonventre, 2008, Tögel et al., 2005).  
 
The inability of HSCs to reduce leukocyte recruitment could be a result of sub-therapeutic 
HSC recruitment. In order to achieve optimal anti-inflammatory potential, cells were 
introduced into the liver via the hepatic portal vein which resulted in significantly more 
hepatic recruitment.  Since cells introduced via the carotid artery pass through the lungs, 
the evasion of the pulmonary circulation may explain the increased adhesion seen with 
intraportal injection.  However, selective recruitment of HSCs is lost when high cell doses 
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are introduced intraportally and may be due to masking of the selective recruitment 
component seen following carotid injection. Alternatively, the levels of adhesion observed 
following portal vein injection may represent the upper limit of hepatic HSC recruitment 
which cannot be exceeded even in the presence of injury. 
 
Intra-arterial injection of stem cells is one of the common routes used in several clinical 
settings.  However, this route of HSC delivery to mice after hepatic IR injury is limited by 
entrapment of donor cells predominantly in the lungs.  Indeed, adhesion of both HPC-5 and 
HPC-7 in the pulmonary circulation is over five times that seen in the liver. This 
phenomenon has also been observed for activated peripheral blood neutrophils and 
monocytes with recruitment mediated by adhesion molecules (Aoki et al., 1997, Aldonyte 
et al., 2003).  It is therefore possible that HSCs are also activated in the peripheral 
circulation which would then promote their recruitment within the pulmonary vasculature.  
In addition, recruitment of mature leukocytes into the pulmonary vasculature has been 
attributed to their reduced deformability. The capillaries of the pulmonary circulation are 
relatively small in diameter (approximately 5μm) and circulating cells are initially trapped 
due to their size. For instance, the average leukocyte diameter is 8.5µm (Ting-Beall et al., 
1993). Interestingly, HSCs are similar in size to leukocytes with diameters between 6-10μm 
(Zuba-Surma et al., 2008). Subsequent to this initial entrapment, blood flow causes 
entrapped leukocytes to change shape which facilitates their further transit through the 
pulmonary vasculature (Gebb et al., 1995). Indeed, stiffening due to the intracellular 
formation of filamentous actin has been implicated in leukocyte recruitment to the lung 
(Doerschuk, 2001). Very little work has carefully examined the physical characteristics of 
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HSCs and so currently the mechanism underlying pulmonary recruitment is unclear and 
certainly warranting of further studies.  
 
During embryonic and fetal development, haematopoiesis occurs in a number of different 
anatomical sites including the fetal liver, yolk sac and spleen. It is therefore unsurprising 
that a significant number of HSCs are also found adherent in the spleen following systemic 
injection. The spleen has been shown to contain a reserve of HSCs (Kodama et al., 2005), so 
recruitment of exogenously administered HSCs may represent a physiological 
replenishment mechanism.    
 
In contrast, relatively little HSC recruitment is seen in the renal microcirculation in either 
basal or hepatic IR treated animals.  Renal recruitment has been observed following BM 
transplant both in the absence (Forbes et al., 2002) and presence (Lin et al., 2003) of injury, 
although others have shown no renal engraftment of purified HSCs and no subsequent 
contribution to regeneration (Krause et al., 2001). Whether HSCs are recruited to the renal 
microvasculature remains unclear, but the results from this study suggest they are not. 
 
Interestingly, adhesion in the non-ischemic right hepatic lobe was also raised and 
significantly so for HPC-5s. It is well documented that during various unilobular hepatic 
insults, the non-ischemic lobes also suffer some degree of injury (Singh et al., 1999, 
Nakamitsu et al., 2001, Yoshida et al., 2003). For instance, following partial hepatic IR, P-
selectin is upregulated to the same extent in both the ischemic and non-ischemic lobes 
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(Singh et al., 1999). This may explain the similarly raised HSC adhesion in the both the 
ischemic and non-ischemic liver lobes.  
 
HSC mobilization frequently occurs as a result of peripheral injury, driven by factors such as 
CXCL12, MMP-9 and GM-CSF (Dalakas et al., 2005, Frossard et al., 2002). For example, 
during renal IR injury, GM-CSF is released from cells in the outer medulla of the kidney 
(Lentsch et al., 1998, Zhang et al., 2004). Following hepatic resection, HSCs in the peripheral 
circulation are raised (De Silvestro et al., 2004). Furthermore, HSC mobilization occurs as a 
result of reperfusion injury during orthotopic liver transplantation (Lemoli et al., 2006).  
Therapeutic interventions could therefore focus around augmenting this physiological 
response to injury.   
 
However, in this study, HSC mobilization did not occur as a result of partial hepatic IR injury. 
In fact, the levels of circulating Lin-Sca-1+ cells appear to fall as a result of IR injury which 
could represent recruitment of these cells to the injured organ.  If this is the case, then HSC 
mobilization could potentially be masked by the recruitment of these cells to the injured 
organ. Following IR injury, raised levels of Lin+Sca-1- cells are seen in the circulation. This 
may represent raised circulating granulocytes, as these cells have been shown to be Sca-1 
negative (Vasconcelos et al., 2006). This is accompanied by a significant decrease in 
circulating Lin+Sca-1+ cells. These cells may represent circulating lymphocytes (Spangrude et 
al., 1988, Stanford et al., 1997). These results are in line with blood sampling results from 
Chapter 3 where increased circulating neutrophils are accompanied by a decrease in 
circulating lymphocytes.  
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Recent evidence suggests HSC adhesion to injured endothelium is mediated via platelets, 
with platelets providing a bridge between the HSC and the endothelium (Massberg et al., 
2006). It has additionally been shown that activated platelets, along with fibrin, guide CD34+ 
cells to sites of vascular injury and promote their differentiation into endothelial cells (de 
Boer et al., 2006). Interestingly, platelets express and secrete CXCL12 (Stellos et al., 2008), a 
cytokine shown to promote adhesion of HPC-7 cells to endothelium. However, incubation 
of endothelium with platelets prior to HPC-7 exposure did not increase HPC-7 adhesion. The 
model used in this study is devoid of flow, which may partly explain the inability of platelets 
to promote HSC adhesion. Shear stress activates numerous intracellular pathways within 
platelets including Protein Kinase C and those downstream of platelet integrins (Feng et al., 
2006, Kroll et al., 1993). The absence of shear stress in our model may lead to inadequate 
platelet activation and subsequent HSC recruitment. Furthermore, it is well established that 
activated platelets adherent to endothelium are able to promote cell recruitment by 
providing a P-Selectin rich rolling substrate (de Boer et al., 2006). In the studies by de Boer 
et al, human CD34+ cells initially roll on platelet thrombi and subsequently adhere to 
endothelium downstream of the original thrombus (de Boer et al., 2006). It is likely that the 
absence of flow and the subsequent lack of platelet thrombi may prevent HSC recruitment 
by adherent platelets in the static assays used in these studies.  
 
That said, studies from our lab have demonstrated that HPC-7s can indeed interact with 
platelets in vivo.  Laser induced injury was utilised to denude endothelium in a spatially and 
temporally localised area within a cremaster muscle arteriole (Kalia et al., 2008).  This led to 
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the formation of a thrombus which regressed with time to leave a mural thrombus on the 
surface of the endothelium.  HPC-7 cells subsequently injected into the animal, formed firm 
adhesive binds within the area proximal to the mural platelet thrombus (figure 6.7 – 
courtesy of Dr Kalia). 
 
To summarise, we have demonstrated that HPC-7 cells do not prevent exogenous leukocyte 
recruitment within the time frame of our experimental protocol despite intraportal delivery 
of HSCs which enhances their recruitment.  Perhaps more cells could be recruited if 
protocols could be identified that overcome the barrier of cells becoming entrapped within 
the lungs.  Therefore, it is possible that HSCs confer benefit primarily via fusion or 
differentiation dependent mechanisms (or some as yet unidentified mechanism).  No 
mobilisation of endogenous HSCs was observed but may be due to the fact that an acute 
model of injury is utilised.  This is in contrast to the mobilisation observed when hepatic 
injury is chronic or more severe.  Whether the recruitment of HSCs is dependent upon 
interactions with platelets certainly warrants further investigation using different assays, 
particularly in light of increasing recent evidence that platelets can play a major role in 
regeneration of injured liver (Myronovych et al., 2008, Nocito et al., 2007, Lesurtel et al., 
2006).   
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Figure 6.7. HPC-7 cell firmly adherent to mural platelet thrombus. In a laser model of 
endothelial injury in the mouse cremaster, HPC-7 cells adhere to residual mural thrombi. 
Endogenous platelets were labeled with Alexa 594 (red) and exogenous HPC-7 cells were 
labeled with CFSE (green). Photo courtesy of Dr Kalia, magnification x40. 
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7.  General Discussion 
 
7.1.  Summary of main findings and general discussion 
HSC transplantation has been used routinely over the past 50 years for the treatment of 
various diseases such as cancers, numerous anemias and various inborn errors of 
metabolism (Copelan, 2006). The safety and efficacy of this procedure is well documented 
in both autologous and allogenic transplantation (Gatti et al., 1968, Copelan, 2006). When 
the first studies suggested BM-derived cells could reconstitute injured hepatic tissue 
(Petersen et al., 1999, Theise et al., 2000b), the relatively routine nature of the technique 
fueled much hope in the field of regenerative medicine.   Lagasse and colleagues then 
further demonstrated that HSCs were the major BM-derived stem cell to confer benefit 
within the damaged liver (Lagasse et al., 2000).  Furthermore, purified HSCs have also been 
demonstrated to be beneficial in a number of other injured organs including the 
regeneration of chemically injured skeletal muscle (Abedi et al., 2007) and IR injured renal 
tubules (Lin et al., 2003).  
 
HSCs are rare cells constituting < 0.05% of the BM and this scarcity has hindered their 
clinical use.  If HSCs do prove beneficial in the clinic then a better understanding of the 
molecular adhesive factors regulating engraftment at injured sites is essential in order to 
develop strategies to enhance recruitment. Therefore, the primary aim of this thesis was to 
elucidate the adhesion mechanisms involved in the recruitment of HSCs to the hepatic 
microvasculature.  The major novel findings from this study include the following;  
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• Both adult and embryonic derived HSCs are recruited to the liver as a result of 
hepatic IR injury 
• Primary isolates of Lin- / Sca-1+ cells are recruited to the liver both in the absence 
and presence of injury, but not enhanced during the latter 
• The β1 integrin VLA-4 appears to be the major contributor in securing the firm 
adhesion of HSCs to sinusoidal endothelium within the IR injured murine liver 
• VCAM-1 is the counter-receptor in the liver that mediates HSC recruitment via VLA-4  
• The β2 integrin CD18, while important for neutrophil recruitment, plays no role in 
HSC recruitment to the IR injured murine liver 
• The adhesion molecules CD31 and CD44 on HSCs play no role in HSC recruitment to 
the IR injured murine liver  
• Knockout mice deficient in CD31 present with higher HSC recruitment than wild-
types even without injury 
• Treatment of HSCs with media conditioned by IR injured liver does not significantly 
raise adhesion molecule expression on HSCs, nor does treatment with IR 
conditioned plasma or individual cytokines – conversely, treatment with some 
cytokines reduces adhesion molecule expression 
• Treatment of HSCs with CXCL12 and CXCL1 promotes their adhesion to endothelium 
in vitro, while TNFα and IL-1β do not. Blocking the CXCL12 receptor (CXCR4) on HSCs 
does not reduce in vivo IR mediated HSC recruitment 
• Following system injection, significant numbers of HSCs traffic to the lungs and 
spleen as well as the liver 
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• Significantly more HSCs are recruited if they are delivered via the hepatic portal 
vein, but the specific injury mediated recruitment is lost 
 
The studies contained within this thesis were performed using HPC-7 and HPC-5 cells. Both 
cell lines are derived from primary stem cells. HPC-5 and HPC-7 cells have been generated 
from murine adult BM HSCs and murine embryonic stem cells respectively (Pinto do Ó et 
al., 1998, Pinto do Ó et al., 2002, Pinto do Ó et al., 2001). The cell lines have been 
generated by transfection with the LIM-homeobox gene Lhx2 which generates 
immortalized, SCF-dependent hematopoietic progenitor cell lines. Both these cell lines are 
similar to primary HSCs on the cellular, biochemical and molecular levels and are therefore 
excellent HSC surrogates (Richter et al., 2006). Unfortunately, primary HSCs are rare, so 
isolation of a sufficient number for in vivo studies is difficult. Using these cells, this study 
has shown that both embryonic and adult HSC recruitment to the hepatic microvasculature 
is promoted by IR injury. The similar levels of recruitment seen between adult and 
embryonic HSCs may potentially negate the need to use the latter in clinical studies and 
thus avoid the ethical controversies surrounding their use (Towns and Jones, 2004).  
 
In this study, flow cytometry revealed that both HPC-5 and HPC-7 cells express a large 
repertoire of adhesion molecules. There is much evidence corroborating the adhesion 
molecule expression profile detected on HPC-7 and HPC-5 with primary HSCs (Chan and 
Watt, 2001). Unfortunately we were unable to assess whether the expression levels of 
these adhesion molecules were comparable with those of primary HSCs. As isolation of 
primary HSCs requires multi-colour FACS techniques, it is difficult to then subsequently 
Chapter 7: General Discussion 
189 
re-probe the same cells for other markers. Antibody-mediated adhesion molecule blockade 
revealed that the recruitment of HSCs to the hepatic microvasculature following IR injury 
was dependent on VLA-4. Furthermore, intravital studies also revealed that blocking VCAM-
1, the endothelial counter-receptor for VLA-4, significantly reduced HSC adhesion post IR 
injury. The VLA-4/VCAM-1 pathway is implicated in the homing of HSCs to the BM 
(Papayannopoulou et al., 1995, Frenette et al., 1998), and in leukocyte homing to the 
inflamed liver (Fogler et al., 1996). It is therefore somewhat unsurprising that the 
VLA-4/VCAM-1 pathway plays such an important role in HSC recruitment to injured liver. 
VCAM-1 is expressed at low levels in the non-inflamed liver sinusoids, with upregulation 
following hepatic IR injury driven by NF-κB activation (Bell et al., 1997). However, we were 
unable to detect any upregulation in VCAM-1 expression immunohistochemically following 
IR injury. Although this may be a genuine result, published literature suggests that the  
relatively low sensitivity of the immunostaining protocol most likely renders it unable to 
detect any upregulation that has occurred, especially if such upregulation is small (van 
Maanen et al., 2004) 
 
Alternatively, adhesion could be manipulated independent of VCAM-1 upregulation. 
Factors released from the injured hepatocytes or sinusoidal endothelial cells could 
themselves modulate integrin expression on the HSC (Montecucco et al., 2008). This idea 
was further reinforced by the observation that media conditioned by IR injured hepatic 
tissue was able to elicit a small (but insignificant) upregulation of CD49d expression on 
HSCs, while not influencing expression of CD18 or CD44. Previous studies have shown that 
injured tissue may drive HSC to express hepatocyte differentiation markers such as CK18 
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and albumin rapidly, within 7 hours (Jang et al., 2004). Interestingly, treatment of HSCs with 
cytokines or conditioned plasma failed to reproduce the mild upregulation seen with 
hepatic conditioned media. In fact, with certain cytokines CD49d expression actually 
decreased, suggesting a potential mechanism for removal of these cells from the site of 
injury (or even mobilisation from the BM). Furthermore, cytokine mediated CD49d 
downregulation is time dependent suggesting that downregulation of CD49d is progressive 
from the initial point of adhesion.  
 
Alternatively, factors released from the injured organ itself could modulate integrin 
activation status (Peled et al., 2000). Treatment of HPC-7 cells with CXCL12 or CXCL1 
(murine IL-8 homologue) raised adhesion of HSCs on endothelium in vitro, independent of a 
significant effect on CD49d expression. However, blockade of CXCR4 on HPC-7 cells failed to 
significantly reduce adhesion in vivo, suggesting the presence of alternative compensatory 
pathways to offset the blockade of the CXCL12/CXCR4 pathway. The release of CXCL1 has 
been documented during IR injury (Lentsch et al., 1998) and so makes this a potential factor 
that may modulate stem cell recruitment to injured sites in addition to CXCL12. 
  
While both HPC-7 and HPC-5 express high levels of CD18 and CD44, neither play a role in 
HSC recruitment to the hepatic microvasculature in vivo. During hepatic IR injury, initial 
recruitment of inflammatory neutrophils to the injured organ is independent of CD18, 
which facilitates neutrophil adhesion to hepatocytes after endothelial integrity is lost 
(Kobayashi et al., 2001). Although CD18 has been shown to be important in endothelial 
progenitor cell recruitment to the heart (Wu et al., 2006), no studies have implicated CD18 
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in HSC recruitment. It is possible that during hepatic IR injury, CD18 is important in 
recruitment during the latter stages of injury rather than during the acute phase. Blockade 
of CD44 on HSC in the current study also had no effect on recruitment to IR injured liver.  
Contradictory data exists in the literature regarding the role of CD44 in HSC recruitment.  
Studies using anti-CD44 antibodies reveal impaired BM homing (Avigdor et al., 2004) while 
studies using CD44 knock-out mice demonstrate no defects in recruitment (Oostendorp et 
al., 2000).  
 
The choice of injection route is likely to be critical to the efficacy of stem cell treatment. 
Clinically, BM derived cells for treatment of liver disease have been administered via the 
portal vein, hepatic artery and peripheral veins (Gordon et al., 2006, Terai et al., 2006). The 
results in this thesis suggest that the route of injection plays a crucial role in determining 
the level of hepatic HSC recruitment with more cells recruited to the sinusoids after 
administration via the portal vein compared to the carotid artery. Whether the level of 
recruitment is important in cellular therapy is unclear.  In one study where patients showed 
some degree of functional hepatic improvement, between 1 x 106 and 2 x 108 cells were 
introduced suggesting, surprisingly, that the restoration in function is potentially unrelated 
to the magnitude of the cell dose (Gordon et al., 2006). If the magnitude of recruitment is 
not important, then administration of cells via non-direct routes would potentially be 
sufficient for therapy. However, HSCs may play a protective role by releasing factors that 
promote hepatic regeneration though signals such as growth factors.  In such 
circumstances, it is plausible to assume that increased recruitment may present greater 
benefit.  However, progenitor cells are intricately linked to the formation of hepatic 
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tumours (Tang et al., 2008) and therefore careful consideration must be taken to outweigh 
the potential negatives with clinical benefit. Unfortunately, results from this thesis were 
unable to display any anti-inflammatory effects of HSCs  
 
The understanding gained on the adhesion pathways involved in HSC homing to sites of 
injury should prove invaluable in enhancing their recruitment. Indeed, methods for 
improving the trafficking and subsequent engraftment of HSCs, including other stem cells 
such as MSCs, are a high priority for cellular therapies (Karp and Leng Teo, 2009). Retrovirus 
vectors encoding homing receptors such as CXCR4 have been recently used to enhance 
homing of HSCs and MSCs through increasing their response to CXCL12 (Cheng et al., 2008, 
Porecha et al., 2006). Furthermore increasing the expression of the α4 subunit of VLA-4 on 
MSCs using adenovirus vectors led to a 10 fold increase in their homing to BM (Kumar and 
Ponnazhagan, 2007).  An alternative approach would be to pre-treat cells prior to 
exogenous administration.  Indeed, ex vivo treatment of HSCs with growth factors or 
cytokines significantly enhances their engraftment in their hematopoietic niches (Zanjani et 
al., 1992, Chavakis et al., In Press).  Results from this thesis suggest that pre-stimulation of 
HSCs with CXCL12 or CXCL1 could promote recruitment of cells to injured organs and this 
will be investigated in vivo in ongoing studies within the Kalia lab.  Given the degree of 
pulmonary HSC recruitment, it is critical to ensure that any ex vivo manipulations do not 
significantly promote pulmonary engraftment. Excessive pulmonary engraftment of HSCs 
following transplantation can cause respiratory failure and alveolar hemorrhage (Ho et al., 
2001).  
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The results of this thesis suggest a potential biphasic mechanism of HSC recruitment 
following injury (see figure 7.1). Initially, recruitment and activation of HSCs to the injured 
microvasculature is mediated by cytokines. CXCL12 is released during hepatic injury (Kollet 
et al., 2003) and is likely to be an important player in this initial response. Other cytokines 
are likely to play a role in this initial step since blockade of CXCR4 does not prevent 
recruitment in vivo post IR injury. CXCL1 in particular may play a role in this step. 
Thereafter, integrins on the HSC surface are activated (Peled et al., 2000). This activation of 
integrins, and more specifically VLA-4, promotes adhesion of HSCs to the hepatic 
endothelium via VCAM-1. Although changes in CD49d expression were observed, it is 
possible that integrin avidity for endothelium is increased without a change in expression 
levels.  The adhesion molecule CD31 also appeared to play a role in HSC recruitment, as 
CD31-/- mice display raised post-sham adhesiveness for HSCs when compared to strain/age 
matched controls. This effect is more likely to occur as a result of CD31-mediated 
maintenance of the inflammatory status of the organ, rather than a direct adhesive 
mechanism.  
 
Following firm adhesion of HSCs to the microvasculature, cells are exposed to significant 
levels of cytokines released from the local endothelium. Excessive treatment of HSCs with 
specific cytokines reduced levels of CD49d expression, suggesting that the local 
inflammatory environment may actually promote the egress of cells from the injured tissue. 
This has been demonstrated previously in the kidney whereby stem cells recruited to the IR 
injured renal microcirculation are visible following 2 hours reperfusion but not 24 hours 
reperfusion, suggesting they have migrated out of the injured tissue (Tögel et al., 2005). 
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Cells leaving the tissue could home to a number of anatomical locations. It is possible that 
HSCs ‘released’ from the liver return to their more traditional niche, the BM. Although HSCs 
may be deficient in CD49d expression following this egress, the β2 integrin and selectin 
pathways have been shown to compensate for VLA-4 in BM homing and may still be able to 
facilitate this engraftment (Papayannopoulou et al., 2001). Alternatively, HSCs may egress 
from the liver and engraft within the lung. Pulmonary recruitment may be dependent on 
adhesion molecules.  However, activated leukocytes become more rigid due to 
reorganisation of their actin skeleton and it is likely that this promotes mechanical 
leukostasis in the lungs. The actual true destination of these cells once they have left the 
liver is unclear and warranting of further study. 
 
7.2.  Future Work 
Even though the body of literature on progenitor cell recruitment injured non-BM sites is 
expanding, there are still questions which remain to be answered. As a result, the work 
detailed in this thesis could be expanded in a number of ways. Recent studies have used 
retroviral vectors to over-express the α4 subunit of VLA-4 in both HSCs and MSCs (Cheng et 
al., 2008, Kumar and Ponnazhagan, 2007, Porecha et al., 2006). While these studies provide 
excellent proof-of-principle, over-expression of this integrin has not been investigated in 
the hepatic IR injury model. One would hypothesize that over-expression of the α4 integrin 
(and subsequently VLA-4) would increase hepatic HSC recruitment following IR. 
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Figure 7.1. Proposed mechanism of HSC recruitment following IR injury. HSC recruitment is 
initially promoted by cytokine release which subsequently promotes firm adhesion via 
VLA-4/VCAM-1. Prolonged treatment with cytokines reduces adhesion molecule expression 
on the cell surface and promotes egress of cells from the inflammatory microvasculature. 
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In addition to HSCs, evidence now suggests that MSCs may be protective in animal models 
of hepatic IR (Baijun et al., 2004). However, the molecular mechanisms that govern the 
recruitment of these cells to the liver post IR injury are also unknown. The similarities 
between HSC and MSC recruitment to the hepatic microvasculature could be investigated. 
Based on the results within this thesis, a role for VLA-4 could be speculated.  
 
In our studies, we have been unable to show any anti-inflammatory effects of HSCs, 
although this may be a result of our chosen biological marker or sub-optimal recruitment. It 
has been shown in primates that co-administration of MSCs and HSCs enhances the latter’s 
engraftment of the BM (Masuda et al., 2008). Whether administration of MSCs alongside 
(or prior) to HSCs would promote their recruitment is unclear and warranting further study. 
 
Treatment of HSCs with particular cytokines significantly increases their adhesion to 
endothelium via activation of surface adhesion molecules (Peled et al., 2000). For future 
work, it may be useful to investigate the priming of HSCs with cytokines such as CXCL12 and 
CXCL1 to increase their recruitment in the tissue of interest. Alternatively, priming of the 
liver could be examined by injection of cytokines directly into the hepatic parenchyma. It 
can be appreciated that by making cells (or tissues) more adhesive and delivering them 
systemically, the chances of engraftment in other (non-targeted) tissues is increased. The 
future work in this area would need to carefully consider the site of injection in order to 
maximise delivery to the tissue of interest. Results in thesis show hepatic engraftment 
massively increased when cells are introduced via the portal vein. 
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When using any form of cellular therapy, it is important to consider any detrimental effects 
that ectopic positioning of the introduced cells may have. Indeed, evidence suggests that 
cells of BM origin may contribute to the formation of liver fibrosis highlighting the 
importance of isolation and identification (Russo et al., 2006). Human hepatocellular 
cancers have been shown to express stem cell markers (Oct4, Nanog, Stat3, TBRII and ELF) 
and are thought to be progenitor cells which have adopted aberrant cell signalling (Tang et 
al., 2008). Hence, it is clear that over-engraftment of the liver by HSCs may not be 
beneficial. This is something which needs to be considered carefully prior to entry of any 
HSC therapies to the clinic.  
 
Resting platelets express CD31 on their cell surface, with expression raised following 
thrombin treatment (Metzelaar et al., 1991). Recent evidence suggests that the role of 
CD31 is inhibitory (Falati et al., 2006). Using IVM and laser-induced injury to cremaster 
muscle arterioles, it was demonstarted that the thrombi formed in PECAM-1 deficient mice 
were larger, formed more rapidly and were more stable (Falati et al., 2006).   Therefore in 
the CD31-/- animals used in the current study, it is possible that decreased platelet inhibition 
resulted in increased platelet adhesion even in the absence of injury or another activating 
factor. As HSCs can be recruited via platelets (Massberg et al., 2006), the level of HSC 
adhesion seen following sham treatment may be a result of HSC recruitment to platelets. It 
would be interesting to replace the platelet compartment in CD31-/- animals with platelets 
from a WT mouse and look for changes in HSC adhesion in sham treated animals. The half-
life of platelets is just over 100 hours (Fritz et al., 1986), so it could be feasible to inject 
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wild-type platelets into thrombocytopenic mice and examine acutely whether CD31 
mediates the raised sham adhesion via endothelial CD31 or via CD31 effects on platelets. 
 
7.3.  Concluding Remarks 
Stem cell therapy for tissue disease is still very much in its infancy, with many arguing that 
the step from the bench to the bedside has been taken too soon (Melton, 2006, Leone and 
Crea, 2006). Whether this turns out to be the case has yet to be seen, and should become 
apparent as results from the ongoing clinical trials begin to unfold. However, there is a 
general consensus that many clinical trials have been undertaken without a basic 
knowledge of the biology of these cells. For instance, while there are numerous clinical 
studies examining the potential role of HSCs in liver injury, this thesis is the first to elucidate 
some of the molecular adhesive events that HSCs utilize to home to the injured liver. 
Similarly, in the field of cardiac regeneration, clinical studies have taken place before the 
mechanisms underlying repair have begun to be unraveled (Abdel-Latif et al., 2007, Segers 
and Lee, 2008).  
 
A better understanding of the basic biology underlying stem cell functions is needed if stem 
cell therapy is to be utilized to its optimum.  Such studies need to focus on the pathways of 
retention, incorporation and differentiation within the injured tissue as well as continuing 
to focus on the molecular basis for recruitment. Despite the general excitement about the 
clinical trials, a major lack of understanding of how stem cells target specific tissues quite 
likely hinders their overall success.  As this data is obtained, it should hopefully provide the 
scientific community with the information required to manipulate the behavior of stem 
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cells prior to their administration into the systemic circulation. The more tools for HSC 
manipulation we have, the better we can focus HSCs to where they are needed. 
References 
200 
 
 
 
 
References 
 
 
References 
201 
References 
 
ABBASOGLU, O. (2008) Liver transplantation: Yesterday, today and tomorrow. World J 
Gastroenterol, 14, 3117-22. 
ABDEL-LATIF, A., BOLLI, R., TLEYJEH, I. M., MONTORI, V. M., PERIN, E. C., HORNUNG, C. A., 
ZUBA-SURMA, E. K., AL-MALLAH, M. & DAWN, B. (2007) Adult bone marrow-derived 
cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med, 167, 
989-97. 
ABEDI, M., FOSTER, B. M., WOOD, K. D., COLVIN, G. A., MCLEAN, S. D., JOHNSON, K. W. & 
GREER, D. A. (2007) Haematopoietic stem cells participate in muscle regeneration. 
Br J Haematol, 138, 792-801. 
ABRAM, C. L. & LOWELL, C. A. (2009) The Ins and Outs of Leukocyte Integrin Signalling. 
Annu Rev Immunol, 27, 339-362. 
ADAMS, D. H. & EKSTEEN, B. (2006) Aberrant homing of mucosal T cells and extra-intestinal 
manifestations of inflammatory bowel disease. Nat Rev Immunol, 6, 244-51. 
ADAMS, D. H., HUBSCHER, S. G., FISHER, N. C., WILLIAMS, A. & ROBINSON, M. (1996) 
Expression of E-selectin and E-selectin ligands in human liver inflammation. 
Hepatology, 24, 533-8. 
AKIRA, S., UEMATSU, S. & TAKEUCHI, O. (2006) Pathogen recognition and innate immunity. 
Cell, 124, 783-801. 
ALDONYTE, R., JANSSON, L., PIITULAINEN, E. & JANCIAUSKIENE, S. (2003) Circulating 
monocytes from healthy individuals and COPD patients. Respir Res, 4, 11. 
References 
202 
ALISON, M. R., POULSOM, R., JEFFERY, R., DHILLON, A. P., QUAGLIA, A., JACOB, J., NOVELLI, 
M., PRENTICE, G., WILLIAMSON, J. & WRIGHT, N. A. (2000) Hepatocytes from non-
hepatic adult stem cells. Nature, 406, 257. 
ALON, R., KASSNER, P. D., CARR, M. W., FINGER, E. B., HEMLER, M. E. & SPRINGER, T. A. 
(1995) The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J Cell 
Biol, 128, 1243-53. 
ANASAGASTI, M. J., ALVAREZ, A., MARTIN, J. J., MENDOZA, L. & VIDAL-VANACLOCHA, F. 
(1997) Sinusoidal endothelium release of hydrogen peroxide enhances very late 
antigen-4-mediated melanoma cell adherence and tumor cytotoxicity during 
interleukin-1 promotion of hepatic melanoma metastasis in mice. Hepatology, 25, 
840-6. 
ANDERSON, D. C. & SPRINGER, T. A. (1987) Leukocyte adhesion deficiency: an inherited 
defect in the Mac-1, LFA-1, and p150,95 glycoproteins. Annu Rev Med, 38, 175-94. 
ANDO, T., LANGLEY, R. R., WANG, Y., JORDAN, P. A., MINAGAR, A., ALEXANDER, J. S. & 
JENNINGS, M. H. (2007) Inflammatory cytokines induce MAdCAM-1 in murine 
hepatic endothelial cells and mediate alpha-4 beta-7 integrin dependent lymphocyte 
endothelial adhesion in vitro. BMC Physiol, 7, 10. 
ANGELICO, M. (2005) Donor liver steatosis and graft selection for liver transplantation: a 
short review. Eur Rev Med Pharmacol Sci, 9, 295-7. 
ANTHONI, C., LAUKOETTER, M. G., RIJCKEN, E., VOWINKEL, T., MENNIGEN, R., MULLER, S., 
SENNINGER, N., RUSSELL, J., JAUCH, J., BERGMANN, J., GRANGER, D. N. & 
KRIEGLSTEIN, C. F. (2006) Mechanisms underlying the anti-inflammatory actions of 
References 
203 
boswellic acid derivatives in experimental colitis. Am J Physiol Gastrointest Liver 
Physiol, 290, G1131-7. 
AOKI, T., SUZUKI, Y., NISHIO, K., SUZUKI, K., MIYATA, A., IIGOU, Y., SERIZAWA, H., TSUMURA, 
H., ISHIMURA, Y., SUEMATSU, M. & YAMAGUCHI, K. (1997) Role of CD18-ICAM-1 in 
the entrapment of stimulated leukocytes in alveolar capillaries of perfused rat lungs. 
Am J Physiol, 273, H2361-71. 
ASKARI, A. T., UNZEK, S., POPOVIC, Z. B., GOLDMAN, C. K., FORUDI, F., KIEDROWSKI, M., 
ROVNER, A., ELLIS, S. G., THOMAS, J. D., DICORLETO, P. E., TOPOL, E. J. & PENN, M. S. 
(2003) Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue 
regeneration in ischaemic cardiomyopathy. Lancet, 362, 697-703. 
AVIGDOR, A., GOICHBERG, P., SHIVTIEL, S., DAR, A., PELED, A., SAMIRA, S., KOLLET, O., 
HERSHKOVIZ, R., ALON, R., HARDAN, I., BEN-HUR, H., NAOR, D., NAGLER, A. & 
LAPIDOT, T. (2004) CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking 
of human CD34+ stem/progenitor cells to bone marrow. Blood, 103, 2981-9. 
BAIJUN, F., MINGXIA, S., LIAO, L., YANG, S., LIU, Y. & ZHAO, R. C. (2004) Systemic Infusion of 
FLK1+ Mesenchymal Stem Cells Ameliorates Carbon Tetrachloride-Induced Liver 
Fibrosis in Mice. Transplantation, 78, 83-88. 
BALAZS, A. B., FABIAN, A. J., ESMON, C. T. & MULLIGAN, R. C. (2006) Endothelial protein C 
receptor (CD201) explicitly identifies hematopoietic stem cells in murine bone 
marrow. Blood, 107, 2317-21. 
BARCLAY, A. N. (2003) Membrane proteins with immunoglobulin-like domains--a master 
superfamily of interaction molecules. Semin Immunol, 15, 215-23. 
References 
204 
BECKER, P. S., NILSSON, S. K., LI, Z., BERRIOS, V. M., DOONER, M. S., COOPER, C. L., HSIEH, C. 
C. & QUESENBERRY, P. J. (1999) Adhesion receptor expression by hematopoietic cell 
lines and murine progenitors: modulation by cytokines and cell cycle status. Exp 
Hematol, 27, 533-41. 
BELCHER, J. D., MAHASETH, H., WELCH, T. E., VILBACK, A. E., SONBOL, K. M., KALAMBUR, V. 
S., BOWLIN, P. R., BISCHOF, J. C., HEBBEL, R. P. & VERCELLOTTI, G. M. (2005) Critical 
role of endothelial cell activation in hypoxia-induced vasoocclusion in transgenic 
sickle mice. Am J Physiol Heart Circ Physiol, 288, H2715-25. 
BELL, F. P., ESSANI, N. A., MANNING, A. M. & JAESCHKE, H. (1997) Ischemia-reperfusion 
activates the nuclear transcription factor NF-κB and upregulates messenger RNA 
synthesis of adhesion molecules in the liver in vivo. Hepatology Research, 8, 178-
188. 
BENTEN, D., FOLLENZI, A., BHARGAVA, K. K., KUMARAN, V., PALESTRO, C. J. & GUPTA, S. 
(2005) Hepatic targeting of transplanted liver sinusoidal endothelial cells in intact 
mice. Hepatology, 42, 140-8. 
BIZIULEVICIENE, G., PUIDOKAITE, G., SIAURYS, A. & MAURICAS, M. (2007) An anti-
inflammatory effect of murine fetal liver cells in BALB/c mouse contact 
hypersensitivity model. Int Immunopharmacol, 7, 744-9. 
BOUIS, D., HOSPERS, G. A., MEIJER, C., MOLEMA, G. & MULDER, N. H. (2001) Endothelium in 
vitro: a review of human vascular endothelial cell lines for blood vessel-related 
research. Angiogenesis, 4, 91-102. 
BOWDEN, R. A., DING, Z. M., DONNACHIE, E. M., PETERSEN, T. K., MICHAEL, L. H., 
BALLANTYNE, C. M. & BURNS, A. R. (2002) Role of alpha4 integrin and VCAM-1 in 
References 
205 
CD18-independent neutrophil migration across mouse cardiac endothelium. Circ 
Res, 90, 562-9. 
BREWER, C. F. & DAM, T. K. (2000) Essentials of Glycobiology, Edited by A. Varki, R. 
Cummings, J. Esko, H. Freeze, G. Hart, and J. Marth; Cold Spring Harbor Laboratory 
Press, Cold Spring Harbor, New York, 1999, 653 pp.; ISBN 0-87969-559-5 (cloth, 
$175), ISBN 0-87969-560-9 (printed hard cover, $95). Carbohydrate Research, 325, 
233-234. 
BRITISH LIVER TRUST (2008) Facts About Liver Disease. 
BURKE, J., ZIBARI, G. B., BROWN, M. F., GRANGER, N., KELLY, R., SINGH, I. & MCDONALD, J. 
C. (1998) Hepatic ischemia-reperfusion injury causes E-selectin upregulation. 
Transplant Proc, 30, 2321-3. 
BURNE, M. J., ELGHANDOUR, A., HAQ, M., SABA, S. R., NORMAN, J., CONDON, T., BENNETT, 
F. & RABB, H. (2001) IL-1 and TNF independent pathways mediate ICAM-1/VCAM-1 
up-regulation in ischemia reperfusion injury. J Leukoc Biol, 70, 192-8. 
BUTCHER, E. C. (1991) Leukocyte-endothelial cell recognition: three (or more) steps to 
specificity and diversity. Cell, 67, 1033-1036. 
CALDWELL, C. C., OKAYA, T., MARTIGNONI, A., HUSTED, T., SCHUSTER, R. & LENTSCH, A. B. 
(2005) Divergent functions of CD4+ T lymphocytes in acute liver inflammation and 
injury after ischemia-reperfusion. Am J Physiol Gastrointest Liver Physiol, 289, G969-
76. 
CANDAL, F. J., RAFII, S., PARKER, J. T., ADES, E. W., FERRIS, B., NACHMAN, R. L. & KELLAR, K. 
L. (1996) BMEC-1: A Human Bone Marrow Microvascular Endothelial Cell Line with 
Primary Cell Characteristics. Microvascular Research, 52, 221-234. 
References 
206 
CAPOCCIA, B. J., SHEPHERD, R. M. & LINK, D. C. (2006) G-CSF and AMD3100 mobilize 
monocytes into the blood that stimulate angiogenesis in vivo through a paracrine 
mechanism. Blood, 108, 2438-45. 
CAR, B. D., ENG, V. M., SCHNYDER, B., OZMEN, L., HUANG, S., GALLAY, P., HEUMANN, D., 
AGUET, M. & RYFFEL, B. (1994) Interferon gamma receptor deficient mice are 
resistant to endotoxic shock. J Exp Med, 179, 1437-44. 
CARDEN, D. L. & GRANGER, D. N. (2000) Pathophysiology of ischaemia-reperfusion injury. J 
Pathol, 190, 255-66. 
CARRITHERS, M., TANDON, S., CANOSA, S., MICHAUD, M., GRAESSER, D. & MADRI, J. A. 
(2005) Enhanced susceptibility to endotoxic shock and impaired STAT3 signaling in 
CD31-deficient mice. Am J Pathol, 166, 185-96. 
CERADINI, D. J., KULKARNI, A. R., CALLAGHAN, M. J., TEPPER, O. M., BASTIDAS, N., 
KLEINMAN, M. E., CAPLA, J. M., GALIANO, R. D., LEVINE, J. P. & GURTNER, G. C. 
(2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 
induction of SDF-1. Nat Med, 10, 858-64. 
CHAN, J. Y. & WATT, S. M. (2001) Adhesion receptors on haematopoietic progenitor cells. Br 
J Haematol, 112, 541-57. 
CHAVAKIS, E., URBICH, C. & DIMMELER, S. (In Press) Homing and engraftment of progenitor 
cells: A prerequisite for cell therapy. Journal of Molecular and Cellular Cardiology, In 
Press, Corrected Proof. 
CHEN, B. P., GALY, A. M., FRASER, C. & HILL, B. (1997) Delineation of the human 
hematolymphoid system: potential applications of defined cell populations in 
cellular therapy. Immunol Rev, 157, 41-51. 
References 
207 
CHEN, M. & GENG, J. G. (2006) P-selectin mediates adhesion of leukocytes, platelets, and 
cancer cells in inflammation, thrombosis, and cancer growth and metastasis. Arch 
Immunol Ther Exp (Warsz), 54, 75-84. 
CHEN, T. & XIE, Y. (2003) Role of adhesion molecules in mobilization of hematopoietic cells. 
Chin Med J (Engl), 116, 273-7. 
CHENG, Z., OU, L., ZHOU, X., LI, F., JIA, X., ZHANG, Y., LIU, X., LI, Y., WARD, C. A., MELO, L. G. 
& KONG, D. (2008) Targeted migration of mesenchymal stem cells modified with 
CXCR4 gene to infarcted myocardium improves cardiac performance. Mol Ther, 16, 
571-9. 
CIVIN, C. I., STRAUSS, L. C., BROVALL, C., FACKLER, M. J., SCHWARTZ, J. F. & SHAPER, J. H. 
(1984) Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell 
surface antigen defined by a monoclonal antibody raised against KG-1a cells. J 
Immunol, 133, 157-65. 
CLARK, R. A., ALON, R. & SPRINGER, T. A. (1996) CD44 and hyaluronan-dependent rolling 
interactions of lymphocytes on tonsillar stroma. J Cell Biol, 134, 1075-87. 
COHNHEIM, J. (1877) Vorlesungen über allgemeine Pathologie, Berlin, August Hirschwald 
Verlag. 
COLLETTI, L. M., CORTIS, A., LUKACS, N., KUNKEL, S. L., GREEN, M. & STRIETER, R. M. (1998) 
Tumor necrosis factor up-regulates intercellular adhesion molecule 1, which is 
important in the neutrophil-dependent lung and liver injury associated with hepatic 
ischemia and reperfusion in the rat. Shock, 10, 182-91. 
References 
208 
CONKLYN, M. J., NEOTE, K. & SHOWELL, H. J. (1996) Chemokine-dependent upregulation of 
CD11b on specific leukocyte subpopulations in human whole blood: effect of 
anticoagulant on rantes and MIP-1 beta stimulation. Cytokine, 8, 762-6. 
COPELAN, E. A. (2006) Hematopoietic stem-cell transplantation. N Engl J Med, 354, 1813-
26. 
CROCKETT, E. T., SPIELMAN, W., DOWLATSHAHI, S. & HE, J. (2006) Sex differences in 
inflammatory cytokine production in hepatic ischemia-reperfusion. J Inflamm 
(Lond), 3, 16. 
CYWES, R., PACKHAM, M. A., TIETZE, L., SANABRIA, J. R., HARVEY, P. R., PHILLIPS, M. J. & 
STRASBERG, S. M. (1993) Role of platelets in hepatic allograft preservation injury in 
the rat. Hepatology, 18, 635-47. 
DAHLKE, M. H., LOI, R., WARREN, A., HOLZ, L., POPP, F. C., WEISS, D. J., PISO, P., BOWEN, D. 
G., MCCAUGHAN, G. W., SCHLITT, H. J. & BERTOLINO, P. (2006) Immune-mediated 
hepatitis drives low-level fusion between hepatocytes and adult bone marrow cells. 
J Hepatol, 44, 334-341. 
DALAKAS, E., NEWSOME, P. N., HARRISON, D. J. & PLEVRIS, J. N. (2005) Hematopoietic stem 
cell trafficking in liver injury. Faseb J, 19, 1225-31. 
DE BOER, H. C., VERSEYDEN, C., ULFMAN, L. H., ZWAGINGA, J. J., BOT, I., BIESSEN, E. A., 
RABELINK, T. J. & VAN ZONNEVELD, A. J. (2006) Fibrin and activated platelets 
cooperatively guide stem cells to a vascular injury and promote differentiation 
towards an endothelial cell phenotype. Arterioscler Thromb Vasc Biol, 26, 1653-9. 
References 
209 
DE SILVESTRO, G., VICARIOTO, M., DONADEL, C., MENEGAZZO, M., MARSON, P. & CORSINI, 
A. (2004) Mobilization of peripheral blood hematopoietic stem cells following liver 
resection surgery. Hepatogastroenterology, 51, 805-10. 
DEJANA, E. (2004) Endothelial cell-cell junctions: happy together. Nat Rev Mol Cell Biol, 5, 
261-70. 
DELNESTE, Y., LASSALLE, P., JEANNIN, P., JOSEPH, M., TONNEL, A. B. & GOSSET, P. (1994) 
Histamine induces IL-6 production by human endothelial cells. Clin Exp Immunol, 98, 
344-9. 
DEVEY, L., FESTING, M. F. & WIGMORE, S. J. (2008) Effect of temperature control upon a 
mouse model of partial hepatic ischaemia/reperfusion injury. Lab Anim, 42, 12-8. 
DIMITROFF, C. J., DESCHENY, L., TRUJILLO, N., KIM, R., NGUYEN, V., HUANG, W., PIENTA, K. 
J., KUTOK, J. L. & RUBIN, M. A. (2005) Identification of leukocyte E-selectin ligands, 
P-selectin glycoprotein ligand-1 and E-selectin ligand-1, on human metastatic 
prostate tumor cells. Cancer Res, 65, 5750-60. 
DIMITROFF, C. J., LEE, J. Y., FUHLBRIGGE, R. C. & SACKSTEIN, R. (2000) A distinct glycoform 
of CD44 is an L-selectin ligand on human hematopoietic cells. Proc Natl Acad Sci U S 
A, 97, 13841-6. 
DIMITROFF, C. J., LEE, J. Y., SCHOR, K. S., SANDMAIER, B. M. & SACKSTEIN, R. (2001) 
Differential L-selectin binding activities of human hematopoietic cell L-selectin 
ligands, HCELL and PSGL-1. J Biol Chem, 276, 47623-31. 
DOERSCHUK, C. M. (2001) Mechanisms of leukocyte sequestration in inflamed lungs. 
Microcirculation, 8, 71-88. 
References 
210 
DUFFIELD, J. S., PARK, K. M., HSIAO, L. L., KELLEY, V. R., SCADDEN, D. T., ICHIMURA, T. & 
BONVENTRE, J. V. (2005) Restoration of tubular epithelial cells during repair of the 
postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin 
Invest, 115, 1743-55. 
DUNCAN, G. S., ANDREW, D. P., TAKIMOTO, H., KAUFMAN, S. A., YOSHIDA, H., SPELLBERG, 
J., LUIS DE LA POMPA, J., ELIA, A., WAKEHAM, A., KARAN-TAMIR, B., MULLER, W. A., 
SENALDI, G., ZUKOWSKI, M. M. & MAK, T. W. (1999) Genetic evidence for functional 
redundancy of Platelet/Endothelial cell adhesion molecule-1 (PECAM-1): CD31-
deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions. J 
Immunol, 162, 3022-30. 
ELICES, M. J., OSBORN, L., TAKADA, Y., CROUSE, C., LUHOWSKYJ, S., HEMLER, M. E. & LOBB, 
R. R. (1990) VCAM-1 on activated endothelium interacts with the leukocyte integrin 
VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell, 60, 577-84. 
ELTZSCHIG, H. K. & COLLARD, C. D. (2004) Vascular ischaemia and reperfusion injury. Br 
Med Bull, 70, 71-86. 
ENIOLA, A. O., WILLCOX, P. J. & HAMMER, D. A. (2003) Interplay between rolling and firm 
adhesion elucidated with a cell-free system engineered with two distinct receptor-
ligand pairs. Biophys J, 85, 2720-31. 
ESSANI, N. A., BAJT, M. L., FARHOOD, A., VONDERFECHT, S. L. & JAESCHKE, H. (1997) 
Transcriptional activation of vascular cell adhesion molecule-1 gene in vivo and its 
role in the pathophysiology of neutrophil-induced liver injury in murine endotoxin 
shock. J Immunol, 158, 5941-8. 
References 
211 
ETZIONI, A., DOERSCHUK, C. M. & HARLAN, J. M. (1999) Of man and mouse: leukocyte and 
endothelial adhesion molecule deficiencies. Blood, 94, 3281-8. 
FALATI, S., PATIL, S., GROSS, P. L., STAPLETON, M., MERRILL-SKOLOFF, G., BARRETT, N. E., 
PIXTON, K. L., WEILER, H., COOLEY, B., NEWMAN, D. K., NEWMAN, P. J., FURIE, B. C., 
FURIE, B. & GIBBINS, J. M. (2006) Platelet PECAM-1 inhibits thrombus formation in 
vivo. Blood, 107, 535-41. 
FENG, D., NAGY, J. A., PYNE, K., DVORAK, H. F. & DVORAK, A. M. (1998) Neutrophils 
emigrate from venules by a transendothelial cell pathway in response to FMLP. J Exp 
Med, 187, 903-15. 
FENG, S., LU, X., RESENDIZ, J. C. & KROLL, M. H. (2006) Pathological shear stress directly 
regulates platelet alphaIIbbeta3 signaling. Am J Physiol Cell Physiol, 291, C1346-54. 
FOGLER, W. E., VOLKER, K., MCCORMICK, K. L., WATANABE, M., ORTALDO, J. R. & 
WILTROUT, R. H. (1996) NK cell infiltration into lung, liver, and subcutaneous B16 
melanoma is mediated by VCAM-1/VLA-4 interaction. J Immunol, 156, 4707-14. 
FONDEVILA, C., BUSUTTIL, R. W. & KUPIEC-WEGLINSKI, J. W. (2003) Hepatic 
ischemia/reperfusion injury--a fresh look. Exp Mol Pathol, 74, 86-93. 
FORBES, S. J., POULSOM, R. & WRIGHT, N. A. (2002) Hepatic and renal differentiation from 
blood-borne stem cells. Gene Ther, 9, 625-30. 
FORLOW, S. B., MCEVER, R. P. & NOLLERT, M. U. (2000) Leukocyte-leukocyte interactions 
mediated by platelet microparticles under flow. Blood, 95, 1317-23. 
FOX-ROBICHAUD, A., PAYNE, D., HASAN, S. U., OSTROVSKY, L., FAIRHEAD, T., REINHARDT, P. 
& KUBES, P. (1998) Inhaled NO as a viable antiadhesive therapy for 
References 
212 
ischemia/reperfusion injury of distal microvascular beds. J Clin Invest, 101, 2497-
505. 
FOX, I. J. & CHOWDHURY, J. R. (2004) Hepatocyte transplantation. Am J Transplant, 4 Suppl 
6, 7-13. 
FRENETTE, P. S., SUBBARAO, S., MAZO, I. B., VON ANDRIAN, U. H. & WAGNER, D. D. (1998) 
Endothelial selectins and vascular cell adhesion molecule-1 promote hematopoietic 
progenitor homing to bone marrow. Proc Natl Acad Sci U S A, 95, 14423-8. 
FRITZ, E., LUDWIG, H., SCHEITHAUER, W. & SINZINGER, H. (1986) Shortened platelet half-life 
in multiple myeloma. Blood, 68, 514-20. 
FROSSARD, J. L., SALUJA, A. K., MACH, N., LEE, H. S., BHAGAT, L., HADENQUE, A., RUBBIA-
BRANDT, L., DRANOFF, G. & STEER, M. L. (2002) In vivo evidence for the role of GM-
CSF as a mediator in acute pancreatitis-associated lung injury. Am J Physiol Lung Cell 
Mol Physiol, 283, L541-8. 
FUJISAKI, T., TANAKA, Y., FUJII, K., MINE, S., SAITO, K., YAMADA, S., YAMASHITA, U., 
IRIMURA, T. & ETO, S. (1999) CD44 stimulation induces integrin-mediated adhesion 
of colon cancer cell lines to endothelial cells by up-regulation of integrins and c-Met 
and activation of integrins. Cancer Res, 59, 4427-34. 
FUKUSHIMA, S., COPPEN, S. R., LEE, J., YAMAHARA, K., FELKIN, L. E., TERRACCIANO, C. M., 
BARTON, P. J., YACOUB, M. H. & SUZUKI, K. (2008) Choice of cell-delivery route for 
skeletal myoblast transplantation for treating post-infarction chronic heart failure in 
rat. PLoS ONE, 3, e3071. 
GAIA, S., SMEDILE, A., OMEDE, P., OLIVERO, A., SANAVIO, F., BALZOLA, F., OTTOBRELLI, A., 
ABATE, M. L., MARZANO, A., RIZZETTO, M. & TARELLA, C. (2006) Feasibility and 
References 
213 
safety of G-CSF administration to induce bone marrow-derived cells mobilization in 
patients with end stage liver disease. J Hepatol, 45, 13-9. 
GATTI, R. A., MEUWISSEN, H. J., ALLEN, H. D., HONG, R. & GOOD, R. A. (1968) 
Immunological reconstitution of sex-linked lymphopenic immunological deficiency. 
Lancet, 2, 1366-9. 
GEBB, S. A., GRAHAM, J. A., HANGER, C. C., GODBEY, P. S., CAPEN, R. L., DOERSCHUK, C. M. 
& WAGNER, W. W., JR. (1995) Sites of leukocyte sequestration in the pulmonary 
microcirculation. J Appl Physiol, 79, 493-7. 
GHOSH, S., MAY, M. J. & KOPP, E. B. (1998) NF-kappa B and Rel proteins: evolutionarily 
conserved mediators of immune responses. Annu Rev Immunol, 16, 225-60. 
GNECCHI, M., HE, H., LIANG, O. D., MELO, L. G., MORELLO, F., MU, H., NOISEUX, N., ZHANG, 
L., PRATT, R. E., INGWALL, J. S. & DZAU, V. J. (2005) Paracrine action accounts for 
marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat 
Med, 11, 367-8. 
GODDARD, S., WILLIAMS, A., MORLAND, C., QIN, S., GLADUE, R., HUBSCHER, S. G. & 
ADAMS, D. H. (2001) Differential expression of chemokines and chemokine 
receptors shapes the inflammatory response in rejecting human liver transplants. 
Transplantation, 72, 1957-67. 
GOEL, R., BOYLAN, B., GRUMAN, L., NEWMAN, P. J., NORTH, P. E. & NEWMAN, D. K. (2007) 
The proinflammatory phenotype of PECAM-1-deficient mice results in atherogenic 
diet-induced steatohepatitis. Am J Physiol Gastrointest Liver Physiol, 293, G1205-14. 
GOGER, B., HALDEN, Y., REK, A., MOSL, R., PYE, D., GALLAGHER, J. & KUNGL, A. J. (2002) 
Different affinities of glycosaminoglycan oligosaccharides for monomeric and 
References 
214 
dimeric interleukin-8: a model for chemokine regulation at inflammatory sites. 
Biochemistry, 41, 1640-6. 
GONZALEZ-FLECHA, B., CUTRIN, J. C. & BOVERIS, A. (1993) Time course and mechanism of 
oxidative stress and tissue damage in rat liver subjected to in vivo ischemia-
reperfusion. J Clin Invest, 91, 456-64. 
GOODELL, M. A., BROSE, K., PARADIS, G., CONNER, A. S. & MULLIGAN, R. C. (1996) Isolation 
and functional properties of murine hematopoietic stem cells that are replicating in 
vivo. J Exp Med, 183, 1797-806. 
GORDON, M. Y., LEVICAR, N., PAI, M., BACHELLIER, P., DIMARAKIS, I., AL-ALLAF, F., 
M'HAMDI, H., THALJI, T., WELSH, J. P., MARLEY, S. B., DAVIES, J., DAZZI, F., MARELLI-
BERG, F., TAIT, P., PLAYFORD, R., JIAO, L., JENSEN, S., NICHOLLS, J. P., AYAV, A., 
NOHANDANI, M., FARZANEH, F., GAKEN, J., DODGE, R., ALISON, M., APPERLEY, J. F., 
LECHLER, R. & HABIB, N. A. (2006) Characterization and clinical application of human 
CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte 
colony-stimulating factor. Stem Cells, 24, 1822-30. 
GRABOVSKY, V., FEIGELSON, S., CHEN, C., BLEIJS, D. A., PELED, A., CINAMON, G., BALEUX, F., 
ARENZANA-SEISDEDOS, F., LAPIDOT, T., VAN KOOYK, Y., LOBB, R. R. & ALON, R. 
(2000) Subsecond Induction of alpha4 Integrin Clustering by Immobilized 
Chemokines Stimulates Leukocyte Tethering and Rolling on Endothelial Vascular Cell 
Adhesion Molecule 1 under Flow Conditions J Exp Med, 192, 495-506. 
GRANT, A. J., LALOR, P. F., HUBSCHER, S. G., BRISKIN, M. & ADAMS, D. H. (2001) MAdCAM-1 
expressed in chronic inflammatory liver disease supports mucosal lymphocyte 
References 
215 
adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver 
disease). Hepatology, 33, 1065-72. 
GRANT, M. B., MAY, W. S., CABALLERO, S., BROWN, G. A., GUTHRIE, S. M., MAMES, R. N., 
BYRNE, B. J., VAUGHT, T., SPOERRI, P. E., PECK, A. B. & SCOTT, E. W. (2002) Adult 
hematopoietic stem cells provide functional hemangioblast activity during retinal 
neovascularization. Nat Med, 8, 607-12. 
GROMPE, M. (2003) The role of bone marrow stem cells in liver regeneration. Semin Liver 
Dis, 23, 363-72. 
GUSEV, Y., SPARKOWSKI, J., RAGHUNATHAN, A., FERGUSON, H., JR., MONTANO, J., 
BOGDAN, N., SCHWEITZER, B., WILTSHIRE, S., KINGSMORE, S. F., MALTZMAN, W. & 
WHEELER, V. (2001) Rolling circle amplification: a new approach to increase 
sensitivity for immunohistochemistry and flow cytometry. Am J Pathol, 159, 63-9. 
GUSSONI, E., SONEOKA, Y., STRICKLAND, C. D., BUZNEY, E. A., KHAN, M. K., FLINT, A. F., 
KUNKEL, L. M. & MULLIGAN, R. C. (1999) Dystrophin expression in the mdx mouse 
restored by stem cell transplantation. Nature, 401, 390-4. 
HARDER, F., KIRCHHOF, N., PETROVIC, S., SCHMITTWOLF, C., DURR, M. & MULLER, A. M. 
(2002) Developmental potentials of hematopoietic and neural stem cells following 
injection into pre-implantation blastocysts. Ann Hematol, 81 Suppl 2, S20-1. 
HATCH, H. M., ZHENG, D., JORGENSEN, M. L. & PETERSEN, B. E. (2002) SDF-1alpha/CXCR4: a 
mechanism for hepatic oval cell activation and bone marrow stem cell recruitment 
to the injured liver of rats. Cloning Stem Cells, 4, 339-51. 
HATTORI, K., HEISSIG, B., TASHIRO, K., HONJO, T., TATENO, M., SHIEH, J. H., HACKETT, N. R., 
QUITORIANO, M. S., CRYSTAL, R. G., RAFII, S. & MOORE, M. A. (2001) Plasma 
References 
216 
elevation of stromal cell-derived factor-1 induces mobilization of mature and 
immature hematopoietic progenitor and stem cells. Blood, 97, 3354-60. 
HEEL, K., BLENNERHASSETT, L., KONG, S. E., MCCAULEY, R. & HALL, J. (1998) Influence of 
ischaemia-reperfusion injury on CD44 expression in rat small intestine. Br J Surg, 85, 
1086-9. 
HIDALGO, A. & FRENETTE, P. S. (2005) Enforced fucosylation of neonatal CD34+ cells 
generates selectin ligands that enhance the initial interactions with microvessels but 
not homing to bone marrow. Blood, 105, 567-75. 
HO, V. T., WELLER, E., LEE, S. J., ALYEA, E. P., ANTIN, J. H. & SOIFFER, R. J. (2001) Prognostic 
factors for early severe pulmonary complications after hematopoietic stem cell 
transplantation. Biology of Blood and Marrow Transplantation, 7, 223-229. 
HOLT, A. P., HAUGHTON, E. L., LALOR, P. F., FILER, A., BUCKLEY, C. D. & ADAMS, D. H. (2009) 
Liver myofibroblasts regulate infiltration and positioning of lymphocytes in human 
liver. Gastroenterology, 136, 705-14. 
HOULIHAN, D. D. & NEWSOME, P. N. (2008) Critical review of clinical trials of bone marrow 
stem cells in liver disease. Gastroenterology, 135, 438-50. 
HUMPHREYS, B. D. & BONVENTRE, J. V. (2008) Mesenchymal stem cells in acute kidney 
injury. Annu Rev Med, 59, 311-25. 
IVANOVA, N. B., DIMOS, J. T., SCHANIEL, C., HACKNEY, J. A., MOORE, K. A. & LEMISCHKA, I. 
R. (2002) A stem cell molecular signature. Science, 298, 601-4. 
IVETIC, A. & RIDLEY, A. J. (2004) The telling tail of L-selectin. Biochem Soc Trans, 32, 1118-
21. 
References 
217 
IWASAKI, M., ADACHI, Y., MINAMINO, K., SUZUKI, Y., ZHANG, Y., OKIGAKI, M., NAKANO, K., 
KOIKE, Y., WANG, J., MUKAIDE, H., TAKETANI, S., MORI, Y., TAKAHASHI, H., 
IWASAKA, T. & IKEHARA, S. (2005) Mobilization of bone marrow cells by G-CSF 
rescues mice from cisplatin-induced renal failure, and M-CSF enhances the effects of 
G-CSF. J Am Soc Nephrol, 16, 658-66. 
JACOBSEN, K., KRAVITZ, J., KINCADE, P. W. & OSMOND, D. G. (1996) Adhesion receptors on 
bone marrow stromal cells: in vivo expression of vascular cell adhesion molecule-1 
by reticular cells and sinusoidal endothelium in normal and gamma-irradiated mice. 
Blood, 87, 73-82. 
JAESCHKE, H. (2003) Molecular mechanisms of hepatic ischaemia-reperfusion injury and 
preconditioning. Am J Physiol Gastrointest Liver Physiol, 284, G15-G26. 
JAESCHKE, H., FARHOOD, A., BAUTISTA, A. P., SPOLARICS, Z., SPITZER, J. J. & SMITH, C. W. 
(1993) Functional inactivation of neutrophils with a Mac-1 (CD11b/CD18) 
monoclonal antibody protects against ischemia-reperfusion injury in rat liver. 
Hepatology, 17, 915-23. 
JAESCHKE, H., FARHOOD, A. & SMITH, C. W. (1990) Neutrophils contribute to 
ischemia/reperfusion injury in rat liver in vivo. FASEB J, 4, 3355-9. 
JANG, Y. Y., COLLECTOR, M. I., BAYLIN, S. B., DIEHL, A. M. & SHARKIS, S. J. (2004) 
Hematopoietic stem cells convert into liver cells within days without fusion. Nat Cell 
Biol, 6, 532-9. 
JIANG, Y., JAHAGIRDAR, B. N., REINHARDT, R. L., SCHWARTZ, R. E., KEENE, C. D., ORTIZ-
GONZALEZ, X. R., REYES, M., LENVIK, T., LUND, T., BLACKSTAD, M., DU, J., ALDRICH, 
S., LISBERG, A., LOW, W. C., LARGAESPADA, D. A. & VERFAILLIE, C. M. (2002) 
References 
218 
Pluripotency of mesenchymal stem cells derived from adult marrow. Nature, 418, 
41-9. 
JOHN, B. & CRISPE, I. N. (2004) Passive and active mechanisms trap activated CD8+ T cells in 
the liver. J Immunol, 172, 5222-9. 
JOHNSTON, B. & KUBES, P. (1999) The alpha4-integrin: an alternative pathway for 
neutrophil recruitment? Immunol Today, 20, 545-50. 
JUNG, U., NORMAN, K. E., SCHARFFETTER-KOCHANEK, K., BEAUDET, A. L. & LEY, K. (1998) 
Transit time of leukocytes rolling through venules controls cytokine-induced 
inflammatory cell recruitment in vivo. J Clin Invest, 102, 1526-33. 
JUSTICIA, C., MARTIN, A., ROJAS, S., GIRONELLA, M., CERVERA, A., PANES, J., CHAMORRO, A. 
& PLANAS, A. M. (2006) Anti-VCAM-1 antibodies did not protect against ischemic 
damage either in rats or in mice. J Cereb Blood Flow Metab, 26, 421-32. 
KAIFI, J. T., YEKEBAS, E. F., SCHURR, P., OBONYO, D., WACHOWIAK, R., BUSCH, P., HEINECKE, 
A., PANTEL, K. & IZBICKI, J. R. (2005) Tumor-cell homing to lymph nodes and bone 
marrow and CXCR4 expression in esophageal cancer. J Natl Cancer Inst, 97, 1840-7. 
KALIA, N., AUGER, J. M., ATKINSON, B. & WATSON, S. P. (2008) Critical role of FcR gamma-
chain, LAT, PLCgamma2 and thrombin in arteriolar thrombus formation upon mild, 
laser-induced endothelial injury in vivo. Microcirculation, 15, 325-335. 
KALIA, N., BROWN, N. J., HOPKINSON, K., STEPHENSON, T. J., WOOD, R. F. & POCKLEY, A. G. 
(2002a) FK409 inhibits both local and remote organ damage after intestinal 
ischaemia. J Pathol, 197, 595-602. 
References 
219 
KALIA, N., POCKLEY, A. G., WOOD, R. F. & BROWN, N. J. (2002b) Effects of hypothermia and 
rewarming on the mucosal villus microcirculation and survival after rat intestinal 
ischemia-reperfusion injury. Ann Surg, 236, 67-74. 
KARP, J. M. & LENG TEO, G. S. (2009) Mesenchymal stem cell homing: the devil is in the 
details. Cell Stem Cell, 4, 206-16. 
KATAYAMA, Y., HIDALGO, A., FURIE, B. C., VESTWEBER, D., FURIE, B. & FRENETTE, P. S. 
(2003) PSGL-1 participates in E-selectin-mediated progenitor homing to bone 
marrow: evidence for cooperation between E-selectin ligands and alpha4 integrin. 
Blood, 102, 2060-7. 
KATAYAMA, Y., HIDALGO, A., PEIRED, A. & FRENETTE, P. S. (2004) Integrin alpha4beta7 and 
its counterreceptor MAdCAM-1 contribute to hematopoietic progenitor recruitment 
into bone marrow following transplantation. Blood, 104, 2020-6. 
KHURANA, S. & MUKHOPADHYAY, A. (2008) In vitro transdifferentiation of adult 
hematopoietic stem cells: An alternative source of engraftable hepatocytes. J 
Hepatol. 
KIM, M., CARMAN, C. V., YANG, W., SALAS, A. & SPRINGER, T. A. (2004) The primacy of 
affinity over clustering in regulation of adhesiveness of the integrin αLβ2. J Cell Biol, 
167, 1241-1253. 
KIRCHHOFER, D., RIEDERER, M. A. & BAUMGARTNER, H. R. (1997) Specific accumulation of 
circulating monocytes and polymorphonuclear leukocytes on platelet thrombi in a 
vascular injury model. Blood, 89, 1270-8. 
KOBAYASHI, A., IMAMURA, H., ISOBE, M., MATSUYAMA, Y., SOEDA, J., MATSUNAGA, K. & 
KAWASAKI, S. (2001) Mac-1 (CD11b/CD18) and intercellular adhesion molecule-1 in 
References 
220 
ischemia-reperfusion injury of rat liver. Am J Physiol Gastrointest Liver Physiol, 281, 
G577-85. 
KODAMA, S., DAVIS, M. & FAUSTMAN, D. L. (2005) Diabetes and stem cell researchers turn 
to the lowly spleen. Sci Aging Knowledge Environ, 2005, pe2. 
KOEFFLER, H. P., BILLING, R., LUSIS, A. J., SPARKES, R. & GOLDE, D. W. (1980) An 
undifferentiated variant derived from the human acute myelogenous leukemia cell 
line (KG-1). Blood, 56, 265-73. 
KOLLET, O., SHIVTIEL, S., CHEN, Y. Q., SURIAWINATA, J., THUNG, S. N., DABEVA, M. D., 
KAHN, J., SPIEGEL, A., DAR, A., SAMIRA, S., GOICHBERG, P., KALINKOVICH, A., 
ARENZANA-SEISDEDOS, F., NAGLER, A., HARDAN, I., REVEL, M., SHAFRITZ, D. A. & 
LAPIDOT, T. (2003) HGF, SDF-1, and MMP-9 are involved in stress-induced human 
CD34+ stem cell recruitment to the liver. J Clin Invest, 112, 160-9. 
KOPP, H. G., AVECILLA, S. T., HOOPER, A. T. & RAFII, S. (2005) The bone marrow vascular 
niche: home of HSC differentiation and mobilization. Physiology (Bethesda), 20, 349-
56. 
KORTESIDIS, A., ZANNETTINO, A., ISENMANN, S., SHI, S., LAPIDOT, T. & GRONTHOS, S. 
(2005) Stromal-derived factor-1 promotes the growth, survival, and development of 
human bone marrow stromal stem cells. Blood, 105, 3793-801. 
KOTOWICZ, K., CALLARD, R. E., FRIEDRICH, K., MATTHEWS, D. J. & KLEIN, N. (1996) 
Biological activity of IL-4 and IL-13 on human endothelial cells: functional evidence 
that both cytokines act through the same receptor. Int Immunol, 8, 1915-25. 
References 
221 
KRAUSE, D. S., THEISE, N. D., COLLECTOR, M. I., HENEGARIU, O., HWANG, S., GARDNER, R., 
NEUTZEL, S. & SHARKIS, S. J. (2001) Multi-organ, multi-lineage engraftment by a 
single bone marrow-derived stem cell. Cell, 105, 369-377. 
KREBSBACH, P. H., KUZNETSOV, S. A., BIANCO, P. & ROBEY, P. G. (1999) Bone marrow 
stromal cells: characterization and clinical application. Crit Rev Oral Biol Med, 10, 
165-81. 
KROLL, M. H., HELLUMS, J. D., GUO, Z., DURANTE, W., RAZDAN, K., HRBOLICH, J. K. & 
SCHAFER, A. I. (1993) Protein kinase C is activated in platelets subjected to 
pathological shear stress. J Biol Chem, 268, 3520-4. 
KUBES, P., PAYNE, D. & WOODMAN, R. C. (2002) Molecular mechanisms of leukocyte 
recruitment in postischemic liver microcirculation. Am J Physiol Gastrointest Liver 
Physiol, 283, G139-47. 
KUCIA, M., RATAJCZAK, J., RECA, R., JANOWSKA-WIECZOREK, A. & RATAJCZAK, M. Z. (2004) 
Tissue-specific muscle, neural and liver stem/progenitor cells reside in the bone 
marrow, respond to an SDF-1 gradient and are mobilized into peripheral blood 
during stress and tissue injury. Blood Cells Mol Dis, 32, 52-7. 
KUMAMOTO, Y., SUEMATSU, M., SHIMAZU, M., KATO, Y., SANO, T., MAKINO, N., HIRANO, 
K. I., NAITO, M., WAKABAYASHI, G., ISHIMURA, Y. & KITAJIMA, M. (1999) Kupffer 
cell-independent acute hepatocellular oxidative stress and decreased bile formation 
in post-cold-ischemic rat liver. Hepatology, 30, 1454-63. 
KUMAR, S. & PONNAZHAGAN, S. (2007) Bone homing of mesenchymal stem cells by ectopic 
alpha 4 integrin expression. Faseb J, 21, 3917-27. 
References 
222 
KUZUME, M., NAKANO, H., YAMAGUCHI, M., MATSUMIYA, A., SHIMOKOHBE, G., 
KITAMURA, N., NAGASAKI, H. & KUMADA, K. (1997) A monoclonal antibody against 
ICAM-1 suppresses hepatic ischemia-reperfusion injury in rats. Eur Surg Res, 29, 93-
100. 
LABOW, M. A., NORTON, C. R., RUMBERGER, J. M., LOMBARD-GILLOOLY, K. M., SHUSTER, D. 
J., HUBBARD, J., BERTKO, R., KNAACK, P. A., TERRY, R. W., HARBISON, M. L. & ET AL. 
(1994) Characterization of E-selectin-deficient mice: demonstration of overlapping 
function of the endothelial selectins. Immunity, 1, 709-20. 
LACONI, E., OREN, R., MUKHOPADHYAY, D. K., HURSTON, E., LACONI, S., PANI, P., DABEVA, 
M. D. & SHAFRITZ, D. A. (1998) Long-term, near-total liver replacement by 
transplantation of isolated hepatocytes in rats treated with retrorsine. American 
Journal of Pathology, 153, 319-29. 
LAGASSE, E., CONNORS, H., AL-DHALIMY, M., REITSMA, M., DOHSE, M., OSBORNE, L., 
WANG, X., FINEGOLD, M., WEISSMAN, I. L. & GROMPE, M. (2000) Purified 
hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med, 6, 
1229-34. 
LALOR, P. F. & ADAMS, D. H. (1999) Adhesion of lymphocytes to hepatic endothelium. Mol 
Pathol, 52, 214-9. 
LALOR, P. F., FAINT, J., AARBODEM, Y., HUBSCHER, S. G. & ADAMS, D. H. (2007) The role of 
cytokines and chemokines in the development of steatohepatitis. Semin Liver Dis, 
27, 173-93. 
LANGER, H., MAY, A. E., DAUB, K., HEINZMANN, U., LANG, P., SCHUMM, M., VESTWEBER, 
D., MASSBERG, S., SCHONBERGER, T., PFISTERER, I., HATZOPOULOS, A. K. & GAWAZ, 
References 
223 
M. (2006) Adherent platelets recruit and induce differentiation of murine embryonic 
endothelial progenitor cells to mature endothelial cells in vitro. Circ Res, 98, e2-10. 
LAPIDOT, T., DAR, A. & KOLLET, O. (2005) How do stem cells find their way home? Blood, 
106, 1901-10. 
LAPIDOT, T. & KOLLET, O. (2002) The essential roles of the chemokine SDF-1 and its 
receptor CXCR4 in human stem cell homing and repopulation of transplanted 
immune-deficient NOD/SCID and NOD/SCID/B2m(null) mice. Leukemia, 16, 1992-
2003. 
LEMOLI, R. M., CATANI, L., TALARICO, S., LOGGI, E., GRAMENZI, A., BACCARANI, U., FOGLI, 
M., GRAZI, G. L., ALUIGI, M., MARZOCCHI, G., BERNARDI, M., PINNA, A., BRESADOLA, 
F., BACCARANI, M. & ANDREONE, P. (2006) Mobilization of bone marrow-derived 
hematopoietic and endothelial stem cells after orthotopic liver transplantation and 
liver resection. Stem Cells, 24, 2817-25. 
LENTSCH, A. B., YOSHIDOME, H., CHEADLE, W. G., MILLER, F. N. & EDWARDS, M. J. (1998) 
Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for 
macrophage inflammatory protein-2 and KC. Hepatology, 27, 1172-7. 
LEONE, A. M. & CREA, F. (2006) Stem cells in acute myocardial infarction: the good, the bad, 
and the ugly. Eur Heart J, 27, 2911-3. 
LESURTEL, M., GRAF, R., ALEIL, B., WALTHER, D. J., TIAN, Y., JOCHUM, W., GACHET, C., 
BADER, M. & CLAVIEN, P. A. (2006) Platelet-derived serotonin mediates liver 
regeneration. Science, 7, 104-107. 
LEVICAR, N., PAI, M., HABIB, N. A., TAIT, P., JIAO, L. R., MARLEY, S. B., DAVIS, J., DAZZI, F., 
SMADJA, C., JENSEN, S. L., NICHOLLS, J. P., APPERLEY, J. F. & GORDON, M. Y. (2008) 
References 
224 
Long-term clinical results of autologous infusion of mobilized adult bone marrow 
derived CD34+ cells in patients with chronic liver disease. Cell Prolif, 41 Suppl 1, 115-
25. 
LEY, K., LAUDANNA, C., CYBULSKY, M. I. & NOURSHARGH, S. (2007) Getting to the site of 
inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol, 7, 678-
89. 
LIDINGTON, E. A., RAO, R. M., MARELLI-BERG, F. M., JAT, P. S., HASKARD, D. O. & MASON, J. 
C. (2002) Conditional immortalization of growth factor-responsive cardiac 
endothelial cells from H-2K(b)-tsA58 mice. Am J Physiol Cell Physiol, 282, C67-74. 
LIN, F., CORDES, K., LI, L., HOOD, L., COUSER, W. G., SHANKLAND, S. J. & IGARASHI, P. (2003) 
Hematopoietic stem cells contribute to the regeneration of renal tubules after renal 
ischemia-reperfusion injury in mice. J Am Soc Nephrol, 14, 1188-99. 
LIU, F., PAN, X. B., CHEN, G. D., JIANG, D., CONG, X., FEI, R., CHEN, H. S. & WEI, L. (2006) 
Hematopoietic stem cell mobilization after rat partial orthotopic liver 
transplantation. Transplant Proc, 38, 1603-9. 
LLACUNA, L., MARI, M., GARCIA-RUIZ, C., FERNANDEZ-CHECA, J. C. & MORALES, A. (2006) 
Critical role of acidic sphingomyelinase in murine hepatic ischemia-reperfusion 
injury. Hepatology, 44, 561-72. 
LOPEZ-LAZARO, M. (2006) HIF-1: hypoxia-inducible factor or dysoxia-inducible factor? 
FASEB J, 20, 828-32. 
LOU, J., DONATI, Y. R., JUILLARD, P., GIROUD, C., VESIN, C., MILI, N. & GRAU, G. E. (1997) 
Platelets play an important role in TNF-induced microvascular endothelial cell 
pathology. Am J Pathol, 151, 1397-405. 
References 
225 
LUSTER, A. D. (1998) Chemokines--chemotactic cytokines that mediate inflammation. N 
Engl J Med, 338, 436-45. 
LUX, C. T., YOSHIMOTO, M., MCGRATH, K., CONWAY, S. J., PALIS, J. & YODER, M. C. (2008) 
All primitive and definitive hematopoietic progenitor cells emerging before E10 in 
the mouse embryo are products of the yolk sac. Blood, 111, 3435-8. 
LYRA, A. C., SOARES, M. B., DA SILVA, L. F., FORTES, M. F., SILVA, A. G., MOTA, A. C., 
OLIVEIRA, S. A., BRAGA, E. L., DE CARVALHO, W. A., GENSER, B., DOS SANTOS, R. R. & 
LYRA, L. G. (2007) Feasibility and safety of autologous bone marrow mononuclear 
cell transplantation in patients with advanced chronic liver disease. World J 
Gastroenterol, 13, 1067-73. 
MAAS, M., STAPLETON, M., BERGOM, C., MATTSON, D. L., NEWMAN, D. K. & NEWMAN, P. 
J. (2005) Endothelial cell PECAM-1 confers protection against endotoxic shock. Am J 
Physiol Heart Circ Physiol, 288, H159-64. 
MAJKA, M., KUCIA, M. & RATAJCZAK, M. Z. (2005) Stem cell biology - a never ending quest 
for understanding. Acta Biochim Pol, 52, 353-8. 
MARELLI-BERG, F. M., PEEK, E., LIDINGTON, E. A., STAUSS, H. J. & LECHLER, R. I. (2000) 
Isolation of endothelial cells from murine tissue. Journal of Immunological Methods, 
244, 205-215. 
MARTELIUS, T., SALASPURO, V., SALMI, M., KROGERUS, L., HOCKERSTEDT, K., JALKANEN, S. 
& LAUTENSCHLAGER, I. (2004) Blockade of vascular adhesion protein-1 inhibits 
lymphocyte infiltration in rat liver allograft rejection. Am J Pathol, 165, 1993-2001. 
References 
226 
MARTI, R., MURIO, E., VARELA, E., BILBAO, I., PASCUAL, C., MARGARIT, C. & SEGURA, R. M. 
(2004) Xanthine oxidoreductase and preservation injury in human liver 
transplantation. Transplantation, 77, 1239-45. 
MARTIN, C., BURDON, P. C., BRIDGER, G., GUTIERREZ-RAMOS, J. C., WILLIAMS, T. J. & 
RANKIN, S. M. (2003) Chemokines acting via CXCR2 and CXCR4 control the release of 
neutrophils from the bone marrow and their return following senescence. 
Immunity, 19, 583-93. 
MASSA, M., ROSTI, V., FERRARIO, M., CAMPANELLI, R., RAMAJOLI, I., ROSSO, R., DE 
FERRARI, G. M., FERLINI, M., GOFFREDO, L., BERTOLETTI, A., KLERSY, C., PECCI, A., 
MORATTI, R. & TAVAZZI, L. (2005) Increased circulating hematopoietic and 
endothelial progenitor cells in the early phase of acute myocardial infarction. Blood, 
105, 199-206. 
MASSBERG, S., KONRAD, I., SCHURZINGER, K., LORENZ, M., SCHNEIDER, S., ZOHLNHOEFER, 
D., HOPPE, K., SCHIEMANN, M., KENNERKNECHT, E., SAUER, S., SCHULZ, C., 
KERSTAN, S., RUDELIUS, M., SEIDL, S., SORGE, F., LANGER, H., PELUSO, M., GOYAL, 
P., VESTWEBER, D., EMAMBOKUS, N. R., BUSCH, D. H., FRAMPTON, J. & GAWAZ, M. 
(2006) Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-
derived progenitor cells to arterial thrombi in vivo. J Exp Med, 203, 1221-33. 
MASUDA, S., OBARA, Y., AGEYAMA, N., SHIBATA, H., IKEDA, T., UEDA, Y., OZAWA, K. & 
HANAZONO, Y. (2008) Co-Transplantation of MSC Improves the Engraftment of HSC 
after Auto-iBMT in Non-Human Primates 50th ASH Annual Meeting and Exposition. 
San Francisco, CA, USA, American Society of Hematology. 
References 
227 
MATSUMOTO, T., EFRON, P. A., TSUJIMOTO, H., TSCHOEKE, S. K., UNGARO, R., FUJITA, S., 
FOLEY, D. P., HEMMING, A. & MOLDAWER, L. L. (2005) Splenic transposition is 
superior to caudal shunt as a model of murine total hepatic ischemia. Lab Invest, 85, 
90-8. 
MATSUMOTO, T., O'MALLEY, K., EFRON, P. A., BURGER, C., MCAULIFFE, P. F., SCUMPIA, P. 
O., UCHIDA, T., TSCHOEKE, S. K., FUJITA, S., MOLDAWER, L. L., HEMMING, A. W. & 
FOLEY, D. P. (2006) Interleukin-6 and STAT3 protect the liver from hepatic ischemia 
and reperfusion injury during ischemic preconditioning. Surgery, 140, 793-802. 
MAZO, I. B., GUTIERREZ-RAMOS, J., FRENETTE, P. S., HYNES, R. O., WAGNER, D. D. & VON 
ANDRIAN, U. H. (1998) Hematopoietic progenitor cell rolling in Bone Marrow 
Microvessels: Parrallel contributions by endothelial Selectins and Vascular Cell 
Adhesion Molecule 1. J Exp Med, 188, 465-474. 
MCDONALD, B., MCAVOY, E. F., LAM, F., GILL, V., DE LA MOTTE, C., SAVANI, R. C. & KUBES, 
P. (2008) Interaction of CD44 and hyaluronan is the dominant mechanism for 
neutrophil sequestration in inflamed liver sinusoids. J Exp Med, 205, 915-27. 
MELDRUM, D., WANG, M., CHRISOSTOMO, P., WAIRIUKO, M., HERRING, C., LILLEMOE, K. & 
BROWN, J. (2006) Stem cell release of vascular endothelial growth factor following 
hypoxia or endotoxin stress is dependent on TNFR1. Journal of Surgical Research, 
130, 176-176. 
MELTON, L. (2006) Stem Cells - too fast too soon? WellcomeScience. Wellcome Trust. 
METZELAAR, M. J., KORTEWEG, J., SIXMA, J. J. & NIEUWENHUIS, H. K. (1991) Biochemical 
characterization of PECAM-1 (CD31 antigen) on human platelets. Thromb Haemost, 
66, 700-7. 
References 
228 
MIDDLETON, J., PATTERSON, A. M., GARDNER, L., SCHMUTZ, C. & ASHTON, B. A. (2002) 
Leukocyte extravasation: chemokine transport and presentation by the 
endothelium. Blood, 100, 3853-60. 
MILES, A., LIASKOU, E., EKSTEEN, B., LALOR, P. F. & ADAMS, D. H. (2008) CCL25 and CCL28 
promote alpha4 beta7-integrin-dependent adhesion of lymphocytes to MAdCAM-1 
under shear flow. Am J Physiol Gastrointest Liver Physiol, 294, G1257-67. 
MOHAMADNEJAD, M., NAMIRI, M., BAGHERI, M., HASHEMI, S. M., GHANAATI, H., ZARE 
MEHRJARDI, N., KAZEMI ASHTIANI, S., MALEKZADEH, R. & BAHARVAND, H. (2007) 
Phase 1 human trial of autologous bone marrow-hematopoietic stem cell 
transplantation in patients with decompensated cirrhosis. World J Gastroenterol, 13, 
3359-63. 
MONSON, K. M., DOWLATSHAHI, S. & CROCKETT, E. T. (2007) CXC-chemokine regulation 
and neutrophil trafficking in hepatic ischemia-reperfusion injury in P-selectin/ICAM-
1 deficient mice. J Inflamm (Lond), 4, 11. 
MONTALVO-JAVE, E. E., ESCALANTE-TATTERSFIELD, T., ORTEGA-SALGADO, J. A., PINA, E. & 
GELLER, D. A. (2008) Factors in the pathophysiology of the liver ischemia-
reperfusion injury. J Surg Res, 147, 153-9. 
MONTECUCCO, F., STEFFENS, S., BURGER, F., DA COSTA, A., BIANCHI, G., BERTOLOTTO, M., 
MACH, F., DALLEGRI, F. & OTTONELLO, L. (2008) Tumor necrosis factor-alpha (TNF-
alpha) induces integrin CD11b/CD18 (Mac-1) up-regulation and migration to the CC 
chemokine CCL3 (MIP-1alpha) on human neutrophils through defined signalling 
pathways. Cell Signal, 20, 557-68. 
References 
229 
MOORE, C., SHEN, X. D., GAO, F., BUSUTTIL, R. W. & COITO, A. J. (2007) Fibronectin-
alpha4beta1 integrin interactions regulate metalloproteinase-9 expression in 
steatotic liver ischemia and reperfusion injury. Am J Pathol, 170, 567-77. 
MORIMOTO, K., ROBIN, E., LE BOUSSE-KERDILES, M. C., LI, Y., CLAY, D., JASMIN, C. & 
SMADJA-JOFFE, F. (1994) CD44 mediates hyaluronan binding by human myeloid 
KG1A and KG1 cells. Blood, 83, 657-62. 
MOSHER, B., DEAN, R., HARKEMA, J., REMICK, D., PALMA, J. & CROCKETT, E. (2001) 
Inhibition of Kupffer cells reduced CXC chemokine production and liver injury. J Surg 
Res, 99, 201-10. 
MUROHARA, T., DELYANI, J. A., ALBELDA, S. M. & LEFER, A. M. (1996) Blockade of platelet 
endothelial cell adhesion molecule-1 protects against myocardial ischemia and 
reperfusion injury in cats. J Immunol, 156, 3550-7. 
MYRONOVYCH, A., MURATA, S., CHIBA, M., MATSUO, R., IKEDA, O., WATANABE, M., 
HISAKURA, K., NAKANO, Y., KOHNO, K., KAWASAKI, T., HASHIMOTO, I., SHIBASAKI, Y. 
& OHKOHCHI, N. (2008) Role of platelets on liver regeneration after 90% 
hepatectomy in mice. J Hepatol, 49, 363-372. 
NAKAMITSU, A., HIYAMA, E., IMAMURA, Y., MATSUURA, Y. & YOKOYAMA, T. (2001) Kupffer 
cell function in ischemic and nonischemic livers after hepatic partial 
ischemia/reperfusion. Surg Today, 31, 140-8. 
NANDI, A., ESTESS, P. & SIEGELMAN, M. (2004) Bimolecular complex between rolling and 
firm adhesion receptors required for cell arrest; CD44 association with VLA-4 in T 
cell extravasation. Immunity, 20, 455-65. 
References 
230 
NEUBAUER, K., LINDHORST, A., TRON, K., RAMADORI, G. & SAILE, B. (2008) Decrease of 
PECAM-1-gene-expression induced by proinflammatory cytokines IFN-gamma and 
IFN-alpha is reversed by TGF-beta in sinusoidal endothelial cells and hepatic 
mononuclear phagocytes. BMC Physiol, 8, 9. 
NEUBAUER, K., WILFLING, T., RITZEL, A. & RAMADORI, G. (2000) Platelet-endothelial cell 
adhesion molecule-1 gene expression in liver sinusoidal endothelial cells during liver 
injury and repair. J Hepatol, 32, 921-32. 
NEWSOME, P. N., JOHANNESSEN, I., BOYLE, S., DALAKAS, E., MCAULAY, K. A., SAMUEL, K., 
RAE, F., FORRESTER, L., TURNER, M. L., HAYES, P. C., HARRISON, D. J., BICKMORE, W. 
A. & PLEVRIS, J. N. (2003) Human cord blood-derived cells can differentiate into 
hepatocytes in the mouse liver with no evidence of cellular fusion. 
Gastroenterology, 124, 1891-900. 
NISHIDA, M. & HAMAOKA, K. (2006) How does G-CSF act on the kidney during acute tubular 
injury? Nephron Exp Nephrol, 104, e123-8. 
NOCITO, A., GEORGIEV, P., DHAM, F., JOCHUM, W., BADER, M., GRAF, R. & CLAVIEN, P. A. 
(2007) Platelets and platelet-derived serotonin promote tissue repair after 
normothermic hepatic ischemia in mice. Hepatology, 45, 369-376. 
NOLTE, D., KUEBLER, W. M., MULLER, W. A., WOLFF, K. D. & MESSMER, K. (2004) 
Attenuation of leukocyte sequestration by selective blockade of PECAM-1 or VCAM-
1 in murine endotoxemia. Eur Surg Res, 36, 331-7. 
NORTH, T. E., DE BRUIJN, M. F., STACY, T., TALEBIAN, L., LIND, E., ROBIN, C., BINDER, M., 
DZIERZAK, E. & SPECK, N. A. (2002) Runx1 expression marks long-term repopulating 
hematopoietic stem cells in the midgestation mouse embryo. Immunity, 16, 661-72. 
References 
231 
NOURSHARGH, S., KROMBACH, F. & DEJANA, E. (2006) The role of JAM-A and PECAM-1 in 
modulating leukocyte infiltration in inflamed and ischemic tissues. J Leukoc Biol, 80, 
714-8. 
OGAWA, H., BINION, D. G., HEIDEMANN, J., THERIOT, M., FISHER, P. J., JOHNSON, N. A., 
OTTERSON, M. F. & RAFIEE, P. (2005) Mechanisms of MAdCAM-1 gene expression in 
human intestinal microvascular endothelial cells. Am J Physiol Cell Physiol, 288, 
C272-81. 
OH, J. Y., KIM, M. K., SHIN, M. S., LEE, H. J., KO, J. H., WEE, W. R. & LEE, J. H. (2008) The Anti-
Inflammatory and Anti-Angiogenic Role of Mesenchymal Stem Cells in Corneal 
Wound Healing Following Chemical Injury. Stem Cells, 26, 1047-1055. 
OHASHI, K., PARK, F. & KAY, M. A. (2001) Hepatocyte transplantation: clinical and 
experimental application. J Mol Med, 79, 617-30. 
OOSTENDORP, R. A., GHAFFARI, S. & EAVES, C. J. (2000) Kinetics of in vivo homing and 
recruitment into cycle of hematopoietic cells are organ-specific but CD44-
independent. Bone Marrow Transplant, 26, 559-66. 
ORITO, H., FUJIMOTO, M., ISHIURA, N., YANABA, K., MATSUSHITA, T., HASEGAWA, M., 
OGAWA, F., TAKEHARA, K. & SATO, S. (2007) Intercellular adhesion molecule-1 and 
vascular cell adhesion molecule-1 cooperatively contribute to the cutaneous Arthus 
reaction. J Leukoc Biol, 81, 1197-204. 
ORLIC, D., KAJSTURA, J., CHEMENTI, S., JAKONIUK, I., ANDERSON, S. M., LI, B., PICKEL, J., 
MCKAY, R., NADAL-GINARD, B., BODINE, D. M., LERI, A. & ANVERSA, P. (2001a) Bone 
marrow cells regenerate infarcted myocardium. Nature, 410, 701-705. 
References 
232 
ORLIC, D., KAJSTURA, J., CHIMENTI, S., LIMANA, F., JAKONIUK, I., QUAINI, F., NADAL-
GINARD, B., BODINE, D. M., LERI, A. & ANVERSA, P. (2001b) Mobilized bone marrow 
cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U 
S A, 98, 10344-9. 
OSAWA, M., HANADA, K., HAMADA, H. & NAKAUCHI, H. (1996) Long-term 
lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic 
stem cell. Science, 273, 242-5. 
PALABRICA, T., LOBB, R., FURIE, B. C., ARONOVITZ, M., BENJAMIN, C., HSU, Y. M., SAJER, S. 
A. & FURIE, B. (1992) Leukocyte accumulation promoting fibrin deposition is 
mediated in vivo by P-selectin on adherent platelets. Nature, 359, 848-51. 
PAPAYANNOPOULOU, T. (2004) Current mechanistic scenarios in hematopoietic 
stem/progenitor cell mobilization. Blood, 103, 1580-5. 
PAPAYANNOPOULOU, T., CRADDOCK, C., NAKAMOTO, B., PRIESTLEY, G. V. & WOLF, N. S. 
(1995) The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of 
lodgement of transplanted murine hemopoietic progenitors between bone marrow 
and spleen. Proc Natl Acad Sci U S A, 92, 9647-51. 
PAPAYANNOPOULOU, T., PRIESTLEY, G. V., NAKAMOTO, B., ZAFIROPOULOS, V. & SCOTT, L. 
M. (2001) Molecular pathways in bone marrow homing: dominant role of 
alpha(4)beta(1) over beta(2)-integrins and selectins. Blood, 98, 2403-11. 
PELED, A., GRABOVSKY, V., HABLER, L., SANDBANK, J., ARENZANA-SEISDEDOS, F., PETIT, I., 
BEN-HUR, H., LAPIDOT, T. & ALON, R. (1999a) The chemokine SDF-1 stimulates 
integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow. 
J Clin Invest, 104, 1199-211. 
References 
233 
PELED, A., KOLLET, O., PONOMARYOV, T., PETIT, I., FRANITZA, S., GRABOVSKY, V., SLAV, M. 
M., NAGLER, A., LIDER, O., ALON, R., ZIPORI, D. & LAPIDOT, T. (2000) The chemokine 
SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) 
cells: role in transendothelial/stromal migration and engraftment of NOD/SCID 
mice. Blood, 95, 3289-96. 
PELED, A., PETIT, I., KOLLET, O., MAGID, M., PONOMARYOV, T., BYK, T., NAGLER, A., BEN-
HUR, H., MANY, A., SHULTZ, L., LIDER, O., ALON, R., ZIPORI, D. & LAPIDOT, T. (1999b) 
Dependence of Human Stem Cell Engraftment and Repopulation of NOD/SCID Mice 
on CXCR4. Science, 283, 845-848. 
PERLINGEIRO, R. C., KYBA, M. & DALEY, G. Q. (2001) Clonal analysis of differentiating 
embryonic stem cells reveals a hematopoietic progenitor with primitive erythroid 
and adult lymphoid-myeloid potential. Development, 128, 4597-604. 
PETERSEN, B. E., BOWEN, W. C., PATRENE, K. D., MARS, W. M., SULLIVAN, A. K., MURASE, 
N., BOGGS, S. S., GREENBERGER, J. S. & GOFF, J. P. (1999) Bone marrow as a 
potential source of hepatic oval cells. Science, 284, 1168-70. 
PETIT, I., SZYPER-KRAVITZ, M., NAGLER, A., LAHAV, M., PELED, A., HABLER, L., 
PONOMARYOV, T., TAICHMAN, R. S., ARENZANA-SEISDEDOS, F., FUJII, N., 
SANDBANK, J., ZIPORI, D. & LAPIDOT, T. (2002) G-CSF induces stem cell mobilization 
by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol, 3, 687-
94. 
PETRI, B., PHILLIPSON, M. & KUBES, P. (2008) The physiology of leukocyte recruitment: an in 
vivo perspective. J Immunol, 180, 6439-46. 
References 
234 
PICARDO, A., FONG, Y., KARPOFF, H. M., YEH, S., BLUMGART, L. H. & BRENNAN, M. F. (1996) 
Factors influencing hepatocyte trafficking during allogeneic hepatocyte 
transplantation: improved liver sequestration with isolated perfusion. J Surg Res, 63, 
452-6. 
PICKER, L. J., WARNOCK, R. A., BURNS, A. R., DOERSCHUK, C. M., BERG, E. L. & BUTCHER, E. 
C. (1991) The neutrophil selectin LECAM-1 presents carbohydrate ligands to the 
vascular selectins ELAM-1 and GMP-140. Cell, 66, 921-33. 
PIMANDA, J. E., CHAN, W. Y., WILSON, N. K., SMITH, A. M., KINSTON, S., KNEZEVIC, K., 
JANES, M. E., LANDRY, J. R., KOLB-KOKOCINSKI, A., FRAMPTON, J., TANNAHILL, D., 
OTTERSBACH, K., FOLLOWS, G. A., LACAUD, G., KOUSKOFF, V. & GOTTGENS, B. 
(2008) Endoglin expression in blood and endothelium is differentially regulated by 
modular assembly of the Ets/Gata hemangioblast code. Blood, 112, 4512-22. 
PINTO DO Ó, P., KOLTERUD, Å. & CARLSSON, L. (1998) Expression of the LIM-homeobox 
gene LH2 generates immortalized Steel factor-dependent multipotent 
hematopoietic precursors. EMBO J, 17, 5744-5756. 
PINTO DO Ó, P., RICHTER, K. & CARLSSON, L. (2002) Hematopoietic progenitor/stem cells 
immortalized by Lhx2 generate functional hematopoietic cells in vivo. Blood, 99, 
3939-3946. 
PINTO DO Ó, P., WANDZIOCH, E., KOLTERUD, A. & CARLSSON, L. (2001) Multipotent 
hematopoietic progenitor cells immortalized by Lhx2 self-renew by a cell 
nonautonomous mechanism. Exp Hematol, 29, 1019-28. 
PORECHA, N. K., ENGLISH, K., HANGOC, G., BROXMEYER, H. E. & CHRISTOPHERSON, K. W., 
2ND (2006) Enhanced functional response to CXCL12/SDF-1 through retroviral 
References 
235 
overexpression of CXCR4 on M07e cells: implications for hematopoietic stem cell 
transplantation. Stem Cells Dev, 15, 325-33. 
PUSZTASZERI, M. P., SEELENTAG, W. & BOSMAN, F. T. (2006) Immunohistochemical 
expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in 
normal human tissues. J Histochem Cytochem, 54, 385-95. 
REINDERS, M. E., VAN WAGENSVELD, B. A., VAN GULIK, T. M., CORSSMIT, N. P., FREDERIKS, 
W. M., CHAMULEAU, R. A., VAN ROOIJEN, N. & OBERTOP, H. (1997) No attenuation 
of ischemic and reperfusion injury in Kupffer cell-depleted, cold-preserved rat livers. 
Transplantation, 63, 449-54. 
REY-LADINO, J. A., PYSZNIAK, A. M. & TAKEI, F. (1998) Dominant-negative effect of the 
lymphocyte function-associated antigen-1 beta (CD18) cytoplasmic domain on 
leukocyte adhesion to ICAM-1 and fibronectin. J Immunol, 160, 3494-501. 
RICHTER, K., WIRTA, V., DAHL, L., BRUCE, S., LUNDEBERG, J., CARLSSON, L. & WILLIAMS, C. 
(2006) Global gene expression analyses of hematopoietic stem cell-like cell lines 
with inducible Lhx2 expression. BMC Genomics, 7, 75. 
RIJCKEN, E., MENNIGEN, R. B., SCHAEFER, S. D., LAUKOETTER, M. G., ANTHONI, C., SPIEGEL, 
H. U., BRUEWER, M., SENNINGER, N. & KRIEGLSTEIN, C. F. (2007) PECAM-1 (CD 31) 
mediates transendothelial leukocyte migration in experimental colitis. Am J Physiol 
Gastrointest Liver Physiol, 293, G446-52. 
ROBLEDO, M. M., SANZ-RODRIGUEZ, F., HIDALGO, A. & TEIXIDO, J. (1998) Differential use of 
very late antigen-4 and -5 integrins by hematopoietic precursors and myeloma cells 
to adhere to transforming growth factor-beta1-treated bone marrow stroma. J Biol 
Chem, 273, 12056-60. 
References 
236 
ROSEN, S. D. & BERTOZZI, C. R. (1996) Two selectins converge on sulphate. Leukocyte 
adhesion. Curr Biol, 6, 261-4. 
ROSS, E. A., FREEMAN, S., ZHAO, Y., DHANJAL, T. S., ROSS, E. J., LAX, S., AHMED, Z., HOU, T. 
Z., KALIA, N., EGGINTON, S., NASH, G., WATSON, S. P., FRAMPTON, J. & BUCKLEY, C. 
D. (2008) A novel role for PECAM-1 (CD31) in regulating haematopoietic progenitor 
cell compartmentalization between the peripheral blood and bone marrow. PLoS 
ONE, 3, e2338. 
ROT, A. (1992) Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration. 
Immunol Today, 13, 291-4. 
ROUSCHOP, K. M., ROELOFS, J. J., CLAESSEN, N., DA COSTA MARTINS, P., ZWAGINGA, J. J., 
PALS, S. T., WEENING, J. J. & FLORQUIN, S. (2005) Protection against renal ischemia 
reperfusion injury by CD44 disruption. J Am Soc Nephrol, 16, 2034-43. 
RUSSO, F. P., ALISON, M. R., BIGGER, B. W., AMOFAH, E., FLOROU, A., AMIN, F., BOU-
GHARIOS, G., JEFFERY, R., IREDALE, J. P. & FORBES, S. J. (2006) The bone marrow 
functionally contributes to liver fibrosis. Gastroenterology, 130, 1807-21. 
SACKSTEIN, R. (2004) The bone marrow is akin to skin: HCELL and the biology of 
hematopoietic stem cell homing. J Invest Dermatol, 122, 1061-9. 
SACKSTEIN, R., MERZABAN, J. S., CAIN, D. W., DAGIA, N. M., SPENCER, J. A., LIN, C. P. & 
WOHLGEMUTH, R. (2008) Ex vivo glycan engineering of CD44 programs human 
multipotent mesenchymal stromal cell trafficking to bone. Nat Med, 14, 181-7. 
SATO, Y., VAN EEDEN, S. F., ENGLISH, D. & HOGG, J. C. (1998) Pulmonary sequestration of 
polymorphonuclear leukocytes released from bone marrow in bacteremic infection. 
Am J Physiol, 275, L255-61. 
References 
237 
SCHLOSSBERG, H., ZHANG, Y., DUDUS, L. & ENGELHARDT, J. F. (1996) Expression of c-fos 
and c-jun during hepatocellular remodeling following ischemia/reperfusion in 
mouse liver. Hepatology, 23, 1546-55. 
SCHWARTZ, R. E., REYES, M., KOODIE, L., JIANG, Y., BLACKSTAD, M., LUND, T., LENVIK, T., 
JOHNSON, S., HU, W. S. & VERFAILLIE, C. M. (2002) Multipotent adult progenitor 
cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin 
Invest, 109, 1291-302. 
SCOTT, C. T. & REIJO PERA, R. A. (2008) The road to pluripotence: the research response to 
the embryonic stem cell debate. Hum Mol Genet, 17, R3-9. 
SEFTOR, R. E. (1998) Role of the beta3 integrin subunit in human primary melanoma 
progression: multifunctional activities associated with alpha(v)beta3 integrin 
expression. Am J Pathol, 153, 1347-51. 
SEGERS, V. F. & LEE, R. T. (2008) Stem-cell therapy for cardiac disease. Nature, 451, 937-42. 
SEGERS, V. F., TOKUNOU, T., HIGGINS, L. J., MACGILLIVRAY, C., GANNON, J. & LEE, R. T. 
(2007) Local delivery of protease-resistant stromal cell derived factor-1 for stem cell 
recruitment after myocardial infarction. Circulation, 116, 1683-92. 
SERRACINO-INGLOTT, F., HABIB, N. A. & MATHIE, R. T. (2001) Hepatic ischemia-reperfusion 
injury. Am J Surg, 181, 160-6. 
SHAW, S. K., BAMBA, P. S., PERKINS, B. N. & LUSCINSKAS, F. W. (2001) Real-time imaging of 
vascular endothelial-cadherin during leukocyte transmigration across endothelium. J 
Immunol, 167, 2323-30. 
SHIMA, H., TSURUMA, T., SAHARA, H., TAKENOUCHI, M., TAKAHASHI, N., IWAYAMA, Y., 
YAGIHASHI, A., WATANABE, N., SATO, N. & HIRATA, K. (2005) Treatment with beta-
References 
238 
SQAG9 prevents rat hepatic ischemia-reperfusion injury. Transplant Proc, 37, 417-
21. 
SHIRAISHI, M., HIROYASU, S., NAGAHAMA, M., MIYAGUNI, T., HIGA, T., TOMORI, H., 
OKUHAMA, Y., KUSANO, T. & MUTO, Y. (1997) Role of exogenous L-arginine in 
hepatic ischemia-reperfusion injury. J Surg Res, 69, 429-34. 
SINDRAM, D., PORTE, R. J., HOFFMAN, M. R., BENTLEY, R. C. & CLAVIEN, P. A. (2000) 
Platelets induce sinusoidal endothelial cell apoptosis upon reperfusion of the cold 
ischemic rat liver. Gastroenterology, 118, 183-91. 
SINGH, I., ZIBARI, G. B., BROWN, M. F., GRANGER, D. N., EPPIHIMER, M., ZIZZI, H., CRUZ, L., 
MEYER, K., GONZALES, E. & MCDONALD, J. C. (1999) Role of P-selectin expression in 
hepatic ischemia and reperfusion injury. Clin Transplant, 13, 76-82. 
SINGH, I., ZIBARI, G. B., ZIZZI, H., GRANGER, D. N., CRUZ, L., GONSALES, E., MCDONALD, J. C. 
& BROWN, M. F. (1998) Anti-P-selectin antibody protects against hepatic ichemia-
reperfusion injury. Transplant Proc, 30, 2324-6. 
SIPKINS, D. A., WEI, X., WU, J. W., RUNNELS, J. M., COTE, D., MEANS, T. K., LUSTER, A. D., 
SCADDEN, D. T. & LIN, C. P. (2005) In vivo imaging of specialized bone marrow 
endothelial microdomains for tumour engraftment. Nature, 435, 969-73. 
SLACK, J. M. & TOSH, D. (2001) Transdifferentiation and metaplasia--switching cell types. 
Curr Opin Genet Dev, 11, 581-6. 
SPANGRUDE, G. J., AIHARA, Y., WEISSMAN, I. L. & KLEIN, J. (1988) The stem cell antigens 
Sca-1 and Sca-2 subdivide thymic and peripheral T lymphocytes into unique subsets. 
J Immunol, 141, 3697-707. 
References 
239 
SPERANDIO, M., SMITH, M. L., FORLOW, S. B., OLSON, T. S., XIA, L., MCEVER, R. P. & LEY, K. 
(2003) P-selectin glycoprotein ligand-1 mediates L-selectin-dependent leukocyte 
rolling in venules. J Exp Med, 197, 1355-63. 
STAMPER, H. B., JR. & WOODRUFF, J. J. (1976) Lymphocyte homing into lymph nodes: in 
vitro demonstration of the selective affinity of recirculating lymphocytes for high-
endothelial venules. J Exp Med, 144, 828-33. 
STANFORD, W. L., HAQUE, S., ALEXANDER, R., LIU, X., LATOUR, A. M., SNODGRASS, H. R., 
KOLLER, B. H. & FLOOD, P. M. (1997) Altered proliferative response by T 
lymphocytes of Ly-6A (Sca-1) null mice. J Exp Med, 186, 705-17. 
STEEGMAIER, M., LEVINOVITZ, A., ISENMANN, S., BORGES, E., LENTER, M., KOCHER, H. P., 
KLEUSER, B. & VESTWEBER, D. (1995) The E-selectin-ligand ESL-1 is a variant of a 
receptor for fibroblast growth factor. Nature, 373, 615-20. 
STELLOS, K., LANGER, H., DAUB, K., SCHOENBERGER, T., GAUSS, A., GEISLER, T., BIGALKE, B., 
MUELLER, I., SCHUMM, M., SCHAEFER, I., SEIZER, P., KRAEMER, B. F., SIEGEL-AXEL, 
D., MAY, A. E., LINDEMANN, S. & GAWAZ, M. (2008) Platelet-derived stromal cell-
derived factor-1 regulates adhesion and promotes differentiation of human CD34+ 
cells to endothelial progenitor cells. Circulation, 117, 206-15. 
STOKMAN, G., LEEMANS, J. C., CLAESSEN, N., WEENING, J. J. & FLORQUIN, S. (2005) 
Hematopoietic Stem Cell Mobilization Therapy Accelerates Recovery of Renal 
Function Independent of Stem Cell Contribution. J Am Soc Nephrol, 16, 1684-1692. 
STUCKER, M., BAIER, V., REUTHER, T., HOFFMAN, K., KELLAM, K. & ALTMEYER, P. (1996) 
Capillary Blood Cell Velocity in Human Skin Capillaries Located Perpendiculary to the 
References 
240 
Skin Surface: Measured by a New Laser Doppler Anemometer. Microvascular 
Research, 52, 188-192. 
SUMAGIN, R. & SARELIUS, I. H. (2007) A role for ICAM-1 in maintenance of leukocyte-
endothelial cell rolling interactions in inflamed arterioles. Am J Physiol Heart Circ 
Physiol, 293, H2786-98. 
SUZUKI, S. & TOLEDO-PEREYRA, L. H. (1994) Interleukin 1 and tumor necrosis factor 
production as the initial stimulants of liver ischemia and reperfusion injury. J Surg 
Res, 57, 253-8. 
TAKADA, Y., YE, X. & SIMON, S. (2007) The integrins. Genome Biol, 8, 215. 
TAKAHASHI, T., KALKA, C., MASUDA, H., CHEN, D., SILVER, M., KEARNEY, M., MAGNER, M., 
ISNER, J. M. & ASAHARA, T. (1999) Ischemia- and cytokine-induced mobilization of 
bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med, 
5, 434-8. 
TAKAKURA, N., WATANABE, T., SUENOBU, S., YAMADA, Y., NODA, T., ITO, Y., SATAKE, M. & 
SUDA, T. (2000) A role for hematopoietic stem cells in promoting angiogenesis. Cell, 
102, 199-209. 
TAKEUCHI, K. H., MCGARRY, M. P. & SWANK, R. T. (1987) Elastase and cathepsin G activities 
are present in immature bone marrow neutrophils and absent in late marrow and 
circulating neutrophils of beige (Chediak-Higashi) mice. J Exp Med, 166, 1362-76. 
TANAKA, Y., ADAMS, D. H. & SHAW, S. (1993) Proteoglycans on endothelial cells present 
adhesion-inducing cytokines to leukocytes. Immunol Today, 14, 111-5. 
TANG, Y., KITISIN, K., JOGUNOORI, W., LI, C., DENG, C. X., MUELLER, S. C., RESSOM, H. W., 
RASHID, A., HE, A. R., MENDELSON, J. S., JESSUP, J. M., SHETTY, K., ZASLOFF, M., 
References 
241 
MISHRA, B., REDDY, E. P., JOHNSON, L. & MISHRA, L. (2008) Progenitor/stem cells 
give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling. Proc Natl Acad 
Sci U S A, 105, 2445-50. 
TAVOR, S., PETIT, I., POROZOV, S., AVIGDOR, A., DAR, A., LEIDER-TREJO, L., SHEMTOV, N., 
DEUTSCH, V., NAPARSTEK, E., NAGLER, A. & LAPIDOT, T. (2004) CXCR4 regulates 
migration and development of human acute myelogenous leukemia stem cells in 
transplanted NOD/SCID mice. Cancer Res, 64, 2817-24. 
TERAI, S., ISHIKAWA, T., OMORI, K., AOYAMA, K., MARUMOTO, Y., URATA, Y., YOKOYAMA, 
Y., UCHIDA, K., YAMASAKI, T., FUJII, Y., OKITA, K. & SAKAIDA, I. (2006) Improved liver 
function in patients with liver cirrhosis after autologous bone marrow cell infusion 
therapy. Stem Cells, 24, 2292-8. 
THEISE, N. D., BADVE, S., SAXENA, R., HENEGARIU, O., SELL, S., CRAWFORD, J. M. & KRAUSE, 
D. S. (2000a) Derivation of hepatocytes from bone marrow cells in mice after 
radiation-induced myeloablation. Hepatology, 31, 235-40. 
THEISE, N. D., NIMMAKAYALU, M., GARDNER, R., ILLEI, P. B., MORGAN, G., TEPERMAN, L., 
HENEGARIU, O. & KRAUSE, D. S. (2000b) Liver from bone marrow in humans. 
Hepatology, 32, 11-6. 
THORGEIRSSON, S. S. & GRISHAM, J. W. (2006) Hematopoietic cells as hepatocyte stem 
cells: a critical review of the evidence. Hepatology, 43, 2-8. 
TILL, J. E. & MCCULLOCH, E. A. (1961) A direct measurement of the radiation sensitivity of 
normal mouse bone marrow cells. Radiat Res, 14, 213-22. 
References 
242 
TILL, J. E., MCCULLOCH, E. A. & SIMINOVITCH, L. (1964) A Stochastic Model of Stem Cell 
Proliferation, Based on the Growth of Spleen Colony-Forming Cells. Proc Natl Acad 
Sci U S A, 51, 29-36. 
TING-BEALL, H. P., NEEDHAM, D. & HOCHMUTH, R. M. (1993) Volume and osmotic 
properties of human neutrophils. Blood, 81, 2774-2780. 
TÖGEL, F., HU, Z., WEISS, K., ISAAC, J., LANGE, C. & WESTENFELDER, C. (2005) Administered 
mesenchymal stem cells protect against ischemic acute renal failure through 
differentiation-independent mechanisms. Am J Physiol Renal Physiol, 289, F31-F42. 
TOWNS, C. R. & JONES, D. G. (2004) Stem cells, embryos, and the environment: a context 
for both science and ethics. J Med Ethics, 30, 410-3. 
TSUYAMA, H., SHIMIZU, K., YOSHIMOTO, K., NEZUKA, H., ITO, H., YAMAMOTO, S., HASEBE, 
K., ONISHI, I., MURAOKA, K., NINOMIYA, I., TANI, T., HASHIMOTO, T., YAGI, M. & 
MIWA, K. (2000) Protective effect of ischemic preconditioning on hepatic ischemia-
reperfusion injury in mice. Transplant Proc, 32, 2310-3. 
TULL, S. P., ANDERSON, S. I., HUGHAN, S. C., WATSON, S. P., NASH, G. B. & RAINGER, G. E. 
(2006) Cellular pathology of atherosclerosis: smooth muscle cells promote adhesion 
of platelets to cocultured endothelial cells. Circ Res, 98, 98-104. 
VAANANEN, H. K. & LAITALA-LEINONEN, T. (2008) Osteoclast lineage and function. Arch 
Biochem Biophys, 473, 132-8. 
VAN DER MEIDE, P. H. & SCHELLEKENS, H. (1996) Cytokines and the immune response. 
Biotherapy, 8, 243-9. 
VAN MAANEN, C., WOUDA, W., SCHARES, G., VON BLUMRÖDER, D., CONRATHS, F. J., 
NORTON, R., WILLIAMS, D. J. L., ESTEBAN-REDONDO, I., INNES, E. A., MATTSSON, J. 
References 
243 
G., BJÖRKMAN, C., FERNÁNDEZ-GARCÍA, A., ORTEGA-MORA, L. M., MÜLLER, N., 
SAGER, H. & HEMPHILL, A. (2004) An interlaboratory comparison of 
immunohistochemistry and PCR methods for detection of Neospora caninum in 
bovine foetal tissues. Veterinary Parasitology, 126, 351-364. 
VAN PEL, M., VAN OS, R., VELDERS, G. A., HAGOORT, H., HEEGAARD, P. M., LINDLEY, I. J., 
WILLEMZE, R. & FIBBE, W. E. (2006) Serpina1 is a potent inhibitor of IL-8-induced 
hematopoietic stem cell mobilization. Proc Natl Acad Sci U S A, 103, 1469-74. 
VASCONCELOS, Z. F., DOS SANTOS, B. M., FARACHE, J., PALMEIRA, T. S., AREAL, R. B., 
CUNHA, J. M., BARCINSKI, M. A. & BONOMO, A. (2006) G-CSF-treated granulocytes 
inhibit acute graft-versus-host disease. Blood, 107, 2192-9. 
VASSILOPOULOS, G., WANG, P. R. & RUSSELL, D. W. (2003) Transplanted bone marrow 
regenerates liver by cell fusion. Nature, 422, 901-4. 
VERBEEK, M. M., WESTPHAL, J. R., RUITER, D. J. & DE WAAL, R. M. (1995) T lymphocyte 
adhesion to human brain pericytes is mediated via very late antigen-4/vascular cell 
adhesion molecule-1 interactions. J Immunol, 154, 5876-84. 
VINORES, S. A., XIAO, W. H., SHEN, J. & CAMPOCHIARO, P. A. (2007) TNF-alpha is critical for 
ischemia-induced leukostasis, but not retinal neovascularization nor VEGF-induced 
leakage. J Neuroimmunol, 182, 73-9. 
VOLLMAR, B., MENGER, M. D., GLASZ, J., LEIDERER, R. & MESSMER, K. (1994) Impact of 
leukocyte-endothelial cell interaction in hepatic ischemia-reperfusion injury. Am J 
Physiol, 267, G786-93. 
VOLLMAR, B., RICHTER, S. & MENGER, M. D. (1996) Leukocyte stasis in hepatic sinusoids. 
Am J Physiol, 270, G798-803. 
References 
244 
VOWINKEL, T., MORI, M., KRIEGLSTEIN, C. F., RUSSELL, J., SAIJO, F., BHARWANI, S., 
TURNAGE, R. H., DAVIDSON, W. S., TSO, P., GRANGER, D. N. & KALOGERIS, T. J. 
(2004) Apolipoprotein A-IV inhibits experimental colitis. J Clin Invest, 114, 260-9. 
WAGERS, A. J., SHERWOOD, R. I., CHRISTENSEN, J. L. & WEISSMAN, I. L. (2002) Little 
evidence for developmental plasticity of adult hematopoietic stem cells. Science, 
297, 2256-9. 
WAGNER, W., WEIN, F., RODERBURG, C., SAFFRICH, R., DIEHLMANN, A., ECKSTEIN, V. & HO, 
A. D. (2008) Adhesion of human hematopoietic progenitor cells to mesenchymal 
stromal cells involves CD44. Cells Tissues Organs, 188, 160-9. 
WALLACE, J. L., VERGNOLLE, N., MUSCARA, M. N., ASFAHA, S., CHAPMAN, K., MCKNIGHT, 
W., DEL SOLDATO, P., MORELLI, A. & FIORUCCI, S. (1999) Enhanced anti-
inflammatory effects of a nitric oxide-releasing derivative of mesalamine in rats. 
Gastroenterology, 117, 557-66. 
WANG, H. H., NANCE, D. M. & ORR, F. W. (1999) Murine hepatic microvascular adhesion 
molecule expression is inducible and has a zonal distribution. Clin Exp Metastasis, 
17, 149-55. 
WANG, S., DANGERFIELD, J. P., YOUNG, R. E. & NOURSHARGH, S. (2005) PECAM-1, alpha6 
integrins and neutrophil elastase cooperate in mediating neutrophil transmigration. 
J Cell Sci, 118, 2067-76. 
WANG, X., MONTINI, E., AL-DHALIMY, M., LAGASSE, E., FINEGOLD, M. & GROMPE, M. 
(2002) Kinetics of liver repopulation after bone marrow transplantation. Am J 
Pathol, 161, 565-74. 
References 
245 
WANG, X., WILLENBRING, H., AKKARI, Y., TORIMARU, Y., FOSTER, M., AL-DHALIMY, M., 
LAGASSE, E., FINEGOLD, M., OLSON, S. & GROMPE, M. (2003) Cell fusion is the 
principal source of bone-marrow-derived hepatocytes. Nature, 422, 897-901. 
WELNER, R. S., PELAYO, R. & KINCADE, P. W. (2008) Evolving views on the genealogy of B 
cells. Nat Rev Immunol, 8, 95-106. 
WILLENBRING, H., BAILEY, A. S., FOSTER, M., AKKARI, Y., DORRELL, C., OLSON, S., FINEGOLD, 
M., FLEMING, W. H. & GROMPE, M. (2004) Myelomonocytic cells are sufficient for 
therapeutic cell fusion in liver. Nature Medicine, 10, 744-8. 
WILSON, N. K., MIRANDA-SAAVEDRA, D., KINSTON, S., BONADIES, N., FOSTER, S. D., 
CALERO-NIETO, F., DAWSON, M. A., DONALDSON, I. J., DUMON, S., FRAMPTON, J., 
JANKY, R., SUN, X. H., TEICHMANN, S. A., BANNISTER, A. J. & GOTTGENS, B. (2009) 
The transcriptional program controlled by the stem cell leukemia gene Scl/Tal1 
during early embryonic hematopoietic development. Blood, 113, 5456-65. 
WOGNUM, A. W., EAVES, A. C. & THOMAS, T. E. (2003) Identification and isolation of 
hematopoietic stem cells. Arch Med Res, 34, 461-75. 
WOLLENBERG, G. K., LAMARRE, J. & HAYES, M. A. (1993) Cytokine interactions with α2-
Macroglobulin. IN MATUSCHAK, G. M. (Ed.) Multiple Systems Organ Failure. Informa 
Health Care. 
WRIGHT, D. E., WAGERS, A. J., GULATI, A. P., JOHNSON, F. L. & WEISSMAN, I. L. (2001) 
Physiological migration of hematopoietic stem and progenitor cells. Science, 294, 
1933-6. 
References 
246 
WU, Y., IP, J. E., HUANG, J., ZHANG, L., MATSUSHITA, K., LIEW, C. C., PRATT, R. E. & DZAU, V. 
J. (2006) Essential role of ICAM-1/CD18 in mediating EPC recruitment, angiogenesis, 
and repair to the infarcted myocardium. Circ Res, 99, 315-22. 
XU, H. L., SALTER-CID, L., LINNIK, M. D., WANG, E. Y., PAISANSATHAN, C. & PELLIGRINO, D. 
A. (2006) Vascular adhesion protein-1 plays an important role in postischemic 
inflammation and neuropathology in diabetic, estrogen-treated ovariectomized 
female rats subjected to transient forebrain ischemia. J Pharmacol Exp Ther, 317, 
19-29. 
YADAV, S. S., HOWELL, D. N., GAO, W., STEEBER, D. A., HARLAND, R. C. & CLAVIEN, P. A. 
(1998) L-selectin and ICAM-1 mediate reperfusion injury and neutrophil adhesion in 
the warm ischemic mouse liver. Am J Physiol, 275, G1341-52. 
YING, Q. L., NICHOLS, J., EVANS, E. P. & SMITH, A. G. (2002) Changing potency by 
spontaneous fusion. Nature, 416, 545-8. 
YOCUM, G. T., WILSON, L. B., ASHARI, P., JORDAN, E. K., FRANK, J. A. & ARBAB, A. S. (2005) 
Effect of human stem cells labeled with ferumoxides-poly-L-lysine on hematologic 
and biochemical measurements in rats. Radiology, 235, 547-52. 
YOSHIDA, M., HORIUCHI, T., UCHINAMI, M., TABO, T., KIMURA, N., YOKOMACHI, J., DOI, K., 
NAKAMURA, T., TAMAGAWA, K. & TANAKA, K. (2003) Intermittent hepatic ischemia-
reperfusion minimizes liver metastasis in rats. J Surg Res, 111, 255-60. 
YOSHIDA, T., HAKUBA, N., MORIZANE, I., FUJITA, K., CAO, F., ZHU, P., UCHIDA, N., KAMEDA, 
K., SAKANAKA, M., GYO, K. & HATA, R. (2007) Hematopoietic stem cells prevent hair 
cell death after transient cochlear ischemia through paracrine effects. Neuroscience, 
145, 923-30. 
References 
247 
YOSHIDOME, H., KATO, A., EDWARDS, M. J. & LENTSCH, A. B. (1999) Interleukin-10 
suppresses hepatic ischemia/reperfusion injury in mice: implications of a central 
role for nuclear factor kappaB. Hepatology, 30, 203-8. 
YU, J. J. & GAFFEN, S. L. (2008) Interleukin-17: a novel inflammatory cytokine that bridges 
innate and adaptive immunity. Front Biosci, 13, 170-7. 
ZANJANI, E. D., ASCENSAO, J. L., HARRISON, M. R. & TAVASSOLI, M. (1992) Ex vivo 
incubation with growth factors enhances the engraftment of fetal hematopoietic 
cells transplanted in sheep fetuses. Blood, 79, 3045-9. 
ZHANG, C. C. & LODISH, H. F. (2005) Murine hematopoietic stem cells change their surface 
phenotype during ex vivo expansion. Blood, 105, 4314-20. 
ZHANG, R. L., CHOPP, M., ZHANG, Z. G., PHILLIPS, M. L., ROSENBLOOM, C. L., CRUZ, R. & 
MANNING, A. (1996) E-selectin in focal cerebral ischemia and reperfusion in the rat. 
J Cereb Blood Flow Metab, 16, 1126-36. 
ZHANG, S., SHPALL, E., WILLERSON, J. T. & YEH, E. T. (2007) Fusion of human hematopoietic 
progenitor cells and murine cardiomyocytes is mediated by alpha 4 beta 1 
integrin/vascular cell adhesion molecule-1 interaction. Circ Res, 100, 693-702. 
ZHANG, Y., WOODWARD, V. K., SHELTON, J. M., RICHARDSON, J. A., ZHOU, X. J., LINK, D., 
KIELAR, M. L., JEYARAJAH, D. R. & LU, C. Y. (2004) Ischemia-reperfusion induces G-
CSF gene expression by renal medullary thick ascending limb cells in vivo and in 
vitro. Am J Physiol Renal Physiol, 286, F1193-201. 
ZHAO, Y., KAVANAGH, D. P. J., THYSSE, J. & KALIA, N. (2008) Factors contributing to 
hematopoietic stem cell recruitment to murine cremaster microcirculation 
[Abstract]. Microcirculation [In Press], Abstract PC71. 
References 
248 
ZHU, H., MITSUHASHI, N., KLEIN, A., BARSKY, L. W., WEINBERG, K., BARR, M. L., 
DEMETRIOU, A. & WU, G. D. (2006) The role of the hyaluronan receptor CD44 in 
mesenchymal stem cell migration in the extracellular matrix. Stem Cells, 24, 928-35. 
ZHUO, L., KANAMORI, A., KANNAGI, R., ITANO, N., WU, J., HAMAGUCHI, M., ISHIGURO, N. & 
KIMATA, K. (2006) SHAP potentiates the CD44-mediated leukocyte adhesion to the 
hyaluronan substratum. J Biol Chem, 281, 20303-14. 
ZOLLNER, O. & VESTWEBER, D. (1996) The E-selectin ligand-1 is selectively activated in 
Chinese hamster ovary cells by the alpha(1,3)-fucosyltransferases IV and VII. J Biol 
Chem, 271, 33002-8. 
ZUBA-SURMA, E. K., KUCIA, M., ABDEL-LATIF, A., DAWN, B., HALL, B., SINGH, R., LILLARD, J. 
W. & RATAJCZAK, M. Z. (2008) Morphological characterization of very small 
embryonic-like stem cells (VSELs) by ImageStream system analysis. J Cell Mol Med, 
12, 292-303. 
ZUND, G., DZUS, A. L., MCGUIRK, D. K., BREUER, C., SHINOKA, T., MAYER, J. E. & COLGAN, S. 
P. (1996) Hypoxic stress alone does not modulate endothelial surface expression of 
bovine E-selectin and intercellular adhesion molecule-1 (ICAM-1). Swiss Surg Suppl, 
Suppl 1, 41-5. 
 
 
